Svoboda | Graniru | BBC Russia | Golosameriki | Facebook
Next Article in Journal
Phenylethanol Glycoside from Cistanche tubulosa Attenuates BSA-Induced Liver Fibrosis in Rats by Modulating the Gut Microbiota–Liver Axis
Previous Article in Journal
Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease
Previous Article in Special Issue
Decreased Risk of Osteoporosis Incident in Subjects Receiving Chinese Herbal Medicine for Sjögren syndrome Treatment: A Retrospective Cohort Study with a Nested Case-Control Analysis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceuticals
Volume 17
Issue 9
10.3390/ph17091148
pharmaceuticals-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Nutritional Epigenomics: Bioactive Dietary Compounds in the Epigenetic Regulation of Osteoarthritis

by
Karla Mariuxi Villagrán-Andrade
1,
Carmen Núñez-Carro
1,
Francisco J. Blanco
1,2 and
María C. de Andrés
1,*
1
Unidad de Epigenética, Grupo de Investigación en Reumatología (GIR), Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario, de A Coruña (CHUAC), Sergas, 15006 A Coruña, Spain
2
Grupo de Investigación en Reumatología y Salud, Departamento de Fisioterapia, Medicina y Ciencias Biomédicas, Facultad de Fisioterapia, Campus de Oza, Universidade da Coruña (UDC), 15008 A Coruña, Spain
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2024, 17(9), 1148; https://doi.org/10.3390/ph17091148
Submission received: 31 July 2024 / Revised: 24 August 2024 / Accepted: 27 August 2024 / Published: 30 August 2024
(This article belongs to the Special Issue Natural Products for the Treatment of Rheumatic Diseases)
Browse Figures
Review Reports Versions Notes

Abstract

:
Nutritional epigenomics is exceptionally important because it describes the complex interactions among food compounds and epigenome modifications. Phytonutrients or bioactive compounds, which are secondary metabolites of plants, can protect against osteoarthritis by suppressing the expression of inflammatory and catabolic mediators, modulating epigenetic changes in DNA methylation, and the histone or chromatin remodelling of key inflammatory genes and noncoding RNAs. The combination of natural epigenetic modulators is crucial because of their additive and synergistic effects, safety and therapeutic efficacy, and lower adverse effects than conventional pharmacology in the treatment of osteoarthritis. In this review, we have summarized the chondroprotective properties of bioactive compounds used for the management, treatment, or prevention of osteoarthritis in both human and animal studies. However, further research is needed into bioactive compounds used as epigenetic modulators in osteoarthritis, in order to determine their potential value for future clinical applications in osteoarthritic patients as well as their relation with the genomic and nutritional environment, in order to personalize food and nutrition together with disease prevention.

1. Osteoarthritis, a Chronic Disease

Osteoarthritis (OA) is one of the most common disabling chronic progressive diseases in middle-aged and elderly people [1,2], and it is among the main public health problems worldwide, due to its high prevalence [3]. The main characteristics of OA are articular cartilage deterioration, subchondral bone remodelling, the formation of osteophytes, joint space reduction, and synovitis [4]. Symptoms generally include severe joint pain, stiffness, joint contractures, muscle atrophy, reduced movement, swelling, tenderness, and variable degrees of local inflammation, limb deformity and crepitus [5]. There are many etiological factors for OA, including genetic predisposition, dietary intake, obesity, sex, aging, traumatic joint injury, mechanical stress, metabolic disease, and sedentary lifestyle [6]. It is important to highlight the synergistic effects of pathologies such as cardiovascular disease and obesity coexisting with OA [7,8].
Pharmacological treatments such as paracetamol, nonsteroidal anti-inflammatory drugs, tramadol, and opioids are used to reduce pain and inflammation, but do not prevent, reverse or cure OA [9]. However, a long-term use of these drugs to relieve OA is associated with substantial gastrointestinal, renal, hepatic, blood, cardiovascular, and cerebrovascular adverse effects [10,11,12]. In this review, we present the importance of a healthy diet in preventing the development or progression of OA, and summarize chondroprotective properties and beneficial epigenetic modifications of bioactive compounds or nutraceuticals against inflammation and catabolic activity in OA.

2. Epigenetics and Osteoarthritis

Over the last 20 years, the study of epigenetics has expanded (especially in the cancer field). However, studies on the importance of epigenetic mechanisms in OA are only now increasing. Roach and collaborators provided the first evidence of how epigenetic changes, such as DNA methylation, may relate to the pathogenesis of OA and can be potentially reversible [13].
Epigenetics can be defined as heritable changes in gene expression and/or phenotype that can occur without changes in the primary DNA sequence [14]. The epigenome of each cell is unique and can undergo temporal changes in response to environmental factors such as diet, physical activity, smoking, pollutants and disease status [15]. OA is distinguished by the unfavorable dynamic regulation of gene transcription in joint tissues due to environmental disturbances; therefore, epigenetics has developed as a new and important area for OA research [16,17,18]. Candidate gene and epigenome-wide studies have demonstrated their association with OA development and progression through epigenetic modifications, and these epigenetic mechanisms can change in response to stimuli and, in some cases, pass on to future generations [19,20,21]. Given the importance of gene expression or silencing, and associated epigenetic modifications, we will briefly mention various epigenetic mechanisms of pro-inflammatory cytokines and metalloproteinases (MMPs) that contribute to cartilage destruction. Three main mechanisms are implicated in epigenetic regulation: (1) DNA methylation changes that covalently alter chromatin structure. In general, DNA hypomethylation enhances gene transcription, and DNA hypermethylation suppresses gene transcription. (2) The post-translational modification of histones that alters chromatin conformation, including the methylation of arginine and lysine, the acetylation of lysines, the phosphorylation of serine and treonine, and the sumoylation and ubiquitination of lysine. (3) Non-coding RNAs regulate gene expression but do not translate into proteins (i.e., microRNAs (miRNAs), long non-coding RNAs) acting at both transcriptional and post-transcriptional levels [22,23,24].

2.1. DNA Methylation

The DNA methylation process is mediated by DNA methyltransferases (DNMTs), including DNMT1 (maintenance), DNMT3A and DNMT3B (de novo), and involves the addition of a methyl group to the 5′ position of cytosine, which most commonly occurs in CpG dinucleotides, forming 5-methylcytosine. The hypermethylation by DNMTs leads to transcriptional gene silencing and gene inactivation [22,23].
Nakano and collaborators found that DNMT1 and DNMT3A expressions were decreased by IL-1β, while DNMT3A also decreased its expression and activity, caused by the TNF-α in fibroblast-like synoviocytes [25]. Both DNA methylation and histone modification are involved in the control of TNF-α expression [26]. Hashimoto and collaborators found that the methylation of the −115 CpG site enhances MMP13 promoter activity as opposed to the inhibitory effect of −110 CpG methylation; also, the demethylation of the specific CpG sites at the −299 position of the IL1B promoter activity correlates with enhanced IL1B gene expression in human primary chondrocytes [27,28]. Furthermore, Bui and collaborators showed that the −104 CpG site is demethylated in OA cartilage, and this is accompanied by elevated MMP13 expression [29]. In articular cartilage, the methylation of cytosines at positions −1680 and −1674 blocks COL10A1 expression in chondrocytes, while gene expression is activated during chondrogenesis in cells, with the partial methylation of these two specific CpG sites [30]. Cheung and collaborators found that DNA demethylation at one or more specific CpG sites in the ADAMTS4 promoter corresponds to the increased expression of ADAMTS4 in human OA chondrocytes, which plays a role in aggrecan degradation in OA [31]. In addition, Roach and collaborators showed an association between the loss of DNA methylation of CpG sites in the promoters and the abnormal expression of MMP3, MMP9, MMP13, and ADAMTS4 by OA chondrocytes [13]. Besides this, the sclerotin (SOST) mRNA and protein expression levels are increased in OA chondrocytes, suggesting the SOST promoter is hypermethylated in normal chondrocytes and hypomethylated in OA [32]. An interesting study suggests that hip OA is associated with reduced SOX9 gene and protein expression, having showed that that the methylation of the SOX9 promoter was increased in OA cartilage [33]. Imagawa and collaborators reported that COL9A1 promoter activity is significantly decreased by DNA hypermethylation, and could be reversed through the inhibition of DNA methylation. In addition, the abnormal DNA methylation of the CpG sites in the COL9A1 promoter is associated with the decreased expression of SOX9 [34]. Moreover, hypomethylation in the IL8 promoter is correlated with higher IL8 gene expression in OA chondrocytes; a significant increase in IL8 promoter activity by the transcription factors NF-κB, AP-1 and C/EBP was also shown [35]. de Andrés and collaborators demonstrated the association between an increase in inducible nitric oxide synthase (NOS2) gene expression in OA chondrocytes and the demethylation of NF-κB responsive enhancer elements [36]. Furthermore, in OA, synovial fibroblasts showed DNA hypomethylation and histone hyperacetylation in the IL6 promoter [37].

2.2. Histone Modifications

Methylation/demethylation and acetylation/deacetylation are the main and recurrent histone changes in OA [38]. Two families of enzymes catalyze the modification of histones: histone methyltransferases (HMTs) and histone demethylases (HDMTs), or acetyltransferases (HATs) and histone deacetylases (HDACs) [39]. The majority of these modifications take place in lysine, arginine and serine residues within the histone tails, and regulate key cellular processes such as transcription, replication and repair [40]. The hyperacetylation of histone tails induces transcriptional activation, while hypoacetylation is associated with transcriptional repression [41]. HDAC family members have been associated with OA, and HDAC inhibitors (HDACi) can protect chondrocytes and prevent cartilage damage, while possessing therapeutic potential against OA [15,42]. Young and collaborators demonstrated that HDACi decreased the expression and activity of MMPs and ADAMTSs [43]. In addition, histone deacetylase-1 (HDAC1) and HDAC2 levels are elevated in both chondrocytes and synovium from OA patients compared to controls [44,45]. Higashiyama and collaborators demonstrated the increased expression of HDAC7 in human OA cartilage, which was correlated with elevated MMP13 gene expression, contributing to cartilage degradation [46]. Class III HDACs (sirtuins) are a class of NAD+-dependent histone deacetylases that differ from the class I and II HDACs. Sirtuin 1 (SIRT-1) is a positive regulator of cartilage-specific gene expression in chondrocytes [47]. SIRT-1 activation has the potential to prevent cartilage damage and inhibit its destruction [48,49]. SIRT-1 suppresses protein tyrosine phosphatase 1B and activates the insulin-like growth factor (IGF) receptor pathway, enhancing the survival of chondrocytes [50]. Also, the decreased expression of COL2A1 mRNA and type II collagen protein correlates with decreased SIRT1 activity [51]. In addition, in OA cartilage, the overexpression of E74-like factor 3 (ELF3) inhibited Sox9/cAMP-response element-binding (CREB) protein (CBP)-driven HAT activity, and decreased COL2A1 [52]. The disruptor of telomeric silencing, the 1-like (DOT1L) gene (an HMT), is a protector of cartilage health, and as such is reduced in damaged areas of OA joints; the protective function of DOT1L is attributable to Wnt signalling inhibition [53,54].

2.3. Non-Coding RNA (ncRNAs)

ncRNAs, including small non-coding RNAs (miRNA) and long non-coding RNAs (lncRNAs), have the ability to regulate gene expression at both transcriptional (lncRNAs) and post-transcriptional levels (small and lncRNAs) [55]. lncRNAs are key regulators of gene expression; thus, the overexpression of lncRNA-CIR increases the expression of MMPs, whereas collagen and aggrecan expression are reduced in OA cartilage [56]. Small ncRNA mainly includes miRNAs, siRNAs and piRNAs. miRNAs have historically been the most frequently investigated; they are considered an alternative mechanism of post-transcriptional or translational regulation. At the post-transcriptional level, they bind to complementary mRNA, leading to the degradation of mRNA or the prevention of its translation into a protein [55,57,58,59]. Several miRNAs have shown altered expressions in OA, and are involved in various aspects of cartilage homeostasis and OA pathogenesis [60]. Rasheed and collaborators showed that IL-1β-induced iNOS gene expression is correlated with the down-regulation of miR-26a-5p in human OA chondrocytes [61]. Furthermore, miRNAs such as miR-320, miR-381, miR-9, miR-602, miR-608, miR-127-5p, miR-140, miR-27b, miR-98 and miR-146 play a significant role in the regulation of genes relevant to OA pathogenesis [59]. In another study, the overexpression of miR-27b inhibited IL-1β-stimulated MMP13 gene and protein expression in human OA chondrocytes [62]. Moreover, the overexpression of miR-558 directly inhibited COX2 mRNA and protein expression [63]. Also, miR-199a levels are inversely correlated with COX2 mRNA and protein levels in IL-1β-stimulated human chondrocytes [64]. There is a relationship between HDACs and miRNA in OA; thus, the overexpression of miR-92a-3p suppressed HDAC2 production and increased the level of histone H3 acetylation of the COMP/ACAN/COL2A1 promoter [65]. The overexpression of miR-193b-3p inhibited HDAC3 expression, enhanced histone H3 hyperacetylation, and increased the expressions of SOX9, COL2A1, ACAN, and COMP in chondrocytes [66]. Guan and collaborators showed that miR-146a protects against OA, inhibiting inflammatory factors [67]. In addition, a study demonstrated the significant increase in miR-146a expression that was induced by the HDAC inhibitors in OA-fibroblast-like synoviocytes [68]. Another study demonstrated that miR-146b is downregulated in the chondrogenic differentiation of human stem cells, and upregulated in OA [69]. The overexpression of miR193b-5p inhibited HDAC7 expression and decreased MMP3 and MMP13 expression [70]. Both miR-199a-3p and miR-193b expressions are upregulated with age, and may be involved in chondrocyte senescence by downregulating anabolic factors such as type 2 collagen, aggrecan, and SOX9; therefore, they may be involved in cartilage degeneration [71]. In addition, the increases in TNFA, IL1B and IL6 gene expression were correlated with miR-149 downregulation through the inhibition of post-transcriptional control in human OA chondrocytes [72]. miR-140, the most well-studied miRNA in OA, plays a protective role in OA development. It is important for chondrogenesis and osteogenesis, and is highly expressed in normal cartilage, but its expression levels are decreased in OA chondrocytes; its overexpression could inhibit inflammation and cartilage degradation [73,74,75,76,77]. A study showed that miR-140 is specifically expressed in cartilage tissues during mouse embryonic development, and that siRNA-140 significantly downregulated the accumulation of the Hdac4 protein in fibroblast cells [78]. Further, miR-140-3p and its isomiRs (miR-140-3p.1 and miR-140-3p.2) are abundantly expressed in cartilage [79]. Decreased miR-let7e expression has been suggested as a potential predictor of hip OA [57,80]. The increase in miR-145 levels directly represses SOX9 expression, resulting in the inhibition of COL2A1 and ACAN, with increased expressions of RUNX2 and MMP13 in human chondrocytes [81].

3. Inflammation and Diet

Inflammation is a complex biological response of the immune system to pathogens, damaged cells, injury, toxic compounds, and infection. The immune system utilizes a large number of specialized cells, such as lymphocyte, monocytes and macrophages, to restore homeostasis [82,83,84]. Inflammation is an important pathway in OA pathogenesis and development [85,86]. Inflammation in OA joints is chronic and low-grade, and involves the interplay of the innate immune system and inflammatory mediators [85,87,88]. These include cytokines, chemokines, growth factors, adipokines, prostaglandins, leukotrienes, nitric oxide, and neuropeptides [87,89]. Strikingly, reductions in this low-grade inflammation are closely linked with a greater adherence to healthier diets, such us the Mediterranean diet [90,91,92].
Diet plays an important role in the development or prevention of many chronic diseases [93,94], and may regulate chronic inflammation, improving quality of life [95,96,97]. Thus, dietary composition is able to modulate epigenetic markers such as changes in DNA methylation, the histone or chromatin remodelling of key inflammatory genes, and ncRNAs that may be causal for the development of chronic diseases or beneficial against inflammation; in this way, it can block, retard, or reverse pathologic processes [98,99,100,101,102].
A diet with high a dietary inflammatory index (DII) score has been associated with severe pain and lower quality of life in patients with knee OA [103,104]. Another study showed that the energy-adjusted DII (E-DII) score was associated with a high risk of knee OA in the osteoarthritis initiative (OAI) cohort [105]. The DII has been used to predict inflammatory biomarkers [103,106]. Biomarkers of inflammation, especially serum C-reactive protein (CRP), IL-6, TNF-α and MMPs, have been associated with pain and the progression of OA [107,108,109,110]. Dyer and collaborators showed that biomarkers of inflammation and cartilage degradation related to OA were lower with greater uptake of the Mediterranean diet [111]. In addition, several studies have found that a better quality of life is associated with a higher adherence to this diet [112,113,114,115]. Veronesse and collaborators, in a large cohort of North Americans from the OAI database, demonstrated that a greater adherence to the Mediterranean diet is associated with better quality of life, which is correlated with less pain, disability and depression, better cognitive performance, and better physical functioning [116]. The adherence to the Mediterranean diet was assessed in these studies according to the Mediterranean diet score by established Panagiotakos [117], based on a food frequency questionnaire [118]. Strikingly, greater adherence to the Mediterranean diet is associated with a lower prevalence of knee OA [119]. A high adherence to this diet increases the antioxidant levels in serum samples, with a reduction in oxidative stress biomarkers levels [120,121], such as F2-isoprostane, an indicator of oxidative stress in plasma [122]. Moreover, Martín-Núñez and collaborators found a correlation between lower adherence to the Mediterranean diet pattern and changes in DNA methylation levels and diseases [123].

4. Bioactive Compounds: Health-Protective Benefits

The complex biological activities of plants can promote their abundance in secondary metabolites or bioactive compounds, and they are also known as phytonutrients or nutraceuticals. These bioactive compounds are widely known for their unique medicinal properties; they possess antimicrobial [124], anti-inflammatory [125], antiviral [126,127], cardioprotective [128], neuroprotective [129], chemopreventive [130], phytohormone [131], and antioxidant properties [132]. Multiple pathological processes are involved in the pathogenesis of OA, such as inflammation, oxidative stress, apoptosis, autophagy and senescence; hence, phytochemical or bioactive compounds have been used as therapeutic and nutraceutical agents, showing their antiarthritic potential. They mainly exert anti-inflammatory effects through the blockade of pro-inflammatory cytokines (IL1-β, IL-6, IL-8, TNF-α), the inhibition of the NF-κB pathway, antiapoptotic effects, the prevention of oxidative damage to proteins and DNA (reduction in both reactive oxygen species (ROS) and reactive nitrogen species), suppression of the production of prostaglandins and leukotrienes, and reductions in levels of MMPs [133,134,135,136,137].
Bioactive phytochemicals feature a wide variety of compounds, and are classified into phenolics, alkaloids, organosulfur compounds, terpenes and terpenoids, among others, with each class divided into further classes (Figure 1). They are present in fruits, vegetables and spices, and can modify metabolic, cellular, molecular, and epigenetic processes [138]. Polyphenols represent the largest and most ubiquitous group of natural phytochemicals structures; these compounds are present in fruits, vegetables, cereals, tea, dark chocolate, cocoa powder, coffee, extra virgin oil, and wine [139,140,141]. The main groups of polyphenols are flavonoids, phenolic acids, and secoiridoids, among others. Flavonoids a lone comprise more than 10,000 natural compounds, including anthocyanidins, proanthocyanidins flavones, flavanones, flavonols, isoflavones and flavan-3-ols [142,143,144,145].
In this review, a total of 85 bioactive compounds and nutraceuticals with potential anti-OA properties were analysed for use in the management, treatment, or prevention of OA in both humans (Table 1) and animals (Table 2).
In OA, most studied bioactive compounds are curcuminoids [164,165,166,167,168,169,170,171,172,173,174,175,176,177,178,179,180,181,182,183,184,274,275,276,277,278,279], epigallocatechin-3-O-gallate [187,188,189,190,191,192,193], hydroxytyrosol [208,209,210,296], icariin [298,299,300,301,302], oleuropein [223,224], resveratrol [228,229,230,231,232,233,234,321,322,323,324] and sulfuronate [238,239,240,241,242,243]. The most common effects founded in vitro are related to decreased inflammatory and cartilage degradation markers, like MMPs, NO, PGE2 or ROS. On the other hand, in vivo effects observed in OA-induced animal models are critically linked to the reduction in symptoms at the joint level (cartilage, synovium and subchondral bone). Finally, case studies were carried out in humans, showing alleviated pain and enhanced quality of life among other symptoms. Several case studies showed interesting results compared to the conventional analgesic therapy taken by OA patients, especially curcuminoids. It has been proven that they can be as efficacious as ibuprofen [168,169], show potential beneficial effects when used as an adjuvant therapy with diclofenac [170] and meloxican [229] and an alternative therapy for those intolerants to diclofenac’s side effects [171], reduce the use of NSAIDs and gastrointestinal complications [178], and lower adverse effects compared to diacerhein [205,206].
Regarding bioactive compounds’ applications, there are important considerations to take into account: (i) it will be crucial to increase their stability and bioavailability, especially for clinical applications; (ii) a deep understanding must be developed of the underlying molecular mechanisms to increase their bioactivity; and (iii) we must investigate their long-term toxicity and possible side effects.

5. Nutritional Epigenomics: Bioactive Compounds in Dietary Balance and Health

Nutritional epigenomics is exceptionally important because it holds great potential in the prevention, suppression and therapy of a wide variety of diseases by altering various epigenetic factors. This novel field involves the lifelong remodelling of our epigenomes, even during cellular differentiation in embryonic and foetal development, by nutritional factors; it also describes how the bioactive molecules can influence and modify gene expression at the transcriptional level [336,337,338,339]. For example, DNA methylation depends on the methyl group donors and cofactors found in foods, thus dietary excess or deficiencies in a critical and sensitive period like embryogenesis can alter the methylation process and gene expression, and therefore the metabolism and physiology of the individual, programming pathologic processes during a lifetime [340,341]. Jirtle and Skinner observed that hypermethylating dietary compounds could reduce the effects of environmental toxicants that cause DNA hypomethylation [342]. An interesting study on Apis mellifera, into the different honeybee phenotypes, demonstrated that silencing Dnmt3 gene expression decreased methylation in the dynactin p62 gene in larval heads, which led to an increase in the number of queens and a reduction in the number of workers; these epigenetic changes in DNA methylation depended on whether they were fed royal jelly or beebread [343].
Wolff and collaborators provided some of the first evidence that maternal nutrition can impact the epigenome and phenotype of the offspring of dams fed with folate-supplemented diets; this nutrition affected agouti gene expression in Avy/a mice and caused a wide variation in coat colour, ranging from yellow (unmethylated) to light brown (methylated). Pseudoagouti Avy/a brown mice were lean, healthy, and longer-lived than their yellow phenotype siblings (larger, obese, hyperinsulinemic, more susceptible to cancer) [344]. Furthermore, in macaques that were fed a high-fat diet during pregnancy (predisposing offspring to metabolic syndrome), foetal offspring had increased H3 acetylation and decreased Hdac1 gene expression in the liver compared to macaques fed with a low-fat diet [345]. An experimental study in Agouti Avy/a mice fed with genistein (a soy polyphenol), which acts during early embryonic development, showed that genistein-induced hypermethylation persisted into adulthood, by altering the epigenome, decreasing ectopic agouti expression, and protecting offspring from obesity, diabetes, and cancer across multiple generations [346]. In addition, experimental data have shown that the maternal consumption of dietary polyphenols such as resveratrol during preconception, gestation and lactation ameliorated metabolic programming. Resveratrol reduced renal oxidative stress, activated nutrient-sensing signals, modulated gut microbiota, and prevented associated high-fructose-intake-induced programmed hypertension in the rat offspring [347].
The four primary targets for epigenetic therapy are DNMTs, HDACs, HATs and miRNA; thereby, numerous bioactive compounds such as sulforaphane, tea polyphenols, ellagic acid, genistein, curcumin, hydroxytyrosol, resveratrol, organosulfur compound, oleanolic acid, and alkaloids have been studied as potent agents for regulating epigenetic mechanisms [102,339,348]. Bioactive compounds can influence epigenetic processes through different mechanisms that interfere with the 1-carbon metabolism and affect S-adenosyl methionine (SAM) levels, meaning they are able to modulate DNA and histone methylation [349]. Many polyphenols, such as quercetin, fisetin, and myricetin, inhibit DNMT by decreasing SAM and increasing S-adenosyl-L-homocysteine (SAH) and homocysteine levels [350].
Global DNA hypomethylation has been associated with the hypermethylation and inactivation of specific genes [351], thus the hypermethylation of cytidine by DNMTs usually results in transcriptional gene silencing and gene inactivation, including of tumour-suppressor genes, while promoters of transcriptionally active genes typically remain hypomethylated [352]. Genes such as O6-methylguanine methyltransferase, retinoic acid receptor β (RARB), the tumour-suppressor p16INK4a, and the DNA repair gene human mutL homologue 1 (hMLH1) were shown to be frequently inactivated by hypermethylation, and polyphenols such as epigallocatechin-3-gallate and genistein from soybean were demonstrated to be strong DNMT-inhibitors, leading to the demethylation and reactivation of methylation-silenced genes [353]. DNMTs do not act alone, and they also recruit HDACs to synergistically repress gene transcription [354].
The combination of bioactive compounds acting as DNMT inhibitors, together with phytochemicals that can alter histone modifications, and those that can influence miRNAs expression in OA, are all potentially more synergistic and significant approaches when used as therapeutical strategies to prevent and treat various diseases, including cancer [355,356]. In this context of nutriepigenomics, we have specifically analysed the epigenetic mechanisms related to 12 bioactive compounds, focusing on the prevention or treatment of OA in both humans (Table 3) and animals (Table 4).
Few (but insightful) studies have shown the epigenetic effects of bioactive compounds in OA. The majority of studies are focused on curcuminoids [377,378,379], epigallocatechin-3-O-gallate [361,362,363], hydroxytyrosol [365,366,367,368,381], oleanoic acid [369,370] and resveratrol [372,373,374,375,385,386,387]. By far, the most studied epigenetic mechanisms are miRNAs, which are generally linked to the regulation of inflammatory and cartilage degradation markers. Sirtuins are also well explored in the context of OA.

6. Conclusions

In this review, we analysed the importance of bioactive compounds as epigenetic modulators in the prevention and treatment of OA. The reduction in inflammation, as well as catabolic and oxidative activity, is essential in OA treatment. Bioactive compounds or nutraceuticals can directly protect and repair DNA damage, modulating signalling pathways and genes implicated in OA pathogenesis or modifying intra- and extracellular activities. Bioactive compounds are potentially capable of reversing the phenotype of OA chondrocytes. Moreover, the combination of bioactive compounds that act as DNMT inhibitors together with HDAC inhibitors, HAT inhibitors or activators, and miRNA regulators offer more synergistic potential approaches with significance in preventing and treating OA (Figure 2).
Several mixtures have also demonstrated the additive and synergistic potential of bioactive compounds; these mixtures enhanced their chondroprotective properties via anti-inflammatory mechanisms, and reducing oxidative stress. Bioactive compounds are also effective in reducing pain and decreasing the need for NSAIDs, with fewer adverse effects that provide safety and therapeutic efficacy in OA treatment. In addition, new formulations of bioactive compounds have been developed for example with nanoparticles; these phytonutraceuticals possess higher absorption and bioavailability and, could serve as a therapeutic strategy in the prevention and treatment of OA. However, the potential of bioactive compounds as epigenetic regulators in OA has been little studied; further research is needed towards this promising area of research. For this reason, the proposal nutriepigenomic arises and focusses on the ability of numerous bioactive compounds as an alternative to prevent or treat OA.
Future perspectives of bioactive dietary compounds in OA are mainly preventive more than therapeutic. Mostly because the effects of these natural products probably are very small during short periods of time; however, they could be effective when consumed continuously as part of the diet. This indeed could be crucial for a disease like OA, where prevention before symptoms appear is key to stop the progression of the disease. Finally, it will be critical to identify biomarkers to test the efficacy of bioactive compounds at both inter-individual and population levels.

Author Contributions

Conceptualisation, K.M.V.-A. and M.C.d.A.; methodology, K.M.V.-A. and C.N.-C.; investigation, K.M.V.-A. and C.N.-C.; resources, F.J.B.; writing—original draft preparation, K.M.V.-A.; writing—review and editing, K.M.V.-A., C.N.-C., F.J.B. and M.C.d.A.; supervision, M.C.d.A.; project administration, M.C.d.A.; funding acquisition, M.C.d.A. All authors have read and agreed to the published version of the manuscript.

Funding

This study has been funded by Instituto de Salud Carlos III (ISCIII) through the projects “PI19/01213” and “RICORSREI-RD21/0002/0009”, and co-funded by the European Union; and grants IN607D2022/12 and IN607A2021/07 from Xunta de Galicia, Axencia Galega de Innovación GAIN.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

ACANaggrecan
ACTLanterior cruciate ligament transection
ADAMTSa disintegrin and metalloproteinase with thrombospondin motifs
AKTa serine/threonine protein kinase
ALPalkaline phosphatase
AP-1activator protein 1
BAXBcl-2-associated X protein
BCL-2B cell lymphoma-2
BMSCbone marrow stromal cells
C/EBPCCAAT/enhancer-binding protein
CASPcaspase
c-FOSfos proto-oncogene
COLcollagen
COMPcartilage oligomeric matrix protein
COX2clyclooxygenase 2
CRPC-reactive protein
DHAdocosahexaenoic acid
DMSOdimethylsulphoxide
DNMTDNA methyltransferase
DOT1Ldisruptor of telomeric silencing 1-like
ECMextracellular matrix
EPAeicosapentaenoic acid
ERendoplasmatic reticulum
ERKextracellular signal-regulated kinase
FLSfibroblast-like synoviocytes
FOXOforkhead box O
GAGglycosaminoglycan
HAThistone acetyltransferase
HDAChistone deacetylases
HDMThistone demethylase
HIFhypoxia Inducible factor
hMSCshuman mesenchymal stem cells
HO-1heme oxygenase 1
HSP90Bheat shock protein 90-beta
HThydroxytyrosol
HTMhistone methyltransferase
IKKikappaB kinase
ILinterleuquin
iNOSinducible nitric oxyde synthase
JNKjun N-terminal kinase
lncRNAlong non-coding RNA
LPSlipopolysaccharides
MAPKmitogen-activated protein kinases
MIAmonosodium iodoacetate
miRNAmicroRNA
MMPmetalloproteinase
NF-ĸBnuclear factor kappa-light-chain-enhancer of activated B cells
NLRP3nucleotide-binding domain, leucine-rich–containing family, pyrin domain–containing-3
NOnitric oxide
NOSnitric oxide synthase
NRF2nuclear factor erythroid 2–related factor 2
NSAIDnon-steroidal anti-inflammatory drugs
OAosteoarthritis
OACOA chondrocyte
OARSIosteoarthritis research society international
OCNosteocalcin
OPNosteopontin
OSMoncostatin M
PARPpoly-ADP ribose polymerase
PGproteoglycan
PGE2prostaglandin E2
PPAR-γperoxisome proliferator-activated receptor gamma
PTENphosphatase and tensin homolog
PUFApolyunsaturated fatty acids
RANKLreceptor activator of nuclear factor kappa beta ligand
RESresveratrol
ROSReactive oxygen species
RUNX2receptor activator of nuclear factor kappa-Β ligand
SIRTsirtuin
SOSTsclerostin
SOX9SRY-Box Transcription Factor 9
SSDsaikosaponin D
STATsignal transducer and activator of transcription
TGF-β1transforming growth factor beta-1
TIMPtissue inhibitor of metalloproteinase
TLR4toll-like receptor 4
TNF-αtumoral necrosis factor alpha
VASvisual analog scale
VEGFvascular endothelial growth factor
WOMACWestern Ontario and McMaster Universities Arthritis Index

References

  1. Buckwalter, J.A.; Martin, J.A. Osteoarthritis. Adv. Drug Deliv. Rev. 2006, 58, 150–167. [Google Scholar] [CrossRef] [PubMed]
  2. Brooks, P.M. Impact of osteoarthritis on individuals and society: How much disability? Social consequences and health economic implications. Curr. Opin. Rheumatol. 2002, 14, 573–577. [Google Scholar] [CrossRef]
  3. Pereira, D.; Peleteiro, B.; Araújo, J.; Branco, J.; Santos, R.A.; Ramos, E. The effect of osteoarthritis definition on prevalence and incidence estimates: A systematic review. Osteoarthr. Cartil. 2011, 19, 1270–1285. [Google Scholar] [CrossRef]
  4. Malemud, C.J. Biologic basis of osteoarthritis: State of the evidence. Curr. Opin. Rheumatol. 2015, 27, 289–294. [Google Scholar] [CrossRef] [PubMed]
  5. Dieppe, P.A.; Lohmander, L.S. Pathogenesis and management of pain in osteoarthritis. Lancet 2005, 365, 965–973. [Google Scholar] [CrossRef]
  6. Mobasheri, A.; Fonseca, J.E.; Gualillo, O.; Henrotin, Y.; Largo, R.; Herrero-Beaumont, G.; Rocha, F.A.C. Editorial: Inflammation and Biomarkers in Osteoarthritis. Front. Med. 2021, 8, 727700. [Google Scholar] [CrossRef] [PubMed]
  7. Kanthawang, T.; Bodden, J.; Joseph, G.B.; Lane, N.E.; Nevitt, M.; McCulloch, C.E.; Link, T.M. Obese and overweight individuals have greater knee synovial inflammation and associated structural and cartilage compositional degeneration: Data from the osteoarthritis initiative. Skeletal Radiol. 2021, 50, 217–229. [Google Scholar] [CrossRef]
  8. Fernandes, G.S.; Valdes, A.M. Cardiovascular disease and osteoarthritis: Common pathways and patient outcomes. Eur. J. Clin. Investig. 2015, 45, 405–414. [Google Scholar] [CrossRef]
  9. Zhang, W.; Ouyang, H.; Dass, C.R.; Xu, J. Current research on pharmacologic and regenerative therapies for osteoarthritis. Bone Res. 2016, 4, 15040. [Google Scholar] [CrossRef]
  10. Patrignani, P.; Tacconelli, S.; Bruno, A.; Sostres, C.; Lanas, A. Managing the adverse effects of nonsteroidal anti-inflammatory drugs. Expert. Rev. Clin. Pharmacol. 2011, 4, 605–621. [Google Scholar] [CrossRef]
  11. Cheng, D.S.; Visco, C.J. Pharmaceutical therapy for osteoarthritis. PM&R 2012, 4, S82–S88. [Google Scholar] [CrossRef]
  12. O’Neil, C.K.; Hanlon, J.T.; Marcum, Z.A. Adverse effects of analgesics commonly used by older adults with osteoarthritis: Focus on non-opioid and opioid analgesics. Am. J. Geriatr. Pharmacother. 2012, 10, 331–342. [Google Scholar] [CrossRef]
  13. Roach, H.I.; Yamada, N.; Cheung, K.S.; Tilley, S.; Clarke, N.M.; Oreffo, R.O.; Kokubun, S.; Bronner, F. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 2005, 52, 3110–3124. [Google Scholar] [CrossRef]
  14. Bird, A. Perceptions of epigenetics. Nature 2007, 447, 396–398. [Google Scholar] [CrossRef]
  15. Khan, N.M.; Haqqi, T.M. Epigenetics in osteoarthritis: Potential of HDAC inhibitors as therapeutics. Pharmacol. Res. 2018, 128, 73–79. [Google Scholar] [CrossRef]
  16. Ramos, Y.F.; Meulenbelt, I. The role of epigenetics in osteoarthritis: Current perspective. Curr. Opin. Rheumatol. 2017, 29, 119–129. [Google Scholar] [CrossRef] [PubMed]
  17. Im, G.I.; Choi, Y.J. Epigenetics in osteoarthritis and its implication for future therapeutics. Expert. Opin. Biol. Ther. 2013, 13, 713–721. [Google Scholar] [CrossRef] [PubMed]
  18. Shen, J.; Abu-Amer, Y.; O’Keefe, R.J.; McAlinden, A. Inflammation and epigenetic regulation in osteoarthritis. Connect. Tissue Res. 2017, 58, 49–63. [Google Scholar] [CrossRef]
  19. Rogers, E.L.; Reynard, L.N.; Loughlin, J. The role of inflammation-related genes in osteoarthritis. Osteoarthr. Cartil. 2015, 23, 1933–1938. [Google Scholar] [CrossRef]
  20. Simon, T.C.; Jeffries, M.A. The Epigenomic Landscape in Osteoarthritis. Curr. Rheumatol. Rep. 2017, 19, 30. [Google Scholar] [CrossRef]
  21. van Meurs, J.B. Osteoarthritis year in review 2016: Genetics, genomics and epigenetics. Osteoarthr. Cartil. 2017, 25, 181–189. [Google Scholar] [CrossRef]
  22. Barter, M.J.; Bui, C.; Young, D.A. Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs. Osteoarthr. Cartil. 2012, 20, 339–349. [Google Scholar] [CrossRef]
  23. Chatterjee, A.; Eccles, M.R. DNA methylation and epigenomics: New technologies and emerging concepts. Genome Biol. 2015, 16, 103. [Google Scholar] [CrossRef] [PubMed]
  24. Zhang, M.; Wang, J. Epigenetics and Osteoarthritis. Genes. Dis. 2015, 2, 69–75. [Google Scholar] [CrossRef]
  25. Nakano, K.; Boyle, D.L.; Firestein, G.S. Regulation of DNA methylation in rheumatoid arthritis synoviocytes. J. Immunol. 2013, 190, 1297–1303. [Google Scholar] [CrossRef]
  26. Sullivan, K.E.; Reddy, A.B.; Dietzmann, K.; Suriano, A.R.; Kocieda, V.P.; Stewart, M.; Bhatia, M. Epigenetic regulation of tumor necrosis factor alpha. Mol. Cell Biol. 2007, 27, 5147–5160. [Google Scholar] [CrossRef] [PubMed]
  27. Hashimoto, K.; Otero, M.; Imagawa, K.; de Andrés, M.C.; Coico, J.M.; Roach, H.I.; Oreffo, R.O.C.; Marcu, K.B.; Goldring, M.B. Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1β (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J. Biol. Chem. 2013, 288, 10061–10072. [Google Scholar] [CrossRef]
  28. Hashimoto, K.; Oreffo, R.O.; Gibson, M.B.; Goldring, M.B.; Roach, H.I. DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum. 2009, 60, 3303–3313. [Google Scholar] [CrossRef] [PubMed]
  29. Bui, C.; Barter, M.J.; Scott, J.L.; Xu, Y.; Galler, M.; Reynard, L.N.; Rowan, A.D.; Young, D.A. cAMP response element-binding (CREB) recruitment following a specific CpG demethylation leads to the elevated expression of the matrix metalloproteinase 13 in human articular chondrocytes and osteoarthritis. FASEB J. 2012, 26, 3000–3011. [Google Scholar] [CrossRef] [PubMed]
  30. Zimmermann, P.; Boeuf, S.; Dickhut, A.; Boehmer, S.; Olek, S.; Richter, W. Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter. Arthritis Rheum. 2008, 58, 2743–2753. [Google Scholar] [CrossRef]
  31. Cheung, K.S.; Hashimoto, K.; Yamada, N.; Roach, H.I. Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation. Rheumatol. Int. 2009, 29, 525–534. [Google Scholar] [CrossRef] [PubMed]
  32. Papathanasiou, I.; Kostopoulou, F.; Malizos, K.N.; Tsezou, A. DNA methylation regulates sclerostin (SOST) expression in osteoarthritic chondrocytes by bone morphogenetic protein 2 (BMP-2) induced changes in Smads binding affinity to the CpG region of SOST promoter. Arthritis Res. Ther. 2015, 17, 160. [Google Scholar] [CrossRef] [PubMed]
  33. Kim, K.I.; Park, Y.S.; Im, G.I. Changes in the epigenetic status of the SOX-9 promoter in human osteoarthritic cartilage. J. Bone Miner. Res. 2013, 28, 1050–1060. [Google Scholar] [CrossRef] [PubMed]
  34. Imagawa, K.; de Andrés, M.C.; Hashimoto, K.; Itoi, E.; Otero, M.; Roach, H.I.; Goldring, M.B.; Oreffo, R.O. Association of reduced type IX collagen gene expression in human osteoarthritic chondrocytes with epigenetic silencing by DNA hypermethylation. Arthritis Rheumatol. 2014, 66, 3040–3051. [Google Scholar] [CrossRef]
  35. Takahashi, A.; de Andrés, M.C.; Hashimoto, K.; Itoi, E.; Oreffo, R.O. Epigenetic regulation of interleukin-8, an inflammatory chemokine, in osteoarthritis. Osteoarthr. Cartil. 2015, 23, 1946–1954. [Google Scholar] [CrossRef]
  36. de Andrés, M.C.; Imagawa, K.; Hashimoto, K.; Gonzalez, A.; Roach, H.I.; Goldring, M.B.; Oreffo, R.O. Loss of methylation in CpG sites in the NF-κB enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes. Arthritis Rheum. 2013, 65, 732–742. [Google Scholar] [CrossRef]
  37. Yang, F.; Zhou, S.; Wang, C.; Huang, Y.; Li, H.; Wang, Y.; Zhu, Z.; Tang, J.; Yan, M. Epigenetic modifications of interleukin-6 in synovial fibroblasts from osteoarthritis patients. Sci. Rep. 2017, 7, 43592. [Google Scholar] [CrossRef]
  38. Kim, H.; Kang, D.; Cho, Y.; Kim, J.H. Epigenetic Regulation of Chondrocyte Catabolism and Anabolism in Osteoarthritis. Mol. Cells 2015, 38, 677–684. [Google Scholar] [CrossRef]
  39. Choudhuri, S.; Cui, Y.; Klaassen, C.D. Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicol. Appl. Pharmacol. 2010, 245, 378–393. [Google Scholar] [CrossRef]
  40. Kouzarides, T. Chromatin modifications and their function. Cell 2007, 128, 693–705. [Google Scholar] [CrossRef]
  41. de Ruijter, A.J.; van Gennip, A.H.; Caron, H.N.; Kemp, S.; van Kuilenburg, A.B. Histone deacetylases (HDACs): Characterization of the classical HDAC family. Biochem. J. 2003, 370, 737–749. [Google Scholar] [CrossRef]
  42. Zhang, H.; Ji, L.; Yang, Y.; Zhang, X.; Gang, Y.; Bai, L. The Role of HDACs and HDACi in Cartilage and Osteoarthritis. Front. Cell Dev. Biol. 2020, 8, 560117. [Google Scholar] [CrossRef] [PubMed]
  43. Young, D.A.; Lakey, R.L.; Pennington, C.J.; Jones, D.; Kevorkian, L.; Edwards, D.R.; Cawston, T.E.; Clark, I.M. Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res. Ther. 2005, 7, R503–R512. [Google Scholar] [CrossRef]
  44. Hong, S.; Derfoul, A.; Pereira-Mouries, L.; Hall, D.J. A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes. FASEB J. 2009, 23, 3539–3552. [Google Scholar] [CrossRef] [PubMed]
  45. Huber, L.C.; Brock, M.; Hemmatazad, H.; Giger, O.T.; Moritz, F.; Trenkmann, M.; Distler, J.H.; Gay, R.E.; Kolling, C.; Moch, H.; et al. Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum. 2007, 56, 1087–1093. [Google Scholar] [CrossRef]
  46. Higashiyama, R.; Miyaki, S.; Yamashita, S.; Yoshitaka, T.; Lindman, G.; Ito, Y.; Sasho, T.; Takahashi, K.; Lotz, M.; Asahara, H. Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis. Mod. Rheumatol. 2010, 20, 11–17. [Google Scholar] [CrossRef] [PubMed]
  47. Dvir-Ginzberg, M.; Gagarina, V.; Lee, E.J.; Hall, D.J. Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 and nicotinamide phosphoribosyltransferase. J. Biol. Chem. 2008, 283, 36300–36310. [Google Scholar] [CrossRef] [PubMed]
  48. Dvir-Ginzberg, M.; Mobasheri, A.; Kumar, A. The Role of Sirtuins in Cartilage Homeostasis and Osteoarthritis. Curr. Rheumatol. Rep. 2016, 18, 43. [Google Scholar] [CrossRef]
  49. Li, W.; Cai, L.; Zhang, Y.; Cui, L.; Shen, G. Intra-articular resveratrol injection prevents osteoarthritis progression in a mouse model by activating SIRT1 and thereby silencing HIF-2α. J. Orthop. Res. 2015, 33, 1061–1070. [Google Scholar] [CrossRef]
  50. Gagarina, V.; Gabay, O.; Dvir-Ginzberg, M.; Lee, E.J.; Brady, J.K.; Quon, M.J.; Hall, D.J. SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis Rheum. 2010, 62, 1383–1392. [Google Scholar] [CrossRef]
  51. Oppenheimer, H.; Kumar, A.; Meir, H.; Schwartz, I.; Zini, A.; Haze, A.; Kandel, L.; Mattan, Y.; Liebergall, M.; Dvir-Ginzberg, M. Set7/9 impacts COL2A1 expression through binding and repression of SirT1 histone deacetylation. J. Bone Miner. Res. 2014, 29, 348–360. [Google Scholar] [CrossRef] [PubMed]
  52. Otero, M.; Peng, H.; Hachem, K.E.; Culley, K.L.; Wondimu, E.B.; Quinn, J.; Asahara, H.; Tsuchimochi, K.; Hashimoto, K.; Goldring, M.B. ELF3 modulates type II collagen gene (COL2A1) transcription in chondrocytes by inhibiting SOX9-CBP/p300-driven histone acetyltransferase activity. Connect. Tissue Res. 2017, 58, 15–26. [Google Scholar] [CrossRef]
  53. Monteagudo, S.; Cornelis, F.M.F.; Aznar-Lopez, C.; Yibmantasiri, P.; Guns, L.A.; Carmeliet, P.; Cailotto, F.; Lories, R.J. DOT1L safeguards cartilage homeostasis and protects against osteoarthritis. Nat. Commun. 2017, 8, 15889. [Google Scholar] [CrossRef]
  54. Castaño Betancourt, M.C.; Cailotto, F.; Kerkhof, H.J.; Cornelis, F.M.; Doherty, S.A.; Hart, D.J.; Hofman, A.; Luyten, F.P.; Maciewicz, R.A.; Mangino, M.; et al. Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc. Natl. Acad. Sci. USA 2012, 109, 8218–8223. [Google Scholar] [CrossRef]
  55. Peschansky, V.J.; Wahlestedt, C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics 2014, 9, 3–12. [Google Scholar] [CrossRef] [PubMed]
  56. Liu, Q.; Zhang, X.; Dai, L.; Hu, X.; Zhu, J.; Li, L.; Zhou, C.; Ao, Y. Long noncoding RNA related to cartilage injury promotes chondrocyte extracellular matrix degradation in osteoarthritis. Arthritis Rheumatol. 2014, 66, 969–978. [Google Scholar] [CrossRef] [PubMed]
  57. Beyer, C.; Zampetaki, A.; Lin, N.Y.; Kleyer, A.; Perricone, C.; Iagnocco, A.; Distler, A.; Langley, S.R.; Gelse, K.; Sesselmann, S.; et al. Signature of circulating microRNAs in osteoarthritis. Ann. Rheum. Dis. 2015, 74, e18. [Google Scholar] [CrossRef]
  58. Miyaki, S.; Asahara, H. Macro view of microRNA function in osteoarthritis. Nat. Rev. Rheumatol. 2012, 8, 543–552. [Google Scholar] [CrossRef]
  59. Sondag, G.R.; Haqqi, T.M. The Role of MicroRNAs and Their Targets in Osteoarthritis. Curr. Rheumatol. Rep. 2016, 18, 56. [Google Scholar] [CrossRef]
  60. Swingler, T.E.; Niu, L.; Smith, P.; Paddy, P.; Le, L.; Barter, M.J.; Young, D.A.; Clark, I.M. The function of microRNAs in cartilage and osteoarthritis. Clin. Exp. Rheumatol. 2019, 37 (Suppl. 120), 40–47. [Google Scholar]
  61. Rasheed, Z.; Al-Shobaili, H.A.; Rasheed, N.; Mahmood, A.; Khan, M.I. MicroRNA-26a-5p regulates the expression of inducible nitric oxide synthase via activation of NF-κB pathway in human osteoarthritis chondrocytes. Arch. Biochem. Biophys. 2016, 594, 61–67. [Google Scholar] [CrossRef] [PubMed]
  62. Akhtar, N.; Rasheed, Z.; Ramamurthy, S.; Anbazhagan, A.N.; Voss, F.R.; Haqqi, T.M. MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum. 2010, 62, 1361–1371. [Google Scholar] [CrossRef] [PubMed]
  63. Park, S.J.; Cheon, E.J.; Kim, H.A. MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes. Osteoarthr. Cartil. 2013, 21, 981–989. [Google Scholar] [CrossRef] [PubMed]
  64. Akhtar, N.; Haqqi, T.M. MicroRNA-199a* regulates the expression of cyclooxygenase-2 in human chondrocytes. Ann. Rheum. Dis. 2012, 71, 1073–1080. [Google Scholar] [CrossRef]
  65. Mao, G.; Zhang, Z.; Huang, Z.; Chen, W.; Huang, G.; Meng, F.; Kang, Y. MicroRNA-92a-3p regulates the expression of cartilage-specific genes by directly targeting histone deacetylase 2 in chondrogenesis and degradation. Osteoarthr. Cartil. 2017, 25, 521–532. [Google Scholar] [CrossRef]
  66. Meng, F.; Li, Z.; Zhang, Z.; Yang, Z.; Kang, Y.; Zhao, X.; Long, D.; Hu, S.; Gu, M.; He, S.; et al. MicroRNA-193b-3p regulates chondrogenesis and chondrocyte metabolism by targeting HDAC3. Theranostics 2018, 8, 2862–2883. [Google Scholar] [CrossRef]
  67. Guan, Y.J.; Li, J.; Yang, X.; Du, S.; Ding, J.; Gao, Y.; Zhang, Y.; Yang, K.; Chen, Q. Evidence that miR-146a attenuates aging- and trauma-induced osteoarthritis by inhibiting Notch1, IL-6, and IL-1 mediated catabolism. Aging Cell 2018, 17, e12752. [Google Scholar] [CrossRef]
  68. Wang, J.H.; Shih, K.S.; Wu, Y.W.; Wang, A.W.; Yang, C.R. Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1β signaling in osteoarthritis fibroblast-like synoviocytes. Osteoarthr. Cartil. 2013, 21, 1987–1996. [Google Scholar] [CrossRef]
  69. Budd, E.; de Andrés, M.C.; Sanchez-Elsner, T.; Oreffo, R.O.C. MiR-146b is down-regulated during the chondrogenic differentiation of human bone marrow derived skeletal stem cells and up-regulated in osteoarthritis. Sci. Rep. 2017, 7, 46704. [Google Scholar] [CrossRef]
  70. Zhang, C.; Zhang, Z.; Chang, Z.; Mao, G.; Hu, S.; Zeng, A.; Fu, M. miR-193b-5p regulates chondrocytes metabolism by directly targeting histone deacetylase 7 in interleukin-1β-induced osteoarthritis. J. Cell Biochem. 2019, 120, 12775–12784. [Google Scholar] [CrossRef]
  71. Ukai, T.; Sato, M.; Akutsu, H.; Umezawa, A.; Mochida, J. MicroRNA-199a-3p, microRNA-193b, and microRNA-320c are correlated to aging and regulate human cartilage metabolism. J. Orthop. Res. 2012, 30, 1915–1922. [Google Scholar] [CrossRef] [PubMed]
  72. Santini, P.; Politi, L.; Vedova, P.D.; Scandurra, R.; Scotto d’Abusco, A. The inflammatory circuitry of miR-149 as a pathological mechanism in osteoarthritis. Rheumatol. Int. 2014, 34, 711–716. [Google Scholar] [CrossRef] [PubMed]
  73. Miyaki, S.; Nakasa, T.; Otsuki, S.; Grogan, S.P.; Higashiyama, R.; Inoue, A.; Kato, Y.; Sato, T.; Lotz, M.K.; Asahara, H. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum. 2009, 60, 2723–2730. [Google Scholar] [CrossRef] [PubMed]
  74. Araldi, E.; Schipani, E. MicroRNA-140 and the silencing of osteoarthritis. Genes. Dev. 2010, 24, 1075–1080. [Google Scholar] [CrossRef]
  75. Si, H.B.; Yang, T.M.; Li, L.; Tian, M.; Zhou, L.; Li, D.P.; Huang, Q.; Kang, P.D.; Yang, J.; Zhou, Z.K.; et al. miR-140 Attenuates the Progression of Early-Stage Osteoarthritis by Retarding Chondrocyte Senescence. Mol. Ther. Nucleic Acids 2020, 19, 15–30. [Google Scholar] [CrossRef]
  76. Zhang, Y.; Lin, J.; Zhou, X.; Chen, X.; Chen, A.C.; Pi, B.; Pan, G.; Pei, M.; Yang, H.; Liu, T.; et al. Melatonin Prevents Osteoarthritis-Induced Cartilage Degradation via Targeting MicroRNA-140. Oxid. Med. Cell Longev. 2019, 2019, 9705929. [Google Scholar] [CrossRef]
  77. Karlsen, T.A.; de Souza, G.A.; Ødegaard, B.; Engebretsen, L.; Brinchmann, J.E. microRNA-140 Inhibits Inflammation and Stimulates Chondrogenesis in a Model of Interleukin 1β-induced Osteoarthritis. Mol. Ther. Nucleic Acids 2016, 5, e373. [Google Scholar] [CrossRef]
  78. Tuddenham, L.; Wheeler, G.; Ntounia-Fousara, S.; Waters, J.; Hajihosseini, M.K.; Clark, I.; Dalmay, T. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett. 2006, 580, 4214–4217. [Google Scholar] [CrossRef]
  79. Woods, S.; Charlton, S.; Cheung, K.; Hao, Y.; Soul, J.; Reynard, L.N.; Crowe, N.; Swingler, T.E.; Skelton, A.J.; Piróg, K.A.; et al. microRNA-seq of cartilage reveals an overabundance of miR-140-3p which contains functional isomiRs. RNA 2020, 26, 1575–1588. [Google Scholar] [CrossRef]
  80. Feng, L.; Feng, C.; Wang, C.X.; Xu, D.Y.; Chen, J.J.; Huang, J.F.; Tan, P.L.; Shen, J.M. Circulating microRNA let-7e is decreased in knee osteoarthritis, accompanied by elevated apoptosis and reduced autophagy. Int. J. Mol. Med. 2020, 45, 1464–1476. [Google Scholar] [CrossRef]
  81. Martinez-Sanchez, A.; Dudek, K.A.; Murphy, C.L. Regulation of human chondrocyte function through direct inhibition of cartilage master regulator SOX9 by microRNA-145 (miRNA-145). J. Biol. Chem. 2012, 287, 916–924. [Google Scholar] [CrossRef]
  82. Buckley, C.D.; Gilroy, D.W.; Serhan, C.N.; Stockinger, B.; Tak, P.P. The resolution of inflammation. Nat. Rev. Immunol. 2013, 13, 59–66. [Google Scholar] [CrossRef] [PubMed]
  83. Sonnenberg, G.F.; Artis, D. Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat. Med. 2015, 21, 698–708. [Google Scholar] [CrossRef]
  84. Medzhitov, R. Inflammation 2010: New adventures of an old flame. Cell 2010, 140, 771–776. [Google Scholar] [CrossRef]
  85. Goldring, M.B.; Otero, M. Inflammation in osteoarthritis. Curr. Opin. Rheumatol. 2011, 23, 471–478. [Google Scholar] [CrossRef] [PubMed]
  86. Berenbaum, F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthr. Cartil. 2013, 21, 16–21. [Google Scholar] [CrossRef] [PubMed]
  87. Robinson, W.H.; Lepus, C.M.; Wang, Q.; Raghu, H.; Mao, R.; Lindstrom, T.M.; Sokolove, J. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 2016, 12, 580–592. [Google Scholar] [CrossRef]
  88. Pelletier, J.P.; Martel-Pelletier, J.; Abramson, S.B. Osteoarthritis, an inflammatory disease: Potential implication for the selection of new therapeutic targets. Arthritis Rheum. 2001, 44, 1237–1247. [Google Scholar] [CrossRef]
  89. Goldring, M.B.; Otero, M.; Tsuchimochi, K.; Ijiri, K.; Li, Y. Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann. Rheum. Dis. 2008, 67 (Suppl. 3), iii75–iii82. [Google Scholar] [CrossRef]
  90. Park, K.H.; Zaichenko, L.; Peter, P.; Davis, C.R.; Crowell, J.A.; Mantzoros, C.S. Diet quality is associated with circulating C-reactive protein but not irisin levels in humans. Metabolism 2014, 63, 233–241. [Google Scholar] [CrossRef]
  91. Sureda, A.; Bibiloni, M.D.M.; Julibert, A.; Bouzas, C.; Argelich, E.; Llompart, I.; Pons, A.; Tur, J.A. Adherence to the Mediterranean Diet and Inflammatory Markers. Nutrients 2018, 10, 62. [Google Scholar] [CrossRef]
  92. Giugliano, D.; Ceriello, A.; Esposito, K. The effects of diet on inflammation: Emphasis on the metabolic syndrome. J. Am. Coll. Cardiol. 2006, 48, 677–685. [Google Scholar] [CrossRef]
  93. Romagnolo, D.F.; Selmin, O.I. Mediterranean Diet and Prevention of Chronic Diseases. Nutr. Today 2017, 52, 208–222. [Google Scholar] [CrossRef] [PubMed]
  94. Schulze, M.B.; Martínez-González, M.A.; Fung, T.T.; Lichtenstein, A.H.; Forouhi, N.G. Food based dietary patterns and chronic disease prevention. BMJ 2018, 361, k2396. [Google Scholar] [CrossRef] [PubMed]
  95. Casas, R.; Sacanella, E.; Estruch, R. The immune protective effect of the Mediterranean diet against chronic low-grade inflammatory diseases. Endocr. Metab. Immune Disord. Drug Targets 2014, 14, 245–254. [Google Scholar] [CrossRef]
  96. Poli, A.; Agostoni, C.; Graffigna, G.; Bosio, C.; Donini, L.M.; Marangoni, F. The complex relationship between diet, quality of life and life expectancy: A narrative review of potential determinants based on data from Italy. Eat. Weight. Disord. 2019, 24, 411–419. [Google Scholar] [CrossRef]
  97. Nowakowski, A.C.; Graves, K.Y.; Sumerau, J.E. Mediation analysis of relationships between chronic inflammation and quality of life in older adults. Health Qual. Life Outcomes 2016, 14, 46. [Google Scholar] [CrossRef]
  98. McKay, J.A.; Mathers, J.C. Diet induced epigenetic changes and their implications for health. Acta Physiol. 2011, 202, 103–118. [Google Scholar] [CrossRef]
  99. Milagro, F.I.; Mansego, M.L.; De Miguel, C.; Martínez, J.A. Dietary factors, epigenetic modifications and obesity outcomes: Progresses and perspectives. Mol. Aspects Med. 2013, 34, 782–812. [Google Scholar] [CrossRef] [PubMed]
  100. Davis, C.D.; Uthus, E.O. DNA methylation, cancer susceptibility, and nutrient interactions. Exp. Biol. Med. 2004, 229, 988–995. [Google Scholar]
  101. Widiker, S.; Karst, S.; Wagener, A.; Brockmann, G.A. High-fat diet leads to a decreased methylation of the Mc4r gene in the obese BFMI and the lean B6 mouse lines. J. Appl. Genet. 2010, 51, 193–197. [Google Scholar] [CrossRef] [PubMed]
  102. Szarc vel Szic, K.; Declerck, K.; Vidaković, M.; Vanden Berghe, W. From inflammaging to healthy aging by dietary lifestyle choices: Is epigenetics the key to personalized nutrition? Clin. Epigenetics 2015, 7, 33. [Google Scholar] [CrossRef] [PubMed]
  103. Toopchizadeh, V.; Dolatkhah, N.; Aghamohammadi, D.; Rasouli, M.; Hashemian, M. Dietary inflammatory index is associated with pain intensity and some components of quality of life in patients with knee osteoarthritis. BMC Res. Notes 2020, 13, 448. [Google Scholar] [CrossRef] [PubMed]
  104. Veronese, N.; Shivappa, N.; Stubbs, B.; Smith, T.; Hébert, J.R.; Cooper, C.; Guglielmi, G.; Reginster, J.Y.; Rizzoli, R.; Maggi, S. The relationship between the dietary inflammatory index and prevalence of radiographic symptomatic osteoarthritis: Data from the Osteoarthritis Initiative. Eur. J. Nutr. 2019, 58, 253–260. [Google Scholar] [CrossRef]
  105. Liu, Q.; Hebert, J.R.; Shivappa, N.; Guo, J.; Tao, K.; Zeng, C.; Lei, G.; Lin, J.; Zhang, Y. Inflammatory potential of diet and risk of incident knee osteoarthritis: A prospective cohort study. Arthritis Res. Ther. 2020, 22, 209. [Google Scholar] [CrossRef]
  106. Cavicchia, P.P.; Steck, S.E.; Hurley, T.G.; Hussey, J.R.; Ma, Y.; Ockene, I.S.; Hébert, J.R. A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein. J. Nutr. 2009, 139, 2365–2372. [Google Scholar] [CrossRef]
  107. Perruccio, A.V.; Chandran, V.; Power, J.D.; Kapoor, M.; Mahomed, N.N.; Gandhi, R. Systemic inflammation and painful joint burden in osteoarthritis: A matter of sex? Osteoarthr. Cartil. 2017, 25, 53–59. [Google Scholar] [CrossRef]
  108. Larsson, S.; Englund, M.; Struglics, A.; Lohmander, L.S. Interleukin-6 and tumor necrosis factor alpha in synovial fluid are associated with progression of radiographic knee osteoarthritis in subjects with previous meniscectomy. Osteoarthr. Cartil. 2015, 23, 1906–1914. [Google Scholar] [CrossRef]
  109. Jin, X.; Beguerie, J.R.; Zhang, W.; Blizzard, L.; Otahal, P.; Jones, G.; Ding, C. Circulating C reactive protein in osteoarthritis: A systematic review and meta-analysis. Ann. Rheum. Dis. 2015, 74, 703–710. [Google Scholar] [CrossRef]
  110. Pelletier, J.P.; Raynauld, J.P.; Caron, J.; Mineau, F.; Abram, F.; Dorais, M.; Haraoui, B.; Choquette, D.; Martel-Pelletier, J. Decrease in serum level of matrix metalloproteinases is predictive of the disease-modifying effect of osteoarthritis drugs assessed by quantitative MRI in patients with knee osteoarthritis. Ann. Rheum. Dis. 2010, 69, 2095–2101. [Google Scholar] [CrossRef]
  111. Dyer, J.; Davison, G.; Marcora, S.M.; Mauger, A.R. Effect of a Mediterranean Type Diet on Inflammatory and Cartilage Degradation Biomarkers in Patients with Osteoarthritis. J. Nutr. Health Aging 2017, 21, 562–566. [Google Scholar] [CrossRef]
  112. Henríquez Sánchez, P.; Ruano, C.; de Irala, J.; Ruiz-Canela, M.; Martínez-González, M.A.; Sánchez-Villegas, A. Adherence to the Mediterranean diet and quality of life in the SUN Project. Eur. J. Clin. Nutr. 2012, 66, 360–368. [Google Scholar] [CrossRef] [PubMed]
  113. Bonaccio, M.; Di Castelnuovo, A.; Bonanni, A.; Costanzo, S.; De Lucia, F.; Pounis, G.; Zito, F.; Donati, M.B.; de Gaetano, G.; Iacoviello, L.; et al. Adherence to a Mediterranean diet is associated with a better health-related quality of life: A possible role of high dietary antioxidant content. BMJ Open 2013, 3, e003003. [Google Scholar] [CrossRef] [PubMed]
  114. May, A.M.; Struijk, E.A.; Fransen, H.P.; Onland-Moret, N.C.; de Wit, G.A.; Boer, J.M.; van der Schouw, Y.T.; Hoekstra, J.; Bueno-de-Mesquita, H.B.; Peeters, P.H.; et al. The impact of a healthy lifestyle on Disability-Adjusted Life Years: A prospective cohort study. BMC Med. 2015, 13, 39. [Google Scholar] [CrossRef] [PubMed]
  115. Pérez-Tasigchana, R.F.; León-Muñoz, L.M.; López-García, E.; Banegas, J.R.; Rodríguez-Artalejo, F.; Guallar-Castillón, P. Mediterranean Diet and Health-Related Quality of Life in Two Cohorts of Community-Dwelling Older Adults. PLoS ONE 2016, 11, e0151596. [Google Scholar] [CrossRef]
  116. Veronese, N.; Stubbs, B.; Noale, M.; Solmi, M.; Luchini, C.; Maggi, S. Adherence to the Mediterranean diet is associated with better quality of life: Data from the Osteoarthritis Initiative. Am. J. Clin. Nutr. 2016, 104, 1403–1409. [Google Scholar] [CrossRef]
  117. Panagiotakos, D.B.; Pitsavos, C.; Stefanadis, C. Dietary patterns: A Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. Nutr. Metab. Cardiovasc. Dis. 2006, 16, 559–568. [Google Scholar] [CrossRef]
  118. Block, G.; Hartman, A.M.; Naughton, D. A reduced dietary questionnaire: Development and validation. Epidemiology 1990, 1, 58–64. [Google Scholar] [CrossRef]
  119. Veronese, N.; Stubbs, B.; Noale, M.; Solmi, M.; Luchini, C.; Smith, T.O.; Cooper, C.; Guglielmi, G.; Reginster, J.Y.; Rizzoli, R.; et al. Adherence to a Mediterranean diet is associated with lower prevalence of osteoarthritis: Data from the osteoarthritis initiative. Clin. Nutr. 2017, 36, 1609–1614. [Google Scholar] [CrossRef]
  120. Pitsavos, C.; Panagiotakos, D.B.; Tzima, N.; Chrysohoou, C.; Economou, M.; Zampelas, A.; Stefanadis, C. Adherence to the Mediterranean diet is associated with total antioxidant capacity in healthy adults: The ATTICA study. Am. J. Clin. Nutr. 2005, 82, 694–699. [Google Scholar] [CrossRef]
  121. Chatzianagnostou, K.; Del Turco, S.; Pingitore, A.; Sabatino, L.; Vassalle, C. The Mediterranean Lifestyle as a Non-Pharmacological and Natural Antioxidant for Healthy Aging. Antioxidants 2015, 4, 719–736. [Google Scholar] [CrossRef] [PubMed]
  122. Sánchez-Moreno, C.; Cano, M.P.; de Ancos, B.; Plaza, L.; Olmedilla, B.; Granado, F.; Martín, A. Mediterranean vegetable soup consumption increases plasma vitamin C and decreases F2-isoprostanes, prostaglandin E2 and monocyte chemotactic protein-1 in healthy humans. J. Nutr. Biochem. 2006, 17, 183–189. [Google Scholar] [CrossRef] [PubMed]
  123. Martín-Núñez, G.M.; Cabrera-Mulero, R.; Rubio-Martín, E.; Rojo-Martínez, G.; Olveira, G.; Valdés, S.; Soriguer, F.; Castaño, L.; Morcillo, S. Methylation levels of the SCD1 gene promoter and LINE-1 repeat region are associated with weight change: An intervention study. Mol. Nutr. Food Res. 2014, 58, 1528–1536. [Google Scholar] [CrossRef] [PubMed]
  124. Putnik, P.; Gabrić, D.; Roohinejad, S.; Barba, F.J.; Granato, D.; Mallikarjunan, K.; Lorenzo, J.M.; Bursać Kovačević, D. An overview of organosulfur compounds from Allium spp.: From processing and preservation to evaluation of their bioavailability, antimicrobial, and anti-inflammatory properties. Food Chem. 2019, 276, 680–691. [Google Scholar] [CrossRef]
  125. Hussain, T.; Tan, B.; Yin, Y.; Blachier, F.; Tossou, M.C.; Rahu, N. Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? Oxid. Med. Cell Longev. 2016, 2016, 7432797. [Google Scholar] [CrossRef]
  126. Annunziata, G.; Maisto, M.; Schisano, C.; Ciampaglia, R.; Narciso, V.; Tenore, G.C.; Novellino, E. Resveratrol as a Novel Anti-Herpes Simplex Virus Nutraceutical Agent: An Overview. Viruses 2018, 10, 473. [Google Scholar] [CrossRef]
  127. Annunziata, G.; Sanduzzi Zamparelli, M.; Santoro, C.; Ciampaglia, R.; Stornaiuolo, M.; Tenore, G.C.; Sanduzzi, A.; Novellino, E. May Polyphenols Have a Role Against Coronavirus Infection? An Overview of. Front. Med. 2020, 7, 240. [Google Scholar] [CrossRef]
  128. Giglio, R.V.; Patti, A.M.; Cicero, A.F.G.; Lippi, G.; Rizzo, M.; Toth, P.P.; Banach, M. Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular Diseases. Curr. Pharm. Des. 2018, 24, 239–258. [Google Scholar] [CrossRef]
  129. Rossi, L.; Mazzitelli, S.; Arciello, M.; Capo, C.R.; Rotilio, G. Benefits from dietary polyphenols for brain aging and Alzheimer’s disease. Neurochem. Res. 2008, 33, 2390–2400. [Google Scholar] [CrossRef]
  130. Surh, Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 2003, 3, 768–780. [Google Scholar] [CrossRef]
  131. Toda, T.; Sugioka, Y.; Koike, T. Soybean isoflavone can protect against osteoarthritis in ovariectomized rats. J. Food Sci. Technol. 2020, 57, 3409–3414. [Google Scholar] [CrossRef]
  132. Zhang, Y.J.; Gan, R.Y.; Li, S.; Zhou, Y.; Li, A.N.; Xu, D.P.; Li, H.B. Antioxidant Phytochemicals for the Prevention and Treatment of Chronic Diseases. Molecules 2015, 20, 21138–21156. [Google Scholar] [CrossRef] [PubMed]
  133. Sukhikh, S.; Noskova, S.; Ivanova, S.; Ulrikh, E.; Izgaryshev, A.; Babich, O. Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis. Molecules 2021, 26, 2391. [Google Scholar] [CrossRef] [PubMed]
  134. Leong, D.J.; Choudhury, M.; Hirsh, D.M.; Hardin, J.A.; Cobelli, N.J.; Sun, H.B. Nutraceuticals: Potential for chondroprotection and molecular targeting of osteoarthritis. Int. J. Mol. Sci. 2013, 14, 23063–23085. [Google Scholar] [CrossRef]
  135. Chin, K.Y.; Pang, K.L. Therapeutic Effects of Olive and Its Derivatives on Osteoarthritis: From Bench to Bedside. Nutrients 2017, 9, 1060. [Google Scholar] [CrossRef]
  136. D’Adamo, S.; Cetrullo, S.; Panichi, V.; Mariani, E.; Flamigni, F.; Borzì, R.M. Nutraceutical Activity in Osteoarthritis Biology: A Focus on the Nutrigenomic Role. Cells 2020, 9, 1232. [Google Scholar] [CrossRef] [PubMed]
  137. Li, X.Z.; Zhang, S.N. Recent advance in treatment of osteoarthritis by bioactive components from herbal medicine. Chin. Med. 2020, 15, 80. [Google Scholar] [CrossRef] [PubMed]
  138. Silva, L.B.A.R.; Pinheiro-Castro, N.; Novaes, G.M.; Pascoal, G.F.L.; Ong, T.P. Bioactive food compounds, epigenetics and chronic disease prevention: Focus on early-life interventions with polyphenols. Food Res. Int. 2019, 125, 108646. [Google Scholar] [CrossRef]
  139. Crascì, L.; Lauro, M.R.; Puglisi, G.; Panico, A. Natural antioxidant polyphenols on inflammation management: Anti-glycation activity vs metalloproteinases inhibition. Crit. Rev. Food Sci. Nutr. 2018, 58, 893–904. [Google Scholar] [CrossRef]
  140. Kinger, M.; Kumar, S.; Kumar, V. Some Important Dietary Polyphenolic Compounds: An Anti-inflammatory and Immunoregulatory Perspective. Mini Rev. Med. Chem. 2018, 18, 1270–1282. [Google Scholar] [CrossRef]
  141. Han, X.; Shen, T.; Lou, H. Dietary Polyphenols and Their Biological Significance. Int. J. Mol. Sci. 2007, 8, 950–988. [Google Scholar] [CrossRef]
  142. Pandey, K.B.; Rizvi, S.I. Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell Longev. 2009, 2, 270–278. [Google Scholar] [CrossRef] [PubMed]
  143. Durazzo, A.; Lucarini, M.; Souto, E.B.; Cicala, C.; Caiazzo, E.; Izzo, A.A.; Novellino, E.; Santini, A. Polyphenols: A concise overview on the chemistry, occurrence, and human health. Phytother. Res. 2019, 33, 2221–2243. [Google Scholar] [CrossRef] [PubMed]
  144. D’Archivio, M.; Filesi, C.; Di Benedetto, R.; Gargiulo, R.; Giovannini, C.; Masella, R. Polyphenols, dietary sources and bioavailability. Ann. Ist. Super. Sanita 2007, 43, 348–361. [Google Scholar]
  145. Del Bo’, C.; Bernardi, S.; Marino, M.; Porrini, M.; Tucci, M.; Guglielmetti, S.; Cherubini, A.; Carrieri, B.; Kirkup, B.; Kroon, P.; et al. Systematic Review on Polyphenol Intake and Health Outcomes: Is there Sufficient Evidence to Define a Health-Promoting Polyphenol-Rich Dietary Pattern? Nutrients 2019, 11, 1355. [Google Scholar] [CrossRef]
  146. Choi, D.J.; Choi, S.I.; Choi, B.R.; Lee, Y.S.; Lee, D.Y.; Kim, G.S. Cartilage protective and anti-analgesic effects of ALM16 on monosodium iodoacetate induced osteoarthritis in rats. BMC Complement. Altern. Med. 2019, 19, 325. [Google Scholar] [CrossRef]
  147. Schell, J.; Scofield, R.H.; Barrett, J.R.; Kurien, B.T.; Betts, N.; Lyons, T.J.; Zhao, Y.D.; Basu, A. Strawberries Improve Pain and Inflammation in Obese Adults with Radiographic Evidence of Knee Osteoarthritis. Nutrients 2017, 9, 949. [Google Scholar] [CrossRef]
  148. Du, C.; Smith, A.; Avalos, M.; South, S.; Crabtree, K.; Wang, W.; Kwon, Y.H.; Vijayagopal, P.; Juma, S. Blueberries Improve Pain, Gait Performance, and Inflammation in Individuals with Symptomatic Knee Osteoarthritis. Nutrients 2019, 11, 290. [Google Scholar] [CrossRef]
  149. Rasheed, Z.; Akhtar, N.; Haqqi, T.M. Pomegranate extract inhibits the interleukin-1β-induced activation of MKK-3, p38α-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes. Arthritis Res. Ther. 2010, 12, R195. [Google Scholar] [CrossRef]
  150. Ahmed, S.; Wang, N.; Hafeez, B.B.; Cheruvu, V.K.; Haqqi, T.M. Punica granatum L. extract inhibits IL-1beta-induced expression of matrix metalloproteinases by inhibiting the activation of MAP kinases and NF-kappaB in human chondrocytes in vitro. J. Nutr. 2005, 135, 2096–2102. [Google Scholar] [CrossRef]
  151. Tang, S.; Zhou, W.; Zhong, X.; Xu, J.; Huang, H.; Zheng, X.; Zhang, J.; Yang, S.; Shang, P.; Tang, Q.; et al. Arctigenin prevents the progression of osteoarthritis by targeting PI3K/Akt/NF-κB axis: In vitro and in vivo studies. J. Cell Mol. Med. 2020, 24, 4183–4193. [Google Scholar] [CrossRef] [PubMed]
  152. Ma, Z.; Piao, T.; Wang, Y.; Liu, J. Astragalin inhibits IL-1β-induced inflammatory mediators production in human osteoarthritis chondrocyte by inhibiting NF-κB and MAPK activation. Int. Immunopharmacol. 2015, 25, 83–87. [Google Scholar] [CrossRef]
  153. Henrotin, Y.E.; Sanchez, C.; Deberg, M.A.; Piccardi, N.; Guillou, G.B.; Msika, P.; Reginster, J.Y. Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteoarthritic chondrocytes. J. Rheumatol. 2003, 30, 1825–1834. [Google Scholar] [PubMed]
  154. Henrotin, Y.E.; Deberg, M.A.; Crielaard, J.M.; Piccardi, N.; Msika, P.; Sanchez, C. Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes. J. Rheumatol. 2006, 33, 1668–1678. [Google Scholar] [PubMed]
  155. Au, R.Y.; Al-Talib, T.K.; Au, A.Y.; Phan, P.V.; Frondoza, C.G. Avocado soybean unsaponifiables (ASU) suppress TNF-alpha, IL-1beta, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages. Osteoarthr. Cartil. 2007, 15, 1249–1255. [Google Scholar] [CrossRef]
  156. Goudarzi, R.; Taylor, J.F.; Yazdi, P.G.; Pedersen, B.A. Effects of Arthrocen, an avocado/soy unsaponifiables agent, on inflammatory mediators and gene expression in human chondrocytes. FEBS Open Bio 2017, 7, 187–194. [Google Scholar] [CrossRef]
  157. Chen, C.; Zhang, C.; Cai, L.; Xie, H.; Hu, W.; Wang, T.; Lu, D.; Chen, H. Baicalin suppresses IL-1β-induced expression of inflammatory cytokines via blocking NF-κB in human osteoarthritis chondrocytes and shows protective effect in mice osteoarthritis models. Int. Immunopharmacol. 2017, 52, 218–226. [Google Scholar] [CrossRef]
  158. Liu, S.C.; Lee, H.P.; Hung, C.Y.; Tsai, C.H.; Li, T.M.; Tang, C.H. Berberine attenuates CCN2-induced IL-1β expression and prevents cartilage degradation in a rat model of osteoarthritis. Toxicol. Appl. Pharmacol. 2015, 289, 20–29. [Google Scholar] [CrossRef]
  159. Zheng, W.; Zhang, H.; Jin, Y.; Wang, Q.; Chen, L.; Feng, Z.; Chen, H.; Wu, Y. Butein inhibits IL-1β-induced inflammatory response in human osteoarthritis chondrocytes and slows the progression of osteoarthritis in mice. Int. Immunopharmacol. 2017, 42, 1–10. [Google Scholar] [CrossRef]
  160. Mu, Y.; Hao, W.; Li, S. Casticin protects against IL-1β-induced inflammation in human osteoarthritis chondrocytes. Eur. J. Pharmacol. 2019, 842, 314–320. [Google Scholar] [CrossRef]
  161. Ding, Q.H.; Cheng, Y.; Chen, W.P.; Zhong, H.M.; Wang, X.H. Celastrol, an inhibitor of heat shock protein 90β potently suppresses the expression of matrix metalloproteinases, inducible nitric oxide synthase and cyclooxygenase-2 in primary human osteoarthritic chondrocytes. Eur. J. Pharmacol. 2013, 708, 1–7. [Google Scholar] [CrossRef] [PubMed]
  162. Lu, Y.C.; Hsiao, G.; Lin, K.H.; Hsieh, M.S.; Jayakumar, T.; Wu, T.S.; Sheu, J.R. Cinnamophilin isolated from Cinnamomum philippinense protects against collagen degradation in human chondrocytes. Phytother. Res. 2013, 27, 892–899. [Google Scholar] [CrossRef]
  163. Feng, Z.; Zheng, W.; Li, X.; Lin, J.; Xie, C.; Li, H.; Cheng, L.; Wu, A.; Ni, W. Cryptotanshinone protects against IL-1β-induced inflammation in human osteoarthritis chondrocytes and ameliorates the progression of osteoarthritis in mice. Int. Immunopharmacol. 2017, 50, 161–167. [Google Scholar] [CrossRef] [PubMed]
  164. Schulze-Tanzil, G.; Mobasheri, A.; Sendzik, J.; John, T.; Shakibaei, M. Effects of curcumin (diferuloylmethane) on nuclear factor kappaB signaling in interleukin-1beta-stimulated chondrocytes. Ann. N. Y. Acad. Sci. 2004, 1030, 578–586. [Google Scholar] [CrossRef] [PubMed]
  165. Shakibaei, M.; Schulze-Tanzil, G.; John, T.; Mobasheri, A. Curcumin protects human chondrocytes from IL-l1beta-induced inhibition of collagen type II and beta1-integrin expression and activation of caspase-3: An immunomorphological study. Ann. Anat. 2005, 187, 487–497. [Google Scholar] [CrossRef]
  166. Shakibaei, M.; John, T.; Schulze-Tanzil, G.; Lehmann, I.; Mobasheri, A. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem. Pharmacol. 2007, 73, 1434–1445. [Google Scholar] [CrossRef]
  167. Mathy-Hartert, M.; Jacquemond-Collet, I.; Priem, F.; Sanchez, C.; Lambert, C.; Henrotin, Y. Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflamm. Res. 2009, 58, 899–908. [Google Scholar] [CrossRef]
  168. Kuptniratsaikul, V.; Dajpratham, P.; Taechaarpornkul, W.; Buntragulpoontawee, M.; Lukkanapichonchut, P.; Chootip, C.; Saengsuwan, J.; Tantayakom, K.; Laongpech, S. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: A multicenter study. Clin. Interv. Aging 2014, 9, 451–458. [Google Scholar] [CrossRef]
  169. Kuptniratsaikul, V.; Thanakhumtorn, S.; Chinswangwatanakul, P.; Wattanamongkonsil, L.; Thamlikitkul, V. Efficacy and safety of Curcuma domestica extracts in patients with knee osteoarthritis. J. Altern. Complement. Med. 2009, 15, 891–897. [Google Scholar] [CrossRef]
  170. Pinsornsak, P.; Niempoog, S. The efficacy of Curcuma Longa L. extract as an adjuvant therapy in primary knee osteoarthritis: A randomized control trial. J. Med. Assoc. Thai 2012, 95 (Suppl. 1), S51–S58. [Google Scholar]
  171. Shep, D.; Khanwelkar, C.; Gade, P.; Karad, S. Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: A randomized open-label parallel-arm study. Trials 2019, 20, 214. [Google Scholar] [CrossRef] [PubMed]
  172. Jiang, C.; Luo, P.; Li, X.; Liu, P.; Li, Y.; Xu, J. Nrf2/ARE is a key pathway for curcumin-mediated protection of TMJ chondrocytes from oxidative stress and inflammation. Cell Stress. Chaperones 2020, 25, 395–406. [Google Scholar] [CrossRef] [PubMed]
  173. Zhang, Z.; Leong, D.J.; Xu, L.; He, Z.; Wang, A.; Navati, M.; Kim, S.J.; Hirsh, D.M.; Hardin, J.A.; Cobelli, N.J.; et al. Curcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse model. Arthritis Res. Ther. 2016, 18, 128. [Google Scholar] [CrossRef]
  174. Shakibaei, M.; Mobasheri, A.; Buhrmann, C. Curcumin synergizes with resveratrol to stimulate the MAPK signaling pathway in human articular chondrocytes in vitro. Genes. Nutr. 2011, 6, 171–179. [Google Scholar] [CrossRef]
  175. Nakagawa, Y.; Mukai, S.; Yamada, S.; Matsuoka, M.; Tarumi, E.; Hashimoto, T.; Tamura, C.; Imaizumi, A.; Nishihira, J.; Nakamura, T. Short-term effects of highly-bioavailable curcumin for treating knee osteoarthritis: A randomized, double-blind, placebo-controlled prospective study. J. Orthop. Sci. 2014, 19, 933–939. [Google Scholar] [CrossRef]
  176. Nakagawa, Y.; Mukai, S.; Yamada, S.; Murata, S.; Yabumoto, H.; Maeda, T.; Akamatsu, S. The Efficacy and Safety of Highly-Bioavailable Curcumin for Treating Knee Osteoarthritis: A 6-Month Open-Labeled Prospective Study. Clin. Med. Insights Arthritis Musculoskelet. Disord. 2020, 13, 1179544120948471. [Google Scholar] [CrossRef]
  177. Chopra, A.; Lavin, P.; Patwardhan, B.; Chitre, D. A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees. J. Clin. Rheumatol. 2004, 10, 236–245. [Google Scholar] [CrossRef] [PubMed]
  178. Belcaro, G.; Cesarone, M.R.; Dugall, M.; Pellegrini, L.; Ledda, A.; Grossi, M.G.; Togni, S.; Appendino, G. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern. Med. Rev. 2010, 15, 337–344. [Google Scholar]
  179. Kim, L.; Kim, J.Y. Chondroprotective effect of curcumin and lecithin complex in human chondrocytes stimulated by IL-1β via an anti-inflammatory mechanism. Food Sci. Biotechnol. 2019, 28, 547–553. [Google Scholar] [CrossRef]
  180. Comblain, F.; Sanchez, C.; Lesponne, I.; Balligand, M.; Serisier, S.; Henrotin, Y. Curcuminoids extract, hydrolyzed collagen and green tea extract synergically inhibit inflammatory and catabolic mediator’s synthesis by normal bovine and osteoarthritic human chondrocytes in monolayer. PLoS ONE 2015, 10, e0121654. [Google Scholar] [CrossRef]
  181. D’Ascola, A.; Irrera, N.; Ettari, R.; Bitto, A.; Pallio, G.; Mannino, F.; Atteritano, M.; Campo, G.M.; Minutoli, L.; Arcoraci, V.; et al. Exploiting Curcumin Synergy With Natural Products Using Quantitative Analysis of Dose-Effect Relationships in an Experimental. Front. Pharmacol. 2019, 10, 1347. [Google Scholar] [CrossRef] [PubMed]
  182. Heidari-Beni, M.; Moravejolahkami, A.R.; Gorgian, P.; Askari, G.; Tarrahi, M.J.; Bahreini-Esfahani, N. Herbal formulation “turmeric extract, black pepper, and ginger” versus Naproxen for chronic knee osteoarthritis: A randomized, double-blind, controlled clinical trial. Phytother. Res. 2020, 34, 2067–2073. [Google Scholar] [CrossRef] [PubMed]
  183. Kare, S.K.; Vinay, V.; Maresz, K.; Prisk, V.; Vik, H. Seed Extract-Based Botanical Compositions Alleviate Knee Pain and Improve Joint Function in Mild-to-Moderate Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Clinical Study. Evid. Based Complement. Alternat Med. 2022, 2022, 2226139. [Google Scholar] [CrossRef] [PubMed]
  184. Kim, H.L.; Lee, H.J.; Lee, D.R.; Choi, B.K.; Yang, S.H. Anti-osteoarthritic Effects of an Herbal Composition LI73014F2 on Interleukin-1β-induced Primary Human Articular Chondrocytes. Molecules 2020, 25, 2033. [Google Scholar] [CrossRef] [PubMed]
  185. Haseeb, A.; Chen, D.; Haqqi, T.M. Delphinidin inhibits IL-1β-induced activation of NF-κB by modulating the phosphorylation of IRAK-1(Ser376) in human articular chondrocytes. Rheumatology 2013, 52, 998–1008. [Google Scholar] [CrossRef]
  186. Lin, Z.; Lin, C.; Fu, C.; Lu, H.; Jin, H.; Chen, Q.; Pan, J. The protective effect of Ellagic acid (EA) in osteoarthritis: An in vitro and in vivo study. Biomed. Pharmacother. 2020, 125, 109845. [Google Scholar] [CrossRef]
  187. Ahmed, S.; Wang, N.; Lalonde, M.; Goldberg, V.M.; Haqqi, T.M. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J. Pharmacol. Exp. Ther. 2004, 308, 767–773. [Google Scholar] [CrossRef]
  188. Huang, G.S.; Tseng, C.Y.; Lee, C.H.; Su, S.L.; Lee, H.S. Effects of (-)-epigallocatechin-3-gallate on cyclooxygenase 2, PGE(2), and IL-8 expression induced by IL-1beta in human synovial fibroblasts. Rheumatol. Int. 2010, 30, 1197–1203. [Google Scholar] [CrossRef]
  189. Singh, R.; Ahmed, S.; Islam, N.; Goldberg, V.M.; Haqqi, T.M. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: Suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum. 2002, 46, 2079–2086. [Google Scholar] [CrossRef]
  190. Ahmed, S.; Rahman, A.; Hasnain, A.; Lalonde, M.; Goldberg, V.M.; Haqqi, T.M. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic. Biol. Med. 2002, 33, 1097–1105. [Google Scholar] [CrossRef]
  191. Singh, R.; Ahmed, S.; Malemud, C.J.; Goldberg, V.M.; Haqqi, T.M. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes. J. Orthop. Res. 2003, 21, 102–109. [Google Scholar] [CrossRef] [PubMed]
  192. Rasheed, Z.; Anbazhagan, A.N.; Akhtar, N.; Ramamurthy, S.; Voss, F.R.; Haqqi, T.M. Green tea polyphenol epigallocatechin-3-gallate inhibits advanced glycation end product-induced expression of tumor necrosis factor-alpha and matrix metalloproteinase-13 in human chondrocytes. Arthritis Res. Ther. 2009, 11, R71. [Google Scholar] [CrossRef] [PubMed]
  193. Akhtar, N.; Haqqi, T.M. Epigallocatechin-3-gallate suppresses the global interleukin-1beta-induced inflammatory response in human chondrocytes. Arthritis Res. Ther. 2011, 13, R93. [Google Scholar] [CrossRef]
  194. Sakata, S.; Hayashi, S.; Fujishiro, T.; Kawakita, K.; Kanzaki, N.; Hashimoto, S.; Iwasa, K.; Chinzei, N.; Kihara, S.; Haneda, M.; et al. Oxidative stress-induced apoptosis and matrix loss of chondrocytes is inhibited by eicosapentaenoic acid. J. Orthop. Res. 2015, 33, 359–365. [Google Scholar] [CrossRef]
  195. Hooshmand, S.; Soung, D.Y.; Lucas, E.A.; Madihally, S.V.; Levenson, C.W.; Arjmandi, B.H. Genistein reduces the production of proinflammatory molecules in human chondrocytes. J. Nutr. Biochem. 2007, 18, 609–614. [Google Scholar] [CrossRef] [PubMed]
  196. Liu, F.C.; Wang, C.C.; Lu, J.W.; Lee, C.H.; Chen, S.C.; Ho, Y.J.; Peng, Y.J. Chondroprotective Effects of Genistein against Osteoarthritis Induced Joint Inflammation. Nutrients 2019, 11, 1180. [Google Scholar] [CrossRef] [PubMed]
  197. Zou, Y.; Liu, Q.; Guo, P.; Huang, Y.; Ye, Z.; Hu, J. Anti-chondrocyte apoptosis effect of genistein in treating inflammation-induced osteoarthritis. Mol. Med. Rep. 2020, 22, 2032–2042. [Google Scholar] [CrossRef]
  198. Altman, R.D.; Marcussen, K.C. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum. 2001, 44, 2531–2538. [Google Scholar] [CrossRef]
  199. Naderi, Z.; Mozaffari-Khosravi, H.; Dehghan, A.; Nadjarzadeh, A.; Huseini, H.F. Effect of ginger powder supplementation on nitric oxide and C-reactive protein in elderly knee osteoarthritis patients: A 12-week double-blind randomized placebo-controlled clinical trial. J. Tradit. Complement. Med. 2016, 6, 199–203. [Google Scholar] [CrossRef]
  200. Rondanelli, M.; Riva, A.; Morazzoni, P.; Allegrini, P.; Faliva, M.A.; Naso, M.; Miccono, A.; Peroni, G.; Degli Agosti, I.; Perna, S. The effect and safety of highly standardized Ginger (Zingiber officinale) and Echinacea (Echinacea angustifolia) extract supplementation on inflammation and chronic pain in NSAIDs poor responders. A pilot study in subjects with knee arthrosis. Nat. Prod. Res. 2017, 31, 1309–1313. [Google Scholar] [CrossRef]
  201. Amorndoljai, P.; Taneepanichskul, S.; Niempoog, S.; Nimmannit, U. A Comparative of Ginger Extract in Nanostructure Lipid Carrier (NLC) and 1% Diclofenac Gel for Treatment of Knee Osteoarthritis (OA). J. Med. Assoc. Thai 2017, 100, 447–456. [Google Scholar] [PubMed]
  202. Rondanelli, M.; Riva, A.; Allegrini, P.; Faliva, M.A.; Naso, M.; Peroni, G.; Nichetti, M.; Gasparri, C.; Spadaccini, D.; Iannello, G.; et al. The Use of a New Food-Grade Lecithin Formulation of Highly Standardized Ginger (Zingiber officinale) and Acmella Oleracea Extracts for the Treatment of Pain and Inflammation in a Group of Subjects with Moderate Knee Osteoarthritis. J. Pain. Res. 2020, 13, 761–770. [Google Scholar] [CrossRef] [PubMed]
  203. Mariano, A.; Di Sotto, A.; Leopizzi, M.; Garzoli, S.; Di Maio, V.; Gullì, M.; Dalla Vedova, P.; Ammendola, S.; Scotto d’Abusco, A. Antiarthritic Effects of a Root Extract from. Nutrients 2020, 12, 2545. [Google Scholar] [CrossRef] [PubMed]
  204. Haseeb, A.; Ansari, M.Y.; Haqqi, T.M. Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes. J. Orthop. Res. 2017, 35, 311–320. [Google Scholar] [CrossRef]
  205. Chantre, P.; Cappelaere, A.; Leblan, D.; Guedon, D.; Vandermander, J.; Fournie, B. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. Phytomedicine 2000, 7, 177–183. [Google Scholar] [CrossRef] [PubMed]
  206. Leblan, D.; Chantre, P.; Fournié, B. Harpagophytum procumbens in the treatment of knee and hip osteoarthritis. Four-month results of a prospective, multicenter, double-blind trial versus diacerhein. Joint Bone Spine 2000, 67, 462–467. [Google Scholar]
  207. Schulze-Tanzil, G.; Hansen, C.; Shakibaei, M. Effect of a Harpagophytum procumbens DC extract on matrix metalloproteinases in human chondrocytes in vitro. Arzneimittelforschung 2004, 54, 213–220. [Google Scholar] [CrossRef]
  208. Takeda, R.; Koike, T.; Taniguchi, I.; Tanaka, K. Double-blind placebo-controlled trial of hydroxytyrosol of Olea europaea on pain in gonarthrosis. Phytomedicine 2013, 20, 861–864. [Google Scholar] [CrossRef]
  209. Elmazoglu, Z.; Colakoglu, M.; Banerjee, S.; Bitik, B.; Aktekin, C.N.; Goker, B.; Karasu, C. AB0090 Verbascoside and hydroxytyrosol downregulate stress-related pathways in human osteoarthritic articular chondrocytes. Ann. Rheum. Dis. 2018, 77, 1241. [Google Scholar]
  210. Wauquier, F.; Mevel, E.; Krisa, S.; Richard, T.; Valls, J.; Hornedo-Ortega, R.; Granel, H.; Boutin-Wittrant, L.; Urban, N.; Berger, J.; et al. Chondroprotective Properties of Human-Enriched Serum Following Polyphenol Extract Absorption: Results from an Exploratory Clinical Trial. Nutrients 2019, 11, 3071. [Google Scholar] [CrossRef]
  211. Pan, L.; Zhang, Y.; Chen, N.; Yang, L. Icariin Regulates Cellular Functions and Gene Expression of Osteoarthritis Patient-Derived Human Fibroblast-Like Synoviocytes. Int. J. Mol. Sci. 2017, 18, 2656. [Google Scholar] [CrossRef]
  212. Zeng, L.; Rong, X.F.; Li, R.H.; Wu, X.Y. Icariin inhibits MMP-1, MMP-3 and MMP-13 expression through MAPK pathways in IL-1β-stimulated SW1353 chondrosarcoma cells. Mol. Med. Rep. 2017, 15, 2853–2858. [Google Scholar] [CrossRef]
  213. Zuo, S.; Zou, W.; Wu, R.M.; Yang, J.; Fan, J.N.; Zhao, X.K.; Li, H.Y. Icariin Alleviates IL-1β-Induced Matrix Degradation By Activating The Nrf2/ARE Pathway In Human Chondrocytes. Drug Des. Devel Ther. 2019, 13, 3949–3961. [Google Scholar] [CrossRef] [PubMed]
  214. Piscoya, J.; Rodriguez, Z.; Bustamante, S.A.; Okuhama, N.N.; Miller, M.J.; Sandoval, M. Efficacy and safety of freeze-dried cat’s claw in osteoarthritis of the knee: Mechanisms of action of the species Uncaria guianensis. Inflamm. Res. 2001, 50, 442–448. [Google Scholar] [CrossRef] [PubMed]
  215. Jin, J.; Yu, X.; Hu, Z.; Tang, S.; Zhong, X.; Xu, J.; Shang, P.; Huang, Y.; Liu, H. Isofraxidin targets the TLR4/MD-2 axis to prevent osteoarthritis development. Food Funct. 2018, 9, 5641–5652. [Google Scholar] [CrossRef]
  216. Lin, J.; Li, X.; Qi, W.; Yan, Y.; Chen, K.; Xue, X.; Xu, X.; Feng, Z.; Pan, X. Isofraxidin inhibits interleukin-1β induced inflammatory response in human osteoarthritis chondrocytes. Int. Immunopharmacol. 2018, 64, 238–245. [Google Scholar] [CrossRef]
  217. Chen, X.; Zhang, C.; Wang, X.; Huo, S. Juglanin inhibits IL-1β-induced inflammation in human chondrocytes. Artif. Cells Nanomed. Biotechnol. 2019, 47, 3614–3620. [Google Scholar] [CrossRef] [PubMed]
  218. Jia, T.; Qiao, J.; Guan, D.; Chen, T. Anti-Inflammatory Effects of Licochalcone A on IL-1β-Stimulated Human Osteoarthritis Chondrocytes. Inflammation 2017, 40, 1894–1902. [Google Scholar] [CrossRef]
  219. de Andrés, M.C.; Meiss, M.S.; Sánchez-Hidalgo, M.; González-Benjumea, A.; Fernández-Bolaños, J.G.; Alarcón-de-la-Lastra, C.; Oreffo, R.O. Osteoarthritis treatment with a novel nutraceutical acetylated ligstroside aglycone, a chemically modified extra-virgin olive oil polyphenol. J. Tissue Eng. 2020, 11, 2041731420922701. [Google Scholar] [CrossRef]
  220. Rufino, A.T.; Ribeiro, M.; Sousa, C.; Judas, F.; Salgueiro, L.; Cavaleiro, C.; Mendes, A.F. Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis. Eur. J. Pharmacol. 2015, 750, 141–150. [Google Scholar] [CrossRef]
  221. Pan, X.; Chen, T.; Zhang, Z.; Chen, X.; Chen, C.; Chen, L.; Wang, X.; Ying, X. Activation of Nrf2/HO-1 signal with Myricetin for attenuating ECM degradation in human chondrocytes and ameliorating the murine osteoarthritis. Int. Immunopharmacol. 2019, 75, 105742. [Google Scholar] [CrossRef] [PubMed]
  222. Scotece, M.; Conde, J.; Abella, V.; López, V.; Francisco, V.; Ruiz, C.; Campos, V.; Lago, F.; Gomez, R.; Pino, J.; et al. Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB Pathways. Cell Physiol. Biochem. 2018, 49, 2414–2426. [Google Scholar] [CrossRef] [PubMed]
  223. Feng, Z.; Li, X.; Lin, J.; Zheng, W.; Hu, Z.; Xuan, J.; Ni, W.; Pan, X. Oleuropein inhibits the IL-1β-induced expression of inflammatory mediators by suppressing the activation of NF-κB and MAPKs in human osteoarthritis chondrocytes. Food Funct. 2017, 8, 3737–3744. [Google Scholar] [CrossRef] [PubMed]
  224. Varela-Eirín, M.; Carpintero-Fernández, P.; Sánchez-Temprano, A.; Varela-Vázquez, A.; Paíno, C.L.; Casado-Díaz, A.; Continente, A.C.; Mato, V.; Fonseca, E.; Kandouz, M.; et al. Senolytic activity of small molecular polyphenols from olive restores chondrocyte redifferentiation and promotes a pro-regenerative environment in osteoarthritis. Aging 2020, 12, 15882–15905. [Google Scholar] [CrossRef] [PubMed]
  225. Elmazoglu, Z.; Bek, Z.A.; Sarıbaş, G.S.; Özoğul, C.; Goker, B.; Bitik, B.; Aktekin, C.N.; Karasu, Ç. TLR4, RAGE, and p-JNK/JNK mediated inflammatory aggression in osteoathritic human chondrocytes are counteracted by redox-sensitive phenolic olive compounds: Comparison with ibuprofen. J. Tissue Eng. Regen. Med. 2020, 14, 1841–1857. [Google Scholar] [CrossRef]
  226. Peng, L.; Xie, Z.; Pei, J.; Wang, B.; Gao, Y.; Qu, Y. Puerarin alters the function of monocytes/macrophages and exhibits chondroprotection in mice. Mol. Med. Rep. 2019, 19, 2876–2882. [Google Scholar] [CrossRef] [PubMed]
  227. Ma, D.; Yu, T.; Peng, L.; Wang, L.; Liao, Z.; Xu, W. PIM1, CYP1B1, and HSPA2 Targeted by Quercetin Play Important Roles in Osteoarthritis Treatment by. Evid. Based Complement. Alternat Med. 2019, 2019, 1205942. [Google Scholar] [CrossRef]
  228. Xu, X.; Liu, X.; Yang, Y.; He, J.; Gu, H.; Jiang, M.; Huang, Y.; Liu, L. Resveratrol inhibits the development of obesity-related osteoarthritis via the TLR4 and PI3K/Akt signaling pathways. Connect. Tissue Res. 2019, 60, 571–582. [Google Scholar] [CrossRef]
  229. Marouf, B.H.; Hussain, S.A.; Ali, Z.S.; Ahmmad, R.S. Resveratrol Supplementation Reduces Pain and Inflammation in Knee Osteoarthritis Patients Treated with Meloxicam: A Randomized Placebo-Controlled Study. J. Med. Food 2018, 21, 1253–1259. [Google Scholar] [CrossRef]
  230. Shakibaei, M.; John, T.; Seifarth, C.; Mobasheri, A. Resveratrol inhibits IL-1 beta-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro. Ann. N. Y. Acad. Sci. 2007, 1095, 554–563. [Google Scholar] [CrossRef]
  231. Csaki, C.; Keshishzadeh, N.; Fischer, K.; Shakibaei, M. Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem. Pharmacol. 2008, 75, 677–687. [Google Scholar] [CrossRef] [PubMed]
  232. Dave, M.; Attur, M.; Palmer, G.; Al-Mussawir, H.E.; Kennish, L.; Patel, J.; Abramson, S.B. The antioxidant resveratrol protects against chondrocyte apoptosis via effects on mitochondrial polarization and ATP production. Arthritis Rheum. 2008, 58, 2786–2797. [Google Scholar] [CrossRef] [PubMed]
  233. Xu, X.; Liu, X.; Yang, Y.; He, J.; Jiang, M.; Huang, Y.; Liu, L.; Gu, H. Resveratrol Exerts Anti-Osteoarthritic Effect by Inhibiting TLR4/NF-κB Signaling Pathway via the TLR4/Akt/FoxO1 Axis in IL-1β-Stimulated SW1353 Cells. Drug Des. Devel Ther. 2020, 14, 2079–2090. [Google Scholar] [CrossRef]
  234. Csaki, C.; Mobasheri, A.; Shakibaei, M. Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: Inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res. Ther. 2009, 11, R165. [Google Scholar] [CrossRef] [PubMed]
  235. Ma, Y.; Sun, X.; Huang, K.; Shen, S.; Lin, X.; Xie, Z.; Wang, J.; Fan, S.; Ma, J.; Zhao, X. Sanguinarine protects against osteoarthritis by suppressing the expression of catabolic proteases. Oncotarget 2017, 8, 62900–62913. [Google Scholar] [CrossRef]
  236. Liao, S.; Zhou, K.; Li, D.; Xie, X.; Jun, F.; Wang, J. Schisantherin A suppresses interleukin-1β-induced inflammation in human chondrocytes via inhibition of NF-κB and MAPKs activation. Eur. J. Pharmacol. 2016, 780, 65–70. [Google Scholar] [CrossRef]
  237. Phitak, T.; Pothacharoen, P.; Settakorn, J.; Poompimol, W.; Caterson, B.; Kongtawelert, P. Chondroprotective and anti-inflammatory effects of sesamin. Phytochemistry 2012, 80, 77–88. [Google Scholar] [CrossRef]
  238. Kim, H.A.; Yeo, Y.; Jung, H.A.; Jung, Y.O.; Park, S.J.; Kim, S.J. Phase 2 enzyme inducer sulphoraphane blocks prostaglandin and nitric oxide synthesis in human articular chondrocytes and inhibits cartilage matrix degradation. Rheumatology 2012, 51, 1006–1016. [Google Scholar] [CrossRef]
  239. Kim, H.A.; Yeo, Y.; Kim, W.U.; Kim, S. Phase 2 enzyme inducer sulphoraphane blocks matrix metalloproteinase production in articular chondrocytes. Rheumatology 2009, 48, 932–938. [Google Scholar] [CrossRef]
  240. Facchini, A.; Stanic, I.; Cetrullo, S.; Borzì, R.M.; Filardo, G.; Flamigni, F. Sulforaphane protects human chondrocytes against cell death induced by various stimuli. J. Cell Physiol. 2011, 226, 1771–1779. [Google Scholar] [CrossRef]
  241. Davidson, R.K.; Jupp, O.; de Ferrars, R.; Kay, C.D.; Culley, K.L.; Norton, R.; Driscoll, C.; Vincent, T.L.; Donell, S.T.; Bao, Y.; et al. Sulforaphane represses matrix-degrading proteases and protects cartilage from destruction in vitro and in vivo. Arthritis Rheum. 2013, 65, 3130–3140. [Google Scholar] [CrossRef] [PubMed]
  242. Davidson, R.; Gardner, S.; Jupp, O.; Bullough, A.; Butters, S.; Watts, L.; Donell, S.; Traka, M.; Saha, S.; Mithen, R.; et al. Isothiocyanates are detected in human synovial fluid following broccoli consumption and can affect the tissues of the knee joint. Sci. Rep. 2017, 7, 3398. [Google Scholar] [CrossRef]
  243. Ko, J.Y.; Choi, Y.J.; Jeong, G.J.; Im, G.I. Sulforaphane-PLGA microspheres for the intra-articular treatment of osteoarthritis. Biomaterials 2013, 34, 5359–5368. [Google Scholar] [CrossRef]
  244. Piao, T.; Ma, Z.; Li, X.; Liu, J. Taraxasterol inhibits IL-1β-induced inflammatory response in human osteoarthritic chondrocytes. Eur. J. Pharmacol. 2015, 756, 38–42. [Google Scholar] [CrossRef]
  245. Park, C.; Jeong, J.W.; Lee, D.S.; Yim, M.J.; Lee, J.M.; Han, M.H.; Kim, S.; Kim, H.S.; Kim, G.Y.; Park, E.K.; et al. Extract Attenuates Interleukin-1β-Induced Oxidative Stress and Inflammatory Response in Chondrocytes by Suppressing the Activation of NF-κB, p38 MAPK, and PI3K/Akt. Int. J. Mol. Sci. 2018, 19, 2308. [Google Scholar] [CrossRef] [PubMed]
  246. Wang, D.; Qiao, J.; Zhao, X.; Chen, T.; Guan, D. Thymoquinone Inhibits IL-1β-Induced Inflammation in Human Osteoarthritis Chondrocytes by Suppressing NF-κB and MAPKs Signaling Pathway. Inflammation 2015, 38, 2235–2241. [Google Scholar] [CrossRef]
  247. Khan, N.M.; Haseeb, A.; Ansari, M.Y.; Haqqi, T.M. A wogonin-rich-fraction of Scutellaria baicalensis root extract exerts chondroprotective effects by suppressing IL-1β-induced activation of AP-1 in human OA chondrocytes. Sci. Rep. 2017, 7, 43789. [Google Scholar] [CrossRef]
  248. Khan, N.M.; Haseeb, A.; Ansari, M.Y.; Devarapalli, P.; Haynie, S.; Haqqi, T.M. Wogonin, a plant derived small molecule, exerts potent anti-inflammatory and chondroprotective effects through the activation of ROS/ERK/Nrf2 signaling pathways in human Osteoarthritis chondrocytes. Free Radic. Biol. Med. 2017, 106, 288–301. [Google Scholar] [CrossRef]
  249. Khan, N.M.; Ahmad, I.; Ansari, M.Y.; Haqqi, T.M. Wogonin, a natural flavonoid, intercalates with genomic DNA and exhibits protective effects in IL-1β stimulated osteoarthritis chondrocytes. Chem. Biol. Interact. 2017, 274, 13–23. [Google Scholar] [CrossRef]
  250. Ma, P.; Yue, L.; Yang, H.; Fan, Y.; Bai, J.; Li, S.; Yuan, J.; Zhang, Z.; Yao, C.; Lin, M.; et al. Chondroprotective and anti-inflammatory effects of amurensin H by regulating TLR4/Syk/NF-κB signals. J. Cell Mol. Med. 2020, 24, 1958–1968. [Google Scholar] [CrossRef]
  251. Zhao, C.; Liu, Q.; Wang, K. Artesunate attenuates ACLT-induced osteoarthritis by suppressing osteoclastogenesis and aberrant angiogenesis. Biomed. Pharmacother. 2017, 96, 410–416. [Google Scholar] [CrossRef] [PubMed]
  252. Bai, Z.; Guo, X.H.; Tang, C.; Yue, S.T.; Shi, L.; Qiang, B. Effects of Artesunate on the Expressions of Insulin-Like Growth Factor-1, Osteopontin and C-Telopeptides of Type II Collagen in a Rat Model of Osteoarthritis. Pharmacology 2018, 101, 1–8. [Google Scholar] [CrossRef] [PubMed]
  253. Boumediene, K.; Felisaz, N.; Bogdanowicz, P.; Galera, P.; Guillou, G.B.; Pujol, J.P. Avocado/soya unsaponifiables enhance the expression of transforming growth factor beta1 and beta2 in cultured articular chondrocytes. Arthritis Rheum. 1999, 42, 148–156. [Google Scholar] [CrossRef]
  254. Al-Afify, A.S.A.; El-Akabawy, G.; El-Sherif, N.M.; El-Safty, F.E.A.; El-Habiby, M.M. Avocado soybean unsaponifiables ameliorates cartilage and subchondral bone degeneration in mono-iodoacetate-induced knee osteoarthritis in rats. Tissue Cell 2018, 52, 108–115. [Google Scholar] [CrossRef]
  255. Heinecke, L.F.; Grzanna, M.W.; Au, A.Y.; Mochal, C.A.; Rashmir-Raven, A.; Frondoza, C.G. Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate. Osteoarthr. Cartil. 2010, 18, 220–227. [Google Scholar] [CrossRef] [PubMed]
  256. Ownby, S.L.; Fortuno, L.V.; Au, A.Y.; Grzanna, M.W.; Rashmir-Raven, A.M.; Frondoza, C.G. Expression of pro-inflammatory mediators is inhibited by an avocado/soybean unsaponifiables and epigallocatechin gallate combination. J. Inflamm. 2014, 11, 8. [Google Scholar] [CrossRef]
  257. Frondoza, C.G.; Fortuno, L.V.; Grzanna, M.W.; Ownby, S.L.; Au, A.Y.; Rashmir-Raven, A.M. α-Lipoic Acid Potentiates the Anti-Inflammatory Activity of Avocado/Soybean Unsaponifiables in Chondrocyte Cultures. Cartilage 2018, 9, 304–312. [Google Scholar] [CrossRef]
  258. Grzanna, M.W.; Secor, E.J.; Fortuno, L.V.; Au, A.Y.; Frondoza, C.G. Anti-Inflammatory Effect of Carprofen Is Enhanced by Avocado/Soybean Unsaponifiables, Glucosamine and Chondroitin Sulfate Combination in Chondrocyte Microcarrier Spinner Culture. Cartilage 2020, 11, 108–116. [Google Scholar] [CrossRef]
  259. Wang, P.; Zhu, P.; Liu, R.; Meng, Q.; Li, S. Baicalin promotes extracellular matrix synthesis in chondrocytes via the activation of hypoxia-inducible factor-1α. Exp. Ther. Med. 2020, 20, 226. [Google Scholar] [CrossRef]
  260. Pan, Y.; Chen, D.; Lu, Q.; Liu, L.; Li, X.; Li, Z. Baicalin prevents the apoptosis of endplate chondrocytes by inhibiting the oxidative stress induced by H2O2. Mol. Med. Rep. 2017, 16, 2985–2991. [Google Scholar] [CrossRef]
  261. Moon, P.D.; Jeong, H.S.; Chun, C.S.; Kim, H.M. Baekjeolyusin-tang and its active component berberine block the release of collagen and proteoglycan from IL-1β-stimulated rabbit cartilage and down-regulate matrix metalloproteinases in rabbit chondrocytes. Phytother. Res. 2011, 25, 844–850. [Google Scholar] [CrossRef] [PubMed]
  262. Hu, P.F.; Chen, W.P.; Tang, J.L.; Bao, J.P.; Wu, L.D. Protective effects of berberine in an experimental rat osteoarthritis model. Phytother. Res. 2011, 25, 878–885. [Google Scholar] [CrossRef]
  263. Zhao, H.; Zhang, T.; Xia, C.; Shi, L.; Wang, S.; Zheng, X.; Hu, T.; Zhang, B. Berberine ameliorates cartilage degeneration in interleukin-1β-stimulated rat chondrocytes and in a rat model of osteoarthritis via Akt signalling. J. Cell Mol. Med. 2014, 18, 283–292. [Google Scholar] [CrossRef] [PubMed]
  264. Zhou, Y.; Liu, S.Q.; Yu, L.; He, B.; Wu, S.H.; Zhao, Q.; Xia, S.Q.; Mei, H.J. Berberine prevents nitric oxide-induced rat chondrocyte apoptosis and cartilage degeneration in a rat osteoarthritis model via AMPK and p38 MAPK signaling. Apoptosis 2015, 20, 1187–1199. [Google Scholar] [CrossRef] [PubMed]
  265. Zhou, Y.; Tao, H.; Li, Y.; Deng, M.; He, B.; Xia, S.; Zhang, C.; Liu, S. Berberine promotes proliferation of sodium nitroprusside-stimulated rat chondrocytes and osteoarthritic rat cartilage via Wnt/β-catenin pathway. Eur. J. Pharmacol. 2016, 789, 109–118. [Google Scholar] [CrossRef]
  266. Li, X.; He, P.; Hou, Y.; Chen, S.; Xiao, Z.; Zhan, J.; Luo, D.; Gu, M.; Lin, D. Berberine inhibits the interleukin-1 beta-induced inflammatory response via MAPK downregulation in rat articular chondrocytes. Drug Dev. Res. 2019, 80, 637–645. [Google Scholar] [CrossRef]
  267. Feng, K.; Chen, H.; Xu, C. Chondro-protective effects of celastrol on osteoarthritis through autophagy activation and NF-κB signaling pathway inhibition. Inflamm. Res. 2020, 69, 385–400. [Google Scholar] [CrossRef]
  268. Wang, W.; Ha, C.; Lin, T.; Wang, D.; Wang, Y.; Gong, M. Celastrol attenuates pain and cartilage damage via SDF-1/CXCR4 signalling pathway in osteoarthritis rats. J. Pharm. Pharmacol. 2018, 70, 81–88. [Google Scholar] [CrossRef]
  269. Liu, D.D.; Zhang, B.L.; Yang, J.B.; Zhou, K. Celastrol ameliorates endoplasmic stress-mediated apoptosis of osteoarthritis via regulating ATF-6/CHOP signalling pathway. J. Pharm. Pharmacol. 2020, 72, 826–835. [Google Scholar] [CrossRef]
  270. Jin, T.; Wu, D.; Liu, X.M.; Xu, J.T.; Ma, B.J.; Ji, Y.; Jin, Y.Y.; Wu, S.Y.; Wu, T.; Ma, K. Intra-articular delivery of celastrol by hollow mesoporous silica nanoparticles for pH-sensitive anti-inflammatory therapy against knee osteoarthritis. J. Nanobiotechnology 2020, 18, 94. [Google Scholar] [CrossRef]
  271. Kang, S.; Siddiqi, M.H.; Yoon, S.J.; Ahn, S.; Noh, H.Y.; Kumar, N.S.; Kim, Y.J.; Yang, D.C. Therapeutic potential of compound K as an IKK inhibitor with implications for osteoarthritis prevention: An in silico and in vitro study. In Vitro Cell Dev. Biol. Anim. 2016, 52, 895–905. [Google Scholar] [CrossRef] [PubMed]
  272. Lei, M.; Guo, C.; Hua, L.; Xue, S.; Yu, D.; Zhang, C.; Wang, D. Crocin Attenuates Joint Pain and Muscle Dysfunction in Osteoarthritis Rat. Inflammation 2017, 40, 2086–2093. [Google Scholar] [CrossRef]
  273. Ding, Q.; Zhong, H.; Qi, Y.; Cheng, Y.; Li, W.; Yan, S.; Wang, X. Anti-arthritic effects of crocin in interleukin-1β-treated articular chondrocytes and cartilage in a rabbit osteoarthritic model. Inflamm. Res. 2013, 62, 17–25. [Google Scholar] [CrossRef] [PubMed]
  274. Clutterbuck, A.L.; Mobasheri, A.; Shakibaei, M.; Allaway, D.; Harris, P. Interleukin-1beta-induced extracellular matrix degradation and glycosaminoglycan release is inhibited by curcumin in an explant model of cartilage inflammation. Ann. N. Y. Acad. Sci. 2009, 1171, 428–435. [Google Scholar] [CrossRef] [PubMed]
  275. Clutterbuck, A.L.; Allaway, D.; Harris, P.; Mobasheri, A. Curcumin reduces prostaglandin E2, matrix metalloproteinase-3 and proteoglycan release in the secretome of interleukin 1β-treated articular cartilage. F1000Res 2013, 2, 147. [Google Scholar] [CrossRef]
  276. Wang, J.; Ma, J.; Gu, J.H.; Wang, F.Y.; Shang, X.S.; Tao, H.R.; Wang, X. Regulation of type II collagen, matrix metalloproteinase-13 and cell proliferation by interleukin-1β is mediated by curcumin via inhibition of NF-κB signaling in rat chondrocytes. Mol. Med. Rep. 2017, 16, 1837–1845. [Google Scholar] [CrossRef]
  277. Li, X.; Feng, K.; Li, J.; Yu, D.; Fan, Q.; Tang, T.; Yao, X.; Wang, X. Curcumin Inhibits Apoptosis of Chondrocytes through Activation ERK1/2 Signaling Pathways Induced Autophagy. Nutrients 2017, 9, 414. [Google Scholar] [CrossRef]
  278. Yan, D.; He, B.; Guo, J.; Li, S.; Wang, J. Involvement of TLR4 in the protective effect of intra-articular administration of curcumin on rat experimental osteoarthritis. Acta Cir. Bras. 2019, 34, e201900604. [Google Scholar] [CrossRef]
  279. Kim, H.L.; Lee, H.J.; Lee, D.R.; Choi, B.K.; Yang, S.H. Herbal Composition LI73014F2 Alleviates Articular Cartilage Damage and Inflammatory Response in Monosodium Iodoacetate-Induced Osteoarthritis in Rats. Molecules 2020, 25, 5467. [Google Scholar] [CrossRef]
  280. Ding, Q.H.; Ye, C.Y.; Chen, E.M.; Zhang, W.; Wang, X.H. Emodin ameliorates cartilage degradation in osteoarthritis by inhibiting NF-κB and Wnt/β-catenin signaling in-vitro and in-vivo. Int. Immunopharmacol. 2018, 61, 222–230. [Google Scholar] [CrossRef]
  281. Liu, Z.; Lang, Y.; Li, L.; Liang, Z.; Deng, Y.; Fang, R.; Meng, Q. Effect of emodin on chondrocyte viability in an. Exp. Ther. Med. 2018, 16, 5384–5389. [Google Scholar] [CrossRef] [PubMed]
  282. Hu, H.; Song, X.; Li, Y.; Ma, T.; Bai, H.; Zhao, M.; Wang, X.; Liu, L.; Gao, L. Emodin protects knee joint cartilage in rats through anti-matrix degradation pathway: An in vitro and in vivo study. Life Sci. 2021, 269, 119001. [Google Scholar] [CrossRef] [PubMed]
  283. Caron, J.P.; Gandy, J.C.; Brown, J.L.; Sordillo, L.M. Omega-3 fatty acids and docosahexaenoic acid oxymetabolites modulate the inflammatory response of equine recombinant interleukin1β-stimulated equine synoviocytes. Prostaglandins Other Lipid Mediat. 2019, 142, 1–8. [Google Scholar] [CrossRef]
  284. Wann, A.K.; Mistry, J.; Blain, E.J.; Michael-Titus, A.T.; Knight, M.M. Eicosapentaenoic acid and docosahexaenoic acid reduce interleukin-1β-mediated cartilage degradation. Arthritis Res. Ther. 2010, 12, R207. [Google Scholar] [CrossRef]
  285. Zainal, Z.; Longman, A.J.; Hurst, S.; Duggan, K.; Caterson, B.; Hughes, C.E.; Harwood, J.L. Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis. Osteoarthr. Cartil. 2009, 17, 896–905. [Google Scholar] [CrossRef]
  286. Chen, Y.; Shou, K.; Gong, C.; Yang, H.; Yang, Y.; Bao, T. Anti-Inflammatory Effect of Geniposide on Osteoarthritis by Suppressing the Activation of p38 MAPK Signaling Pathway. Biomed. Res. Int. 2018, 2018, 8384576. [Google Scholar] [CrossRef]
  287. Pan, T.; Shi, X.; Chen, H.; Chen, R.; Wu, D.; Lin, Z.; Zhang, J.; Pan, J. Geniposide Suppresses Interleukin-1β-Induced Inflammation and Apoptosis in Rat Chondrocytes via the PI3K/Akt/NF-κB Signaling Pathway. Inflammation 2018, 41, 390–399. [Google Scholar] [CrossRef] [PubMed]
  288. Chen, W.J.; Bao, T.Z.; Chen, K.; Zhu, C.M.; Wan, F.; Tan, Y.L.; Yan, F. Effects of geniposide on SNP-induced apoptosis of chondrocyte and cell cycle. Zhongguo Gu Shang 2013, 26, 232–235. [Google Scholar]
  289. Yuan, J.; Ding, W.; Wu, N.; Jiang, S.; Li, W. Protective Effect of Genistein on Condylar Cartilage through Downregulating NF-. Biomed. Res. Int. 2019, 2019, 2629791. [Google Scholar] [CrossRef]
  290. Cui, Z.; Crane, J.; Xie, H.; Jin, X.; Zhen, G.; Li, C.; Xie, L.; Wang, L.; Bian, Q.; Qiu, T.; et al. Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone. Ann. Rheum. Dis. 2016, 75, 1714–1721. [Google Scholar] [CrossRef]
  291. Mu, W.; Xu, B.; Ma, H.; Li, J.; Ji, B.; Zhang, Z.; Amat, A.; Cao, L. Halofuginone Attenuates Osteoarthritis by Rescuing Bone Remodeling in Subchondral Bone Through Oral Gavage. Front. Pharmacol. 2018, 9, 269. [Google Scholar] [CrossRef] [PubMed]
  292. Mu, W.; Xu, B.; Ma, H.; Ji, B.; Zhang, Z.; Li, J.; Amat, A.; Cao, L. Halofuginone attenuates articular cartilage degeneration by inhibition of elevated TGF-β1 signaling in articular cartilage in a rodent osteoarthritis model. Mol. Med. Rep. 2017, 16, 7679–7684. [Google Scholar] [CrossRef]
  293. Chrubasik, J.E.; Lindhorst, E.; Neumann, E.; Gerlach, U.; Faller-Marquardt, M.; Torda, T.; Müller-Ladner, U.; Chrubasik, S. Potential molecular basis of the chondroprotective effect of Harpagophytum procumbens. Phytomedicine 2006, 13, 598–600. [Google Scholar] [CrossRef] [PubMed]
  294. Gong, D.; Geng, C.; Jiang, L.; Cao, J.; Yoshimura, H.; Zhong, L. Effects of hydroxytyrosol-20 on carrageenan-induced acute inflammation and hyperalgesia in rats. Phytother. Res. 2009, 23, 646–650. [Google Scholar] [CrossRef]
  295. Takuma, M.; Haruka, K.; Mutsuto, W.; Toshiki, M.; Kenshiro, M.; Akane, T.; Hiroshi, M.; Yoshihiro, N. Olive leaf extract prevents cartilage degeneration in osteoarthritis of STR/ort mice. Biosci. Biotechnol. Biochem. 2018, 82, 1101–1106. [Google Scholar] [CrossRef] [PubMed]
  296. Mével, E.; Merceron, C.; Vinatier, C.; Krisa, S.; Richard, T.; Masson, M.; Lesoeur, J.; Hivernaud, V.; Gauthier, O.; Abadie, J.; et al. Olive and grape seed extract prevents post-traumatic osteoarthritis damages and exhibits in vitro anti IL-1β activities before and after oral consumption. Sci. Rep. 2016, 6, 33527. [Google Scholar] [CrossRef]
  297. Sun, K.; Luo, J.; Jing, X.; Xiang, W.; Guo, J.; Yao, X.; Liang, S.; Guo, F.; Xu, T. Hyperoside ameliorates the progression of osteoarthritis: An in vitro and in vivo study. Phytomedicine 2021, 80, 153387. [Google Scholar] [CrossRef]
  298. Tang, W.; Zhang, H.; Liu, D.; Jiao, F. Icariin accelerates cartilage defect repair by promoting chondrogenic differentiation of BMSCs under conditions of oxygen-glucose deprivation. J. Cell Mol. Med. 2022, 26, 202–215. [Google Scholar] [CrossRef]
  299. Xiang, W.; Zhang, J.; Wang, R.; Wang, L.; Wang, S.; Wu, Y.; Dong, Y.; Guo, F.; Xu, T. Role of IFT88 in icariin-regulated maintenance of the chondrocyte phenotype. Mol. Med. Rep. 2018, 17, 4999–5006. [Google Scholar] [CrossRef]
  300. Huang, H.; Zhang, Z.F.; Qin, F.W.; Tang, W.; Liu, D.H.; Wu, P.Y.; Jiao, F. Icariin inhibits chondrocyte apoptosis and angiogenesis by regulating the TDP-43 signaling pathway. Mol. Genet. Genomic Med. 2019, 7, e00586. [Google Scholar] [CrossRef]
  301. Liu, Y.; Mi, B.; Lv, H.; Liu, J.; Xiong, Y.; Hu, L.; Xue, H.; Panayi, A.C.; Liu, G.; Zhou, W. Shared KEGG pathways of icariin-targeted genes and osteoarthritis. J. Cell Biochem. 2018, 120, 7741–7750. [Google Scholar] [CrossRef] [PubMed]
  302. Liu, D.; Tang, W.; Zhang, H.; Huang, H.; Zhang, Z.; Tang, D.; Jiao, F. Icariin protects rabbit BMSCs against OGD-induced apoptosis by inhibiting ERs-mediated autophagy via MAPK signaling pathway. Life Sci. 2020, 253, 117730. [Google Scholar] [CrossRef] [PubMed]
  303. Chen, W.P.; Hu, Z.N.; Jin, L.B.; Wu, L.D. Licochalcone A Inhibits MMPs and ADAMTSs via the NF-κB and Wnt/β-Catenin Signaling Pathways in Rat Chondrocytes. Cell Physiol. Biochem. 2017, 43, 937–944. [Google Scholar] [CrossRef] [PubMed]
  304. Yan, Z.; Qi, W.; Zhan, J.; Lin, Z.; Lin, J.; Xue, X.; Pan, X.; Zhou, Y. Activating Nrf2 signalling alleviates osteoarthritis development by inhibiting inflammasome activation. J. Cell Mol. Med. 2020, 24, 13046–13057. [Google Scholar] [CrossRef]
  305. Hu, S.; Wang, S.; He, J.; Bian, Y. Tetramethylpyrazine alleviates endoplasmic reticulum stress-activated apoptosis and related inflammation in chondrocytes. Mol. Med. Rep. 2022, 25, 1–8. [Google Scholar] [CrossRef]
  306. Zhang, X.; Shi, Y.; Zhang, Z.; Yang, Z.; Huang, G. Intra-articular delivery of tetramethylpyrazine microspheres with enhanced articular cavity retention for treating osteoarthritis. Asian J. Pharm. Sci. 2018, 13, 229–238. [Google Scholar] [CrossRef]
  307. Cai, Z.; Feng, Y.; Li, C.; Yang, K.; Sun, T.; Xu, L.; Chen, Y.; Yan, C.H.; Lu, W.W.; Chiu, K.Y. Magnoflorine with hyaluronic acid gel promotes subchondral bone regeneration and attenuates cartilage degeneration in early osteoarthritis. Bone 2018, 116, 266–278. [Google Scholar] [CrossRef]
  308. Cai, Z.; Hong, M.; Xu, L.; Yang, K.; Li, C.; Sun, T.; Feng, Y.; Zeng, H.; Lu, W.W.; Chiu, K.Y. Prevent action of magnoflorine with hyaluronic acid gel from cartilage degeneration in anterior cruciate ligament transection induced osteoarthritis. Biomed. Pharmacother. 2020, 126, 109733. [Google Scholar] [CrossRef]
  309. Iacono, A.; Gómez, R.; Sperry, J.; Conde, J.; Bianco, G.; Meli, R.; Gómez-Reino, J.J.; Smith, A.B.; Gualillo, O. Effect of oleocanthal and its derivatives on inflammatory response induced by lipopolysaccharide in a murine chondrocyte cell line. Arthritis Rheum. 2010, 62, 1675–1682. [Google Scholar] [CrossRef]
  310. Scotece, M.; Gómez, R.; Conde, J.; Lopez, V.; Gómez-Reino, J.J.; Lago, F.; Smith, A.B.; Gualillo, O. Further evidence for the anti-inflammatory activity of oleocanthal: Inhibition of MIP-1α and IL-6 in J774 macrophages and in ATDC5 chondrocytes. Life Sci. 2012, 91, 1229–1235. [Google Scholar] [CrossRef]
  311. Aini, H.; Ochi, H.; Iwata, M.; Okawa, A.; Koga, D.; Okazaki, M.; Sano, A.; Asou, Y. Procyanidin B3 prevents articular cartilage degeneration and heterotopic cartilage formation in a mouse surgical osteoarthritis model. PLoS ONE 2012, 7, e37728. [Google Scholar] [CrossRef] [PubMed]
  312. Masuda, I.; Koike, M.; Nakashima, S.; Mizutani, Y.; Ozawa, Y.; Watanabe, K.; Sawada, Y.; Sugiyama, H.; Sugimoto, A.; Nojiri, H.; et al. Apple procyanidins promote mitochondrial biogenesis and proteoglycan biosynthesis in chondrocytes. Sci. Rep. 2018, 8, 7229. [Google Scholar] [CrossRef]
  313. Ma, T.W.; Wen, Y.J.; Song, X.P.; Hu, H.L.; Li, Y.; Bai, H.; Zhao, M.C.; Gao, L. Puerarin inhibits the development of osteoarthritis through antiinflammatory and antimatrix-degrading pathways in osteoarthritis-induced rat model. Phytother. Res. 2020, 35, 2579–2593. [Google Scholar] [CrossRef] [PubMed]
  314. Chen, X.; Huang, C.; Sun, H.; Hong, H.; Jin, J.; Bei, C.; Lu, Z.; Zhang, X. Puerarin suppresses inflammation and ECM degradation through Nrf2/HO-1 axis in chondrocytes and alleviates pain symptom in osteoarthritic mice. Food Funct. 2021, 12, 2075–2089. [Google Scholar] [CrossRef]
  315. Wang, L.; Shan, H.; Wang, B.; Wang, N.; Zhou, Z.; Pan, C.; Wang, F. Puerarin Attenuates Osteoarthritis via Upregulating AMP-Activated Protein Kinase/Proliferator-Activated Receptor-γ Coactivator-1 Signaling Pathway in Osteoarthritis Rats. Pharmacology 2018, 102, 117–125. [Google Scholar] [CrossRef] [PubMed]
  316. Wei, B.; Zhang, Y.; Tang, L.; Ji, Y.; Yan, C.; Zhang, X. Protective effects of quercetin against inflammation and oxidative stress in a rabbit model of knee osteoarthritis. Drug Dev. Res. 2019, 80, 360–367. [Google Scholar] [CrossRef]
  317. Hu, Y.; Gui, Z.; Zhou, Y.; Xia, L.; Lin, K.; Xu, Y. Quercetin alleviates rat osteoarthritis by inhibiting inflammation and apoptosis of chondrocytes, modulating synovial macrophages polarization to M2 macrophages. Free Radic. Biol. Med. 2019, 145, 146–160. [Google Scholar] [CrossRef]
  318. Zhang, J.; Yin, J.; Zhao, D.; Wang, C.; Zhang, Y.; Wang, Y.; Li, T. Therapeutic effect and mechanism of action of quercetin in a rat model of osteoarthritis. J. Int. Med. Res. 2020, 48, 300060519873461. [Google Scholar] [CrossRef]
  319. Permatasari, D.A.; Karliana, D.; Iskandarsyah, I.; Arsianti, A.; Bahtiar, A. Quercetin prevent proteoglycan destruction by inhibits matrix metalloproteinase-9, matrix metalloproteinase-13, a disintegrin and metalloproteinase with thrombospondin motifs-5 expressions on osteoarthritis model rats. J. Adv. Pharm. Technol. Res. 2019, 10, 2–8. [Google Scholar] [CrossRef]
  320. Britti, D.; Crupi, R.; Impellizzeri, D.; Gugliandolo, E.; Fusco, R.; Schievano, C.; Morittu, V.M.; Evangelista, M.; Di Paola, R.; Cuzzocrea, S. A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models. BMC Vet. Res. 2017, 13, 229. [Google Scholar] [CrossRef]
  321. Wang, J.; Gao, J.S.; Chen, J.W.; Li, F.; Tian, J. Effect of resveratrol on cartilage protection and apoptosis inhibition in experimental osteoarthritis of rabbit. Rheumatol. Int. 2012, 32, 1541–1548. [Google Scholar] [CrossRef]
  322. Elmali, N.; Esenkaya, I.; Harma, A.; Ertem, K.; Turkoz, Y.; Mizrak, B. Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm. Res. 2005, 54, 158–162. [Google Scholar] [CrossRef]
  323. Wei, Y.; Jia, J.; Jin, X.; Tong, W.; Tian, H. Resveratrol ameliorates inflammatory damage and protects against osteoarthritis in a rat model of osteoarthritis. Mol. Med. Rep. 2018, 17, 1493–1498. [Google Scholar] [CrossRef] [PubMed]
  324. Gu, H.; Li, K.; Li, X.; Yu, X.; Wang, W.; Ding, L.; Liu, L. Oral Resveratrol Prevents Osteoarthritis Progression in C57BL/6J Mice Fed a High-Fat Diet. Nutrients 2016, 8, 233. [Google Scholar] [CrossRef] [PubMed]
  325. Horcajada, M.N.; Sanchez, C.; Membrez Scalfo, F.; Drion, P.; Comblain, F.; Taralla, S.; Donneau, A.F.; Offord, E.A.; Henrotin, Y. Oleuropein or rutin consumption decreases the spontaneous development of osteoarthritis in the Hartley guinea pig. Osteoarthr. Cartil. 2015, 23, 94–102. [Google Scholar] [CrossRef] [PubMed]
  326. Zhong, Y.; Huang, Y.; Santoso, M.B.; Wu, L.D. Sclareol exerts anti-osteoarthritic activities in interleukin-1β-induced rabbit chondrocytes and a rabbit osteoarthritis model. Int. J. Clin. Exp. Pathol. 2015, 8, 2365–2374. [Google Scholar]
  327. Fu, D.; Shang, X.; Ni, Z.; Shi, G. Shikonin inhibits inflammation and chondrocyte apoptosis by regulation of the PI3K/Akt signaling pathway in a rat model of osteoarthritis. Exp. Ther. Med. 2016, 12, 2735–2740. [Google Scholar] [CrossRef]
  328. Li, F.; Yin, Z.; Zhou, B.; Xue, F.; Yang, W.; Chang, R.; Ma, K.; Qiu, Y. Shikonin inhibits inflammatory responses in rabbit chondrocytes and shows chondroprotection in osteoarthritic rabbit knee. Int. Immunopharmacol. 2015, 29, 656–662. [Google Scholar] [CrossRef]
  329. Wang, L.; Gai, P.; Xu, R.; Zheng, Y.; Lv, S.; Li, Y.; Liu, S. Shikonin protects chondrocytes from interleukin-1beta-induced apoptosis by regulating PI3K/Akt signaling pathway. Int. J. Clin. Exp. Pathol. 2015, 8, 298–308. [Google Scholar]
  330. Ju, X.D.; Deng, M.; Ao, Y.F.; Yu, C.L.; Wang, J.Q.; Yu, J.K.; Cui, G.Q.; Hu, Y.L. Protective effect of sinomenine on cartilage degradation and chondrocytes apoptosis. Yakugaku Zasshi 2010, 130, 1053–1060. [Google Scholar] [CrossRef]
  331. Wu, Y.; Lin, Z.; Yan, Z.; Wang, Z.; Fu, X.; Yu, K. Sinomenine contributes to the inhibition of the inflammatory response and the improvement of osteoarthritis in mouse-cartilage cells by acting on the Nrf2/HO-1 and NF-κB signaling pathways. Int. Immunopharmacol. 2019, 75, 105715. [Google Scholar] [CrossRef]
  332. Javaheri, B.; Poulet, B.; Aljazzar, A.; de Souza, R.; Piles, M.; Hopkinson, M.; Shervill, E.; Pollard, A.; Chan, B.; Chang, Y.M.; et al. Stable sulforaphane protects against gait anomalies and modifies bone microarchitecture in the spontaneous STR/Ort model of osteoarthritis. Bone 2017, 103, 308–317. [Google Scholar] [CrossRef]
  333. Sudirman, S.; Chen, C.K.; Long, B.T.; Chang, H.W.; Tsou, D.; Kong, Z.L. Nut Triterpene-Rich Extract Ameliorates Symptoms of Inflammation on Post-Traumatic Osteoarthritis in Obese Rats. J. Pain. Res. 2020, 13, 261–271. [Google Scholar] [CrossRef] [PubMed]
  334. Park, J.S.; Lee, H.J.; Lee, D.Y.; Jo, H.S.; Jeong, J.H.; Kim, D.H.; Nam, D.C.; Lee, C.J.; Hwang, S.C. Chondroprotective Effects of Wogonin in Experimental Models of Osteoarthritis in vitro and in vivo. Biomol. Ther. 2015, 23, 442–448. [Google Scholar] [CrossRef]
  335. Smith, J.F.; Starr, E.G.; Goodman, M.A.; Hanson, R.B.; Palmer, T.A.; Woolstenhulme, J.B.; Weyand, J.A.; Marchant, A.D.; Bueckers, S.L.; Nelson, T.K.; et al. Topical Application of Wogonin Provides a Novel Treatment of Knee Osteoarthritis. Front. Physiol. 2020, 11, 80. [Google Scholar] [CrossRef] [PubMed]
  336. Anderson, O.S.; Sant, K.E.; Dolinoy, D.C. Nutrition and epigenetics: An interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J. Nutr. Biochem. 2012, 23, 853–859. [Google Scholar] [CrossRef] [PubMed]
  337. Choi, S.W.; Friso, S. Epigenetics: A New Bridge between Nutrition and Health. Adv. Nutr. 2010, 1, 8–16. [Google Scholar] [CrossRef] [PubMed]
  338. Kumari, A.; Bhawal, S.; Kapila, S.; Yadav, H.; Kapila, R. Health-promoting role of dietary bioactive compounds through epigenetic modulations: A novel prophylactic and therapeutic approach. Crit. Rev. Food Sci. Nutr. 2022, 62, 619–639. [Google Scholar] [CrossRef]
  339. Vahid, F.; Zand, H.; Nosrat-Mirshekarlou, E.; Najafi, R.; Hekmatdoost, A. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: A review. Gene 2015, 562, 8–15. [Google Scholar] [CrossRef]
  340. Langley-Evans, S.C. Developmental programming of health and disease. Proc. Nutr. Soc. 2006, 65, 97–105. [Google Scholar] [CrossRef]
  341. Chmurzynska, A. Fetal programming: Link between early nutrition, DNA methylation, and complex diseases. Nutr. Rev. 2010, 68, 87–98. [Google Scholar] [CrossRef] [PubMed]
  342. Jirtle, R.L.; Skinner, M.K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 2007, 8, 253–262. [Google Scholar] [CrossRef] [PubMed]
  343. Kucharski, R.; Maleszka, J.; Foret, S.; Maleszka, R. Nutritional control of reproductive status in honeybees via DNA methylation. Science 2008, 319, 1827–1830. [Google Scholar] [CrossRef] [PubMed]
  344. Wolff, G.L.; Kodell, R.L.; Moore, S.R.; Cooney, C.A. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J. 1998, 12, 949–957. [Google Scholar] [CrossRef] [PubMed]
  345. Aagaard-Tillery, K.M.; Grove, K.; Bishop, J.; Ke, X.; Fu, Q.; McKnight, R.; Lane, R.H. Developmental origins of disease and determinants of chromatin structure: Maternal diet modifies the primate fetal epigenome. J. Mol. Endocrinol. 2008, 41, 91–102. [Google Scholar] [CrossRef]
  346. Dolinoy, D.C.; Weidman, J.R.; Waterland, R.A.; Jirtle, R.L. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ. Health Perspect. 2006, 114, 567–572. [Google Scholar] [CrossRef]
  347. Tain, Y.L.; Lee, W.C.; Wu, K.L.H.; Leu, S.; Chan, J.Y.H. Resveratrol Prevents the Development of Hypertension Programmed by Maternal Plus Post-Weaning High-Fructose Consumption through Modulation of Oxidative Stress, Nutrient-Sensing Signals, and Gut Microbiota. Mol. Nutr. Food Res. 2018, 62, e1800066. [Google Scholar] [CrossRef]
  348. Remely, M.; Lovrecic, L.; de la Garza, A.L.; Migliore, L.; Peterlin, B.; Milagro, F.I.; Martinez, A.J.; Haslberger, A.G. Therapeutic perspectives of epigenetically active nutrients. Br. J. Pharmacol. 2015, 172, 2756–2768. [Google Scholar] [CrossRef]
  349. Montgomery, M.; Srinivasan, A. Epigenetic Gene Regulation by Dietary Compounds in Cancer Prevention. Adv. Nutr. 2019, 10, 1012–1028. [Google Scholar] [CrossRef]
  350. Lee, W.J.; Shim, J.Y.; Zhu, B.T. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol. 2005, 68, 1018–1030. [Google Scholar] [CrossRef]
  351. Robertson, K.D. DNA methylation and human disease. Nat. Rev. Genet. 2005, 6, 597–610. [Google Scholar] [CrossRef] [PubMed]
  352. Suzuki, M.M.; Bird, A. DNA methylation landscapes: Provocative insights from epigenomics. Nat. Rev. Genet. 2008, 9, 465–476. [Google Scholar] [CrossRef] [PubMed]
  353. Fang, M.; Chen, D.; Yang, C.S. Dietary polyphenols may affect DNA methylation. J. Nutr. 2007, 137, 223S–228S. [Google Scholar] [CrossRef] [PubMed]
  354. Cameron, E.E.; Bachman, K.E.; Myöhänen, S.; Herman, J.G.; Baylin, S.B. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet. 1999, 21, 103–107. [Google Scholar] [CrossRef]
  355. Shankar, S.; Kumar, D.; Srivastava, R.K. Epigenetic modifications by dietary phytochemicals: Implications for personalized nutrition. Pharmacol. Ther. 2013, 138, 1–17. [Google Scholar] [CrossRef]
  356. Link, A.; Balaguer, F.; Goel, A. Cancer chemoprevention by dietary polyphenols: Promising role for epigenetics. Biochem. Pharmacol. 2010, 80, 1771–1792. [Google Scholar] [CrossRef]
  357. Chen, X.; Liu, J.; Sun, Y.; Wen, J.; Zhou, Q.; Ding, X.; Zhang, X. Correlation analysis of differentially expressed long non-coding RNA HOTAIR with PTEN/PI3K/AKT pathway and inflammation in patients with osteoarthritis and the effect of baicalin intervention. J. Orthop. Surg. Res. 2023, 18, 34. [Google Scholar] [CrossRef]
  358. Li, Z.; Cheng, J.; Liu, J. Baicalin Protects Human OA Chondrocytes Against IL-1β-Induced Apoptosis and ECM Degradation by Activating Autophagy via MiR-766-3p/AIFM1 Axis. Drug Des. Devel Ther. 2020, 14, 2645–2655. [Google Scholar] [CrossRef]
  359. Yang, X.; Zhang, Q.; Gao, Z.; Yu, C.; Zhang, L. Baicalin alleviates IL-1β-induced inflammatory injury via down-regulating miR-126 in chondrocytes. Biomed. Pharmacother. 2018, 99, 184–190. [Google Scholar] [CrossRef]
  360. Ji, Q.; Qi, D.; Xu, X.; Xu, Y.; Goodman, S.B.; Kang, L.; Song, Q.; Fan, Z.; Maloney, W.J.; Wang, Y. Cryptotanshinone Protects Cartilage against Developing Osteoarthritis through the miR-106a-5p/GLIS3 Axis. Mol. Ther. Nucleic Acids 2018, 11, 170–179. [Google Scholar] [CrossRef]
  361. Yang, D.; Cao, G.; Ba, X.; Jiang, H. Epigallocatechin-3-O-Gallate promotes extracellular matrix and inhibits inflammation in IL-1B stimulated chondrocytes by the PTEN/miRNA-29b pathway. Pharm. Biol. 2022, 60, 589–599. [Google Scholar] [CrossRef]
  362. Rasheed, Z.; Rasheed, N.; Al-Shaya, O. Epigallocatechin-3-O-gallate modulates global microRNA expression in interleukin-1β-stimulated human osteoarthritis chondrocytes: Potential role of EGCG on negative co-regulation of microRNA-140-3p and ADAMTS5. Eur. J. Nutr. 2018, 57, 917–928. [Google Scholar] [CrossRef]
  363. Rasheed, Z.; Rasheed, N.; Al-Shobaili, H.A. Epigallocatechin-3-O-gallate up-regulates microRNA-199a-3p expression by down-regulating the expression of cyclooxygenase-2 in stimulated human osteoarthritis chondrocytes. J. Cell Mol. Med. 2016, 20, 2241–2248. [Google Scholar] [CrossRef] [PubMed]
  364. Zheng, W.; Feng, Z.; You, S.; Zhang, H.; Tao, Z.; Wang, Q.; Chen, H.; Wu, Y. Fisetin inhibits IL-1β-induced inflammatory response in human osteoarthritis chondrocytes through activating SIRT1 and attenuates the progression of osteoarthritis in mice. Int. Immunopharmacol. 2017, 45, 135–147. [Google Scholar] [CrossRef] [PubMed]
  365. Cetrullo, S.; D’Adamo, S.; Guidotti, S.; Borzì, R.M.; Flamigni, F. Hydroxytyrosol prevents chondrocyte death under oxidative stress by inducing autophagy through sirtuin 1-dependent and -independent mechanisms. Biochim. Biophys. Acta 2016, 1860, 1181–1191. [Google Scholar] [CrossRef]
  366. Facchini, A.; Cetrullo, S.; D’Adamo, S.; Guidotti, S.; Minguzzi, M.; Borzì, R.M.; Flamigni, F. Hydroxytyrosol prevents increase of osteoarthritis markers in human chondrocytes treated with hydrogen peroxide or growth-related oncogene α. PLoS ONE 2014, 9, e109724. [Google Scholar] [CrossRef]
  367. D’Adamo, S.; Cetrullo, S.; Guidotti, S.; Borzì, R.M.; Flamigni, F. Hydroxytyrosol modulates the levels of microRNA-9 and its target sirtuin-1 thereby counteracting oxidative stress-induced chondrocyte death. Osteoarthr. Cartil. 2017, 25, 600–610. [Google Scholar] [CrossRef]
  368. D’Adamo, S.; Cetrullo, S.; Borzì, R.M.; Flamigni, F. Effect of oxidative stress and 3-hydroxytyrosol on DNA methylation levels of miR-9 promoters. J. Cell Mol. Med. 2019, 23, 7885–7889. [Google Scholar] [CrossRef]
  369. Bao, J.; Yan, W.; Xu, K.; Chen, M.; Chen, Z.; Ran, J.; Xiong, Y.; Wu, L. Oleanolic Acid Decreases IL-1. Oxid. Med. Cell Longev. 2020, 2020, 7517219. [Google Scholar] [CrossRef]
  370. Li, Y.; Nie, J.; Jiang, P. Oleanolic acid mitigates interleukin-1β-induced chondrocyte dysfunction by regulating miR-148-3p-modulated FGF2 expression. J. Gene Med. 2020, 22, e3169. [Google Scholar] [CrossRef]
  371. Dong, S.; Xu, G.; Li, X.; Guo, S.; Bai, J.; Zhao, J.; Chen, L. Exosomes Derived from Quercetin-Treated Bone Marrow Derived Mesenchymal Stem Cells Inhibit the Progression of Osteoarthritis Through Delivering miR-124-3p to Chondrocytes. DNA Cell Biol. 2024, 43, 85–94. [Google Scholar] [CrossRef] [PubMed]
  372. Liang, C.; Xing, H.; Wang, C.; Xu, X.; Hao, Y.; Qiu, B. Resveratrol Improves the Progression of Osteoarthritis by Regulating the SIRT1-FoxO1 Pathway-Mediated Cholesterol Metabolism. Mediators Inflamm. 2023, 2023, 2936236. [Google Scholar] [CrossRef] [PubMed]
  373. Yi, H.; Zhang, W.; Cui, S.Y.; Fan, J.B.; Zhu, X.H.; Liu, W. Identification and validation of key long non-coding RNAs in resveratrol protect against IL-1β-treated chondrocytes via integrated bioinformatic analysis. J. Orthop. Surg. Res. 2021, 16, 421. [Google Scholar] [CrossRef] [PubMed]
  374. Liu, S.; Yang, H.; Hu, B.; Zhang, M. Sirt1 regulates apoptosis and extracellular matrix degradation in resveratrol-treated osteoarthritis chondrocytes via the Wnt/β-catenin signaling pathways. Exp. Ther. Med. 2017, 14, 5057–5062. [Google Scholar] [CrossRef] [PubMed]
  375. Abed, É.; Delalandre, A.; Lajeunesse, D. Beneficial effect of resveratrol on phenotypic features and activity of osteoarthritic osteoblasts. Arthritis Res. Ther. 2017, 19, 151. [Google Scholar] [CrossRef]
  376. Yue, S.; Su, X.; Teng, J.; Wang, J.; Guo, M. Cryptotanshinone interferes with chondrocyte apoptosis in osteoarthritis by inhibiting the expression of miR-574-5p. Mol. Med. Rep. 2021, 23, 424. [Google Scholar] [CrossRef]
  377. Ye, H.; Long, Y.; Yang, J.M.; Wu, Y.L.; Dong, L.Y.; Zhong, Y.B.; Luo, Y.; Wang, M.Y. Curcumin regulates autophagy through SIRT3-SOD2-ROS signaling pathway to improve quadriceps femoris muscle atrophy in KOA rat model. Sci. Rep. 2024, 14, 8176. [Google Scholar] [CrossRef]
  378. Feng, K.; Ge, Y.; Chen, Z.; Li, X.; Liu, Z.; Li, H.; Tang, T.; Yang, F.; Wang, X. Curcumin Inhibits the PERK-eIF2. Oxid. Med. Cell Longev. 2019, 2019, 8574386. [Google Scholar] [CrossRef]
  379. Qiu, B.; Xu, X.; Yi, P.; Hao, Y. Curcumin reinforces MSC-derived exosomes in attenuating osteoarthritis via modulating the miR-124/NF-kB and miR-143/ROCK1/TLR9 signalling pathways. J. Cell Mol. Med. 2020, 24, 10855–10865. [Google Scholar] [CrossRef]
  380. Wang, X.; Li, X.; Zhou, J.; Lei, Z.; Yang, X. Fisetin suppresses chondrocyte senescence and attenuates osteoarthritis progression by targeting sirtuin 6. Chem. Biol. Interact. 2024, 390, 110890. [Google Scholar] [CrossRef]
  381. Zhi, L.Q.; Yao, S.X.; Liu, H.L.; Li, M.; Duan, N.; Ma, J.B. Hydroxytyrosol inhibits the inflammatory response of osteoarthritis chondrocytes via SIRT6-mediated autophagy. Mol. Med. Rep. 2018, 17, 4035–4042. [Google Scholar] [CrossRef]
  382. Ruan, H.; Zhu, T.; Wang, T.; Guo, Y.; Liu, Y.; Zheng, J. Quercetin Modulates Ferroptosis via the SIRT1/Nrf-2/HO-1 Pathway and Attenuates Cartilage Destruction in an Osteoarthritis Rat Model. Int. J. Mol. Sci. 2024, 25, 7461. [Google Scholar] [CrossRef] [PubMed]
  383. Feng, K.; Chen, Z.; Pengcheng, L.; Zhang, S.; Wang, X. Quercetin attenuates oxidative stress-induced apoptosis via SIRT1/AMPK-mediated inhibition of ER stress in rat chondrocytes and prevents the progression of osteoarthritis in a rat model. J. Cell Physiol. 2019, 234, 18192–18205. [Google Scholar] [CrossRef] [PubMed]
  384. Qiu, L.; Luo, Y.; Chen, X. Quercetin attenuates mitochondrial dysfunction and biogenesis via upregulated AMPK/SIRT1 signaling pathway in OA rats. Biomed. Pharmacother. 2018, 103, 1585–1591. [Google Scholar] [CrossRef]
  385. Liang, C.; Xing, H.; Wang, C.; Xu, X.; Hao, Y.; Qiu, B. Resveratrol protection against IL-1β-induced chondrocyte damage via the SIRT1/FOXO1 signaling pathway. J. Orthop. Surg. Res. 2022, 17, 406. [Google Scholar] [CrossRef] [PubMed]
  386. Zhang, G.; Zhang, H.; You, W.; Tang, X.; Li, X.; Gong, Z. Therapeutic effect of Resveratrol in the treatment of osteoarthritis via the MALAT1/miR-9/NF-κB signaling pathway. Exp. Ther. Med. 2020, 19, 2343–2352. [Google Scholar] [CrossRef] [PubMed]
  387. Lei, M.; Wang, J.G.; Xiao, D.M.; Fan, M.; Wang, D.P.; Xiong, J.Y.; Chen, Y.; Ding, Y.; Liu, S.L. Resveratrol inhibits interleukin 1β-mediated inducible nitric oxide synthase expression in articular chondrocytes by activating SIRT1 and thereby suppressing nuclear factor-κB activity. Eur. J. Pharmacol. 2012, 674, 73–79. [Google Scholar] [CrossRef]
  388. Yan, M.; Zhang, D.; Yang, M. Saikosaponin D alleviates inflammatory response of osteoarthritis and mediates autophagy via elevating microRNA-199-3p to target transcription Factor-4. J. Orthop. Surg. Res. 2024, 19, 151. [Google Scholar] [CrossRef]
  389. Dong, H.C.; Li, P.N.; Chen, C.J.; Xu, X.; Zhang, H.; Liu, G.; Zheng, L.J.; Li, P. Sinomenine Attenuates Cartilage Degeneration by Regulating miR-223-3p/NLRP3 Inflammasome Signaling. Inflammation 2019, 42, 1265–1275. [Google Scholar] [CrossRef]
  390. Li, X.; Zhang, Z.; Liang, W.; Zeng, J.; Shao, X.; Xu, L.; Jia, L.; He, X.; Li, H.; Zheng, C.; et al. Tougu Xiaotong capsules may inhibit p38 MAPK pathway-mediated inflammation: In vivo and in vitro verification. J. Ethnopharmacol. 2020, 249, 112390. [Google Scholar] [CrossRef]
Pharmaceuticals 17 01148 g001
Figure 1. Schematic representation of the classification of the main bioactive compounds in foods. Representative plant-based foods are shown, as well as sources and an illustrative chemical structure example.
Figure 1. Schematic representation of the classification of the main bioactive compounds in foods. Representative plant-based foods are shown, as well as sources and an illustrative chemical structure example.
Pharmaceuticals 17 01148 g001
Pharmaceuticals 17 01148 g002
Figure 2. Schematic representation of the impact of bioactive compounds on the main epigenetic mechanisms happening in OA. Several nutraceuticals have been considered as natural epigenetic modulators that can modify the activity of various epigenetic factors (DNA methylation, HATs, HDACs and miRNA) and, altering the expression of genes related to inflammation and cartilage destruction, being potentially able to reverse the phenotype of OA chondrocytes.
Figure 2. Schematic representation of the impact of bioactive compounds on the main epigenetic mechanisms happening in OA. Several nutraceuticals have been considered as natural epigenetic modulators that can modify the activity of various epigenetic factors (DNA methylation, HATs, HDACs and miRNA) and, altering the expression of genes related to inflammation and cartilage destruction, being potentially able to reverse the phenotype of OA chondrocytes.
Pharmaceuticals 17 01148 g002
Table 1. Bioactive compounds and nutraceuticals used for the management, treatment, or prevention of OA in humans.
Table 1. Bioactive compounds and nutraceuticals used for the management, treatment, or prevention of OA in humans.
Bioactive CompoundsSources/ClassesEffects of Bioactive Compounds Ref.
ALM16
Herbal mixture
Major active compounds:
(calycosin, calycosin-7-O-β-d-glucopyranoside)
lithospermic acid		Dried roots of:
(Astragalus membranaceus)
Isoflavonoids

(Lithospermum
erythrorhizon)
Phenolic acid		Effects in IL-1β-stimulated SW1353 chondrocytes:
Prevented glycosaminoglycan degradation
Decreased MMP-1, MMP-3 and MMP-13 levels		[146]
Anthocyanidins:
(Cyanidin-3-glucoside, pelargoni din3-glucoside)
Flavonols:
(Quercetin, kaempferol, mirycetin)
Flavanols:
(Epigallocatechin 3-gallate, catechin)
Ellagitannins		(Fragaria ananassa)
Strawberry
(Vaccinium corymbosum) Blueberry
(Punica granatum L.)
pomegranate
Approx. 40 phenolic compounds identified:
Flavonoids
Tannins		Effects in obese patients with knee OA:
Alleviated pain and enhanced quality of life
Decreased inflammatory and cartilage degradation markers
Decreased IL-6, IL-1β, and MMP-3 levels in blood samples		[147]
Effects in knee OA patients:
Decreased pain and stiffness and improved gait performance and quality of life
Improvement in daily physical activities		[148]
Effects in OA chondrocytes:
Suppressed the IL-1β-induced activation of
RUNX-2, MKK3/6 and p38-MAPK isoforms in
chondrocytes derived from OA cartilage		[149]
Effects in IL-1β-induced OA chondrocytes:
Downregulated MMP1, MMP3, and MMP13
mRNA expression
Inhibited activation of APKs and the DNA-binding activity of NF-κB 		[150]
Arctigenin
(Phenylpropanoid dibenzylbutyrolactone)		Arctium lappa
Greater burdock
Lignan		Effects in IL-1β-induced OA chondrocytes:
Decreased ECM degradation
Enhanced ECM synthesis and upregulated COL2A1 and ACAN
Downregulated MMP-13 and ADAMTS-5
Decreased IL6, NOS2, TNFA and COX2 in mRNA and protein expression
Inhibition of NF-κB/PI3K/Akt signalling pathway		[151]
Astragalin
(kaempferol 3-glu-coside)		Leaf extract of:
Rosa agrestis
Flavonoids		Effects in IL-1β-induced chondrocytes:
Inhibited inflammatory responses
Inhibited NO, PGE2, NF-κB, ERK1/2, JNK, and p38 MAPK production by PPAR-γ activation in a dose-dependent manner		[152]
Avocado/Soybean
Unsaponificables ASU
(β-sitosterol, campesterol, and stigmasterol)
Triterpenes		Persea gratissima and
Glycine max
Mixture of avocado and
soybean unsaponifiables
(Phytosterols)
Triterpene alcohols		Effects in IL-1β-induced OA chondrocytes:
Promoted cartilage repair
Inhibited IL-6, IL-8, MIP-1β, MMP-3, NO, and PGE2 production
Stimulated TIMP-1, TGF-β1, and ACAN production 		[153]
Effects in OA subchondral osteoblasts/OA chondrocytes:
Promoted regulation of anabolic and catabolic processes
Downregulated ALP, OC, and TGF-β1 levels
Prevented inhibition of ECM components (COL2A1 and ACAN mRNA expression)		[154]
Effects in LPS-stimulated monocyte/macrophage-like cell associated with the synovial membrane:
Showed anti-inflammatory effects
Supressed TNFA, IL1B, COX2, NOS2 gene expression
Downregulated PGE2 and nitrite production
[155]
Effects in chondrocytes:
Attenuated inflammatory response at both gene transcription and protein levels
Reduced G-CSF, RANTES and PGE2 levels induced by LPS
Increased 12,13-DiHOME 		[156]
Baicalin (Scutellaria baicalensis
Georgi)
Mainly extracted from
dry root
Flavone glycoside
(flavonoid)		Effects in IL-1β-induced OA chondrocytes:
Reduced COX2, NOS2, MMP3, MMP13 and
ADAMTS5 gene expression via inhibition of NF-κB activation
Inhibited NO and PGE2 production
Inhibited the downregulation of ACAN and
COL2A1 mRNA		[157]
BerberineMedicinal herbs:
Hydrastis canadensis
Berberis aristate
Cortex phellodendri
Coptis chinensis
Isoquinoline-derivative alkaloid		Effects in OA synovial fibroblast:
Attenuated CCN2-induced IL-1β expression, via inhibition of ROS-related ASK1, p38/JNK, NF-κB signalling pathways		[158]
ButeinRhus verniciflua
stem bark of cashews
and the genera Dahlia,
Butea, Searsia (Rhus)
and Coreopsis are
common sources
Chalcones (flavonoids)		Effects in IL-1β-induced OA chondrocytes:
Reduced IκB-α degradation and NF-κB p65 activation
Downregulated COX2, NOS2, IL6, TNFA, MMP13 gene and protein expression
Inhibited MMP1, MMP3, ADAMTS4 and ADAMTS5 mRNA expression
Reduced the degradation of COL2A1 and SOX9 mRNA and protein expression
Downregulated NO and PGE2 production 		[159]
Casticin
(Vitexicarpin)		Vitex rotundifolia L.
Polymethoxyflavonoid		Effects in IL-1β-induced OA chondrocytes:
Prevented inflammation by inhibition of NF-κB signalling pathway
Decreased NO, PGE2, TNF-α, IL-6, MMP-3, MMP-13, ADAMTS-4 and ADAMTS-5 production
Inhibited NOS2 and COX2 mRNA and protein expression
Increased ACAN and COL2A1 mRNA expression		[160]
Celastrol(Tripterygium wilfordii
Hook F.)
root bark “Thunder of
God Vine”
Pentaciclic Triterpenes		Effects in IL-1β-induced OA chondrocytes:
Suppressed the activation of NF-κB in human
osteoarthritic chondrocytes
Inhibited HSP90B, COX2, NOS2, MMP1, MMP3, MMP13 mRNA and protein expression
Decreased NO and PGE2 levels		[161]
Cinnamophilin(Cinnamomum philippinense)
Extracted from the root
Lignan		Effects in IL-1β-stimulated SW1353 chondrocytic cell line:
Showed chondroprotective properties against collagen matrix breakdown
Inhibited MMP-1 and MMP-13 activity via
inhibition of NF-κB, JNK, ERK, and p38 MAPK
Inhibited IκB-α degradation, and IKK-α/β and p65 phosphorylation
Blocked the activity of c-Jun by inhibition of JNK		[162]
Cryptotanshinone(Salvia miltiorrhiza
Bunge)
Extracted from the root of the plant
Diterpene quinones		Effects in IL-1β-induced OA chondrocytes:
Inhibited inflammation by suppression of nuclear translocation of NF-κB p65 and MAPK activation
Inhibited phosphorylation of IκB, IKKα/β and IκBα degradation
Suppressed NO, PGE2, IL-6, TNF-α, NOS2, COX-2, MMP-3, MMP-13, and ADAMTS-5 levels		[163]
Curcuminoids:

Curcumin
Demethoxycurcumin,
Bisdemethoxycurcumin		(Curcuma longa)
(Curcuma domestica)
Turmeric rhizome
Diarylheptanoids
(Phenolic compounds)		Effects in IL-1β-induced chondrocytes:
Protected against catabolic effects
Inhibited suppression of COL2A1 synthesis
Inhibited NF-κB signalling pathway and prevented its translocation to the nucleus
Inhibited MMP-3 synthesis 		[164]
Effects in IL-1β-induced chondrocytes:
Demonstrated chondroprotective, antiapoptotic and anti-catabolic properties
Inhibited cell degradation
Inhibited suppression of COL2A1
Increased β1-integrin receptors synthesis
Decreased caspase-3 activation (antiapoptotic effect) 		[165]
Effects in chondrocytes:
Demonstrated anti-inflammatory effects stimulated by IL-1 and TNF-α
Suppressed NF-κB activation and inhibited p65 phosphorylation and nuclear translocation
Blocked the IκBα phosphorylation and degradation
Inhibited IL-1β-induced Akt phosphorylation
Inhibited COX-2 and MMP-9 synthesis		[166]
Effects in IL-1β-induced OA chondrocytes/OA cartilage explants:
Demonstrated anti-inflammatory activity
Suppressed ECM degradation
Inhibited MMP-3, PGE2, NO, IL-6, and IL-8 production		[167]
Effects in knee OA patients:
Showed that C. domestica extracts were as efficacious as ibuprofen
Demonstrated pain reduction and functional improvement
Showed fewer gastrointestinal adverse effects than ibuprofen		[168]
Effects in knee OA patients:
Enhanced knee functions and reduced knee pain
Demonstrated the efficacy and safety of curcumin extract 2000 mg/day was equivalent to ibuprofen 800 mg/day for 6 weeks therapy		[169]
Effects in knee OA patients:
Showed potential beneficial effects as an adjuvant therapy with diclofenac in knee OA
Showed additive improvements in decreasing pain
Reduced inflammation without increasing the side effects in comparison with diclofenac alone		[170]
Effects in knee OA patients:
Proved to be a substitute treatment option in knee OA patients who are intolerant to the side effects of diclofenac
Demonstrated gastroprotective and antiulcer
effects, compared with the adverse effects of
non-steroidal anti-inflammatory drugs		[171]
Effects in IL-1β-induced temporomandibular joint chondrocytes:
Showed anti-inflammatory, antioxidant, and cartilage-protective effects by activating the NRF2/ARE (HO-1, SOD2, NQO-1, and GCLC) pathway
Inhibited NOS2, COX2, IL6, MMP1, MMP3, MMP9, MMP13, ADAMTS4 and ADAMTS5 mRNA and protein levels
Increased COL2A1 and ACAN mRNA expression 		[172]
Curcumin
nanoparticles		Topical treatmentEffects in IL1β-induced chondrocytes:
Enhanced chondroprotective properties
against the production of inflammatory and catabolic mediators
Reduced IL1B, TNFA, ADAMTS5, MMP1,
MMP3, and MMP13 mRNA expression
Increased levels of the chondroprotective transcriptional regulator CITED2 gene		[173]
Combination:
Curcumin with
resveratrol 		Resveratrol (trans-3, 4′-
trihydroxystilbene)		Effects in IL-1β-induced chondrocytes:
Inhibited inflammatory and catabolic effects and activated β1-integrin and Erk1/2
Demonstrated synergistic effects in suppressing apoptosis 		[174]
TheracurminHighly bioavailable form of curcumin
(A surface-controlled
water-dispersible form of curcumin)		Effects in knee OA patients:
Showed high bioavailability that was 27-fold higher than that of curcumin powder without adverse effects 		[175]
Effects in knee OA patients:
Showed high absorption and enhanced chondroprotective effects
Reduced pain and decreased NSAID necessity
Demonstrated anti-inflammatory effects
Showed therapeutic efficacy and safety (180 mg/day orally for six months)		[176]
RA-11
(Nutraceutical
mixture)		Curcuma longa

(Withania somnifera)
Ashwagandha
Terpenoids, flavonoids,
tannins, alkaloids
(Boswellia serrata)
Olibano
Boswellic acids
(terpenoid)
(Zingiber officinale),
Ginger Phenolic and
terpene compounds		Effects in knee OA patients:
Demonstrated greater potency, efficacy, and excellent security for OA treatment over 32 weeks of therapy
Showed significant reduction in the pain VAS and the modified WOMAC index scores (pain, stiffness, and physical function difficulty)		[177]
Phytosome
complex (Meriva)		Curcuminoid mixture with
phosphatidylcholine (soy lecithin, a phospholipid) 		Effects in OA patients:
Improved oral absorption and bioavailability
Reduced all WOMAC scores after eight months of treatment with 200 mg curcumin/d
Decreased inflammatory markers sCD40L, IL-1β, IL-6, sVCAM-1, and ESR
Decreased use of NSAIDs/painkillers and gastrointestinal complications
Improved emotional functions and quality of life		[178]
Effects in IL-1β-induced HCH-c chondrocytes:
Improved the solubility of curcumin and enhanced the chondroprotective effect via the anti-inflammatory system in chondrocytes
Suppressed MMP1, MMP2, MMP3, MMP9, MMP13, NOS2 and COX2 mRNA expressions
Inhibited TNF-α, IL-1β, IL-6, IL-8 and PGE2 levels		[179]
Mixture:
Curcuminoids
Hydrolysed
collagen and
Epigallocatechin-3-gallate		(Curcuma longa L.)
Turmeric rhizome
Polyphenols
Hydrolysed collagen
(High levels of glycine
and proline, amino acids for the stability and regeneration of cartilage)
(Camellia sinensis)
Green tea
Epigallocatechin-3-gallate (flavanol) 		Effects in IL-1β-induced OA chondrocytes:
Showed additive and synergistic effects
Demonstrated to be significantly more efficient in inhibiting inflammation and catabolic processes
Suppressed NF-κB activation and its translocation to the nucleus via inhibition of phosphorylation and degradation of IκBα and p65 phosphorylation
Inhibited MMP-3, IL-6, NO production		[180]
Combination:
Curcumin
Flavocoxid: baicalin and catechin
β-caryophyllene 		(Curcuma longa)
Phenolic compounds
(Scutellaria baicalensis, Baikal skullcap) and (Acacia catechu, catechu)
Baicalin and catechin
Flavonoids (Copaifera spp, copaiba) and (Cannabis spp., marijuana/hemp)
β-caryophyllene, a (bicyclic sesquiterpene)		Effects in LPS and IL-1β-stimulated chondrocytes:
Demonstrated anti-inflammatory activity and safety and did not affect cell viability in chondrocytes
Reduced IL1B mRNA in a dose-dependent manner
Showed strong synergy potential for OA treatment
Reduced the mRNA expression of transcription factors NFKB and STAT3
Increased COL2A1 mRNA expression 		[181]
Botanical formulation
(Mixodin):
Curcumin,
Gingerols, and
Pyrene		(Curcuma longa)
Turmeric
Phenolic compounds
(Zingiber officinale)
Ginger
Gingerols
Phenolic compounds
(Piper nigrum)
Black pepper
Pyrene (Alkaloid)		Effects in knee OA patients:
Showed synergic, anti-inflammatory and hypoalgesic effects in chronic knee OA (twice a day for 4 weeks)
Observed as a safe alternative to chemical drugs, with lower adverse effects than Naproxen
Decreased PGE2 levels in blood samples (curcumin 300 mg, gingerols 7.5 mg, and piperine 3.75 mg) similar to Naproxen drug (250 mg twice/day)		[182]
Botanical composition
NXT15906F6: ethanol/aqueous extract of tamarind seed (proantocyanidins) and aqueous ethanol extract of turmeric (curcuminoids)
NXT19185: (combination of NXT15906F6 plus an aqueous ethanol extract of mangosteen (α-mangostin, β-mangostin, and γ-mangostin) and (epicatechin and quercetin)		Tamarindus indica
Tamarind seeds
Polyphenols

Curcuma longa

Garcinia mangostana
fruit rind
Polyphenolic xanthones
Flavonoids		Effects in knee OA patients/serum/urine:
NXT15906F6 (250 mg) or NXT19185 (300 mg) daily for 50–6 days
Decreased inflammatory processes, joint pain and stiffness
Improved musculoskeletal function
Inhibited TNF-α, IL-6, MMP-3 and CRP levels in serum
Protected against cartilage erosion
Reduced CTX-II (a cartilage degradation marker) in a urine sample
Reduced WOMAC, VAS, stair climb test scores
Improved Lequesne’s functional index, the 6-min walk test and knee flexion range of motion scores		[183]
Botanical composition
(LI73014F2 2:1:2 ratio):
Gallic acid, chebulagic acid,
chebulic acid, chebulinic acid, gallotannins, ellagitannins (punicalagin), ellagic acid

Diferuloylmethane
Demethoxycurcumin
Bisdemethoxycurcumin, and turmeric acid

Boswellic acids:
3-O-acetyl-11-keto-β-boswellic acid, 11-keto-β-boswellic acid, and β-boswellic acid 		(Terminalia chebula)
fruit myrobalan
Tannins (polyphenols)





(Curcuma longa)
Polyphenols



(Boswellia serrata)
Olibanum
Pentacyclic triterpenes 		Effects in IL-1β-induced HCHs chondrocytes:
Reduced inflammation and apoptosis via NF-κB/MAPK signalling pathway inhibition
Inhibited pro-inflammatory mediators (COX-2, 5-LOX, and metabolic pathways products mPGES-1, PGE2, and LTB-4)
Decreased IL-1β, TNF-α, IL-6, MMP-2, MMP-3, MMP-9 and MMP-13 protein levels
Provided therapeutic efficacy in OA management by reducing cartilage damage		[184]
DelphinidinPomegranate, berries,
dark grapes, aubergine,
tomato, carrot, purple
sweet potatoes, red cabbage, and red onion
Anthocyanidin
(Flavonoid)
Delphinidin, the most
abundant anthocyanidin
present in pomegranate
fruit extract (Punica granatum)		Effects in IL-1β-induced OA chondrocytes:
Inhibited phosphorylation of IκB, IKKα/β, NIK, IRAK1
Inhibited COX2 mRNA and protein expression and PGE2 production via suppression of NF-κB activation
Downregulated IKKB mRNA and protein expression		[185]
Ellagic acidFruit peel of raspberries,
strawberries, cranberries,
pomegranate, walnuts,
pecans, grapes
Dimeric derivative of
gallic acid
Phenolic compound		Effects in IL-1β-induced OA chondrocytes:
Inhibited inflammation and ECM loss
Upregulated COL2A1 and ACAN
Suppressed NF-κB p65 activation
Decreased NO, PGE2, IL-6, TNF-α, ADAMTS-5 and MMP-13 in a dose-dependent manner
Inhibited NOS2, COX2 mRNA and protein expression		[186]
Epigallocatechin-3-O-gallate Camellia sinensis
Green tea
Flavan-3-ols or flavanols
(Flavonoids)		Effects in IL-1β-induced chondrocytes:
Showed anti-inflammatory and anti-catabolic effects in a dose-dependent manner
Inhibited MMP1 and MMP13 mRNA and protein expression
Inhibited NF-κB and AP1 levels
Effects in cartilage explants:
Inhibited cartilage matrix degradation
Downregulated glycosaminoglycans release
[187]
Effects in IL-1β-induced OA synovial fibroblasts:
Showed efficacy in the control of inflammation
Inhibited COX2 mRNA and protein expression
Supressed PGE2 and IL-8 production
[188]
Effects in IL-1β-induced OA chondrocytes:
Decreased NOS2 mRNA and protein expression and NO production
Inhibited NF-κB p65 activation and translocation to the nucleus by suppressing the degradation of its inhibitory protein IκBα in the cytoplasm
[189]
Effects in IL-1β-induced chondrocytes:
Antioxidant properties against cytotoxicity
Inhibited ROS release and accumulation from both intracellular and extracellular environments
Inhibited PGE-2, NO, COX-2 and NOS2 production
[190]
Effects in IL-1β-induced OA chondrocytes:
Inhibited catabolic mediators of cartilage degradation
Inhibited JNK isoforms phosphorylation and activation
Blocked c-Jun phosphorylation in the cytoplasm and reduced the DNA binding activity of AP-1 in the nuclei		[191]
Effects in OA chondrocytes:
Suppressed the AGE-induced TNFA and MMP13 mRNA and protein expression
Inhibited AGE-BSA-induced degradation of IκBα and nuclear translocation of NF-κB p65
Inhibited MAPK and NF-κB activation 		[192]
Effects in IL-1β-stimulated OA chondrocytes:
Showed anti-inflammatory activity
Inhibited NF-κB and MAPKs pathway
Inhibited TRAF6 mRNA and protein expression
Downregulated IL6, IL8, TNFA, IL1B, IL7 and
GMCSF mRNA and protein expression
Blocked ENA78, GRO, GROA, MCP1, MIP1B, MIP3A, GCP2, IP10 and NAP2 chemokines’ expression		[193]
Fatty acids
n-3 PUFAs
omega 3
polyunsaturated
fatty acids		Soybean, canola, olive
oils, flaxseed, walnuts,
marine phytoplankton
and fish oil
ALA: α-linolenic acid
EPA: eicosapentaenoic
DHA: docosahexaenoic		EPA decreased MMP3 and MMP13 mRNA
EPA decreased chondrocyte apoptosis by inhibiting oxidative stress-induced phosphorylation of p38 MAPK and p53 		[194]
Genistein(Gycine max)
soybean
Isoflavone (flavonoids)		Effects in LPS-induced chondrocytes:
Suppressed COX-2 and NO protein levels in a dose-dependent manner
Reduced IL-1β and YKL-40 (a marker of cartilage degradation) levels		[195]
Effects in IL-1β-induced OA chondrocytes:
Reduced inflammation and oxidative stress
Decreased MMP-1, MMP-3, MMP-13, MMP-9, NO, COX-2, NOS2
Stimulated HO-1 associated with NRF-2 pathway activation		[196]
Effects in IL-1β-induced chondrocytes:
Upregulated COL2A1, ACAN and ERα protein expression in a dose-dependent manner
Inhibited apoptosis
Reduced caspase-3 and TNF-α levels		[197]
Gingerols
Shogaols 		Zingiber officinale and
Alpinia galanga
Phenolic compounds		Effects in knee OA patients:
Demonstrated improvements in WOMAC index and VAS pain profiles (6 weeks treatment 225 mg/twice day)
Showed a good safety profile with mostly mild gastrointestinal side effects		[198]
Effects in knee OA patients:
Reduced inflammatory markers (1 g/d for 3 months)
Decreased CRP and NO in serum and improved pain and mobility		[199]
Gingerols and
shogaols +
isobutylamides and 2- methylbutylamimide		Highly standardized ginger and echinacea extract
Zingiber officinale
Echinacea angustifolia
Roots (alkylamides:
fatty acid amides)		Effects in knee OA patients:
Showed anti-inflammatory, synergistic properties during four-week supplementation
Reduced chronic pain and improved knee function
Showed to be secure without important side effects
Could be an alternative for NSAIDs non-responders		[200]
Gingerols
Shogaols
Nanoparticles		Zingiber officinale
ginger extract in
nanostructure lipid
carrier		Effects in knee OA patients:
Decreased stiffness and the reduction in pain was significantly greater than compared to topical diclofenac (12 weeks treatment)
Improved physical function		[201]
Gingerols, shogaols and Spilanthol
(MITIDOL)		Zingiber officinale
Acmella oleracea
Sphilantol (alkamide)
food-grade lecithin formulation of standardized extracts		Effects in knee OA patients:
Inflammatory markers’ reduction (CRP and erythrocyte sedimentation rate)
Antioxidant and analgesic properties
Improved knee function and free of side effects		[202]
Harpargoside, Harpagide y
Procumbide
β-cariofileno, α-humuleno y α-copaeno
Oleanolic acid, Ursolic acid and 3β-acetyloleanolic acid
Eugenol
Acteoside and Isoacteoside		Harpagophytum
procumbens (HP)
devil’s claw root
HP extract
Iridoid glucosides
Sesquiterpenes
Triterpenes
Monoterpene
Phenolic glycosides		Effects in fibroblast-like synoviocytes/synovial
membrane/OA patients:
Showed anti-inflammatory and antinociceptive effects
HPEH2O, HPEDMSO increased CB2 mRNA expression and inhibited PI-PLC β2 isoform expression
All the HPE extracts inhibited FAAH mRNA expression and enzymatic activity (HPEEtOH100 was the most effective)		[203]
Effects in IL-1β-induced chondrocytes:
Suppressed inflammatory cytokines/chemokines
Inhibited IL6, and MMP13 mRNA expression
Suppressed c-FOS/AP-1 transcription factor		[204]
Effects in knee and hip OA patients:
Showed efficacy and superior safety as a therapeutic agent (2610 mg of powdered cryoground) compared to diacerhein (100 mg/day) for 4 months
Showed lower adverse effects than diacerhein		[205,206]
Effects in IL-1β-induced chondrocytes:
Suppressed MMP-1, MMP-3 and MMP-9 production via inhibition of inflammatory cytokines TNF-α and IL-1β synthesis		[207]
Hydroxytyrosol (HT)Olea europea L.
Olive leaf extract
Fruits
Extra virgin oil
HT is more abundant in
the processed fruit and
olive oil
Secoiridoid derivative		Effects in knee OA patients:
Demonstrated pain inhibition over a 4-week period
Decreased pain measurement index (Japanese Orthopedic Association score) and VAS scores
HT was considered effective when it reached the knee joint in an unmetabolized form
Showed antioxidant and anti-inflammatory properties		[208]
HT and
Verbascoside		Verbascoside:
Hydroxycinnamic acid
derivative (phenolic
compound)		Effects in OA chondrocytes:
Showed chondroprotective effects and reduced intracellular ROS generation
Suppressed oxidative stress via p38 and JNK signalling pathways
HT downregulated ICE/caspase-1 indicating a potential anti-inflammatory effect		[209]
Hydroxytyrosol/
Procyanidins

(Oleogrape®SEED)		Extract from olive and
grape seed:
(Olea europea L.)
mainly found in olive leaf and oil
Phenolic compound

(Vitis vinifera, grape)
Flavonoids
Other sources: pine bark, cocoa, raspberry, vegetables, legumes, nuts		Effects in IL-1β-induced chondrocytes:
Demonstrated chondroprotective properties
Decreased NO, PGE2, and MMP-13 production
Reduced NF-κB p65 signalling pathway
Effects of serum enriched with HT/procyanidins metabolites on primary articular chondrocytes stimulated with IL-1β (ex vivo methodology):
Reduced NO, PGE2, and MMP-13 levels		[210]
IcariinEpimedium sagittatum
flavonol glycoside		Effects in OA fibroblast-like synoviocytes:
Inhibited inflammatory response, apoptosis, ER stress and ECM degradation
Decreased IL1β, MMP14, and GRP78 gene and protein expression 		[211]
Effects in IL-1β-induced SW1353 chondrosarcoma cells:
Showed chondroprotective properties and inhibited MMP1, MMP3 and MMP13 gene and protein expression via MAPK pathways
Inhibited p38, ERK and JNK phosphorylation		[212]
Effects in IL-1β-induced chondrocytes:
Demonstrated chondroprotective and antioxidant functions without cytotoxic effects by activation of NRF2 mRNA
Inhibited ECM degradation and ROS production
Promoted SOD1, SOD2 mRNA and GPX activity
Decreased MMP3, MMP9, MMP13 and ADAMTS4 mRNA expression		[213]
Indole tetracyclic alkaloids
Oxindole alkaloids
Indole pentacyclic alkaloid
Glycoindole alkaloids
Quinovic acids
Tannins		Uncaria guianensis
Uncaria tomentosa
Cat’s claw
alkaloids
Triterpenes heterosides
polyphenols		Effects in knee OA patients:
Showed antioxidants and anti-inflammatory
properties
Alleviated knee pain and promoted benefit to the joints, tolerability and safety at high concentrations
Reduced the toxic side effects of NSAIDs and had no deleterious effects on blood or liver function or other significant side-effect
Improved OA management and treatment		[214]
Isofraxidin Siberian ginseng and
Apium graveolens
Coumarin (phenolic
compound)		Effects in LPS-induced OA chondrocytes:
Decreased iNOS, COX-2, NO, PGE2, TNF-α and
IL-6 levels
Suppressed ECM degradation
Inhibited TLR4/MD-2 complex formation and NF-κB signalling pathway 		[215]
Effects in IL-1β-induced OA chondrocytes:
Suppressed inflammatory mediators and ECM degradation through inhibiting the NF-κB pathway
Inhibited IκB-α degradation
Blocked NO and PGE2 production
Inhibited COX2, NOS2, MMP1, MMP3, MMP13, ADAMTS4 and ADAMTS5 mRNA expression and protein levels
Increased ACAN and COL2A1 levels 		[216]
JuglaninPolygonum aviculare
Juglans regia L.
Diarylheptanoid derivative
Flavonoids		Effects in IL-1β-induced OA chondrocytes:
Inhibited inflammatory responses through
suppressing phosphorylation of NF-κB p65
Suppressed IκBα degradation
Inhibited NO, PGE2, IL-6, TNF-α, MMP-1, MMP-3, and MMP-13 levels
Decreased NOS2, COX2, ADAMTS4 and
ADAMTS5 mRNA and protein expression		[217]
Licochalcone A Glycyrrhiza glabra,
liquorice root
Glycyrrhiza inflate
Flavonoids		Effects in IL-1β or TNF-α-induced OA chondrocytes:
Showed anti-inflammatory properties
Inhibited PGE2 and NO production
Inhibited MMP-1, MMP-3, and MMP-13 levels
Inhibited NOS2 and COX2 mRNA expression
Inhibited NF-κB activation and IκBα degradation
Increased NRF2 and HO1 mRNA and protein expression 		[218]
Acetylated ligstroside aglycone:
(Chemically acetylated version of ligstroside aglycone)		(Olea europea L.)
Extra virgin olive oil
Ligstroside aglycone
(p-HPEA-Elenolic acid)
Secoiridoids		Effects in IL-1β/OSM-induced OA chondrocytes/OA cartilage:
Reduced NOS2, MMP13 gene and protein expression
Enhanced anti-inflammatory activity compared to the natural compound ligstroside
Inhibited NO levels, proteoglycan (PG) loss and cartilage degradation 		[219]
Myrcene Eryngium duriaei
monoterpene		Effects in IL-1β-induced chondrocytes:
Showed anti-inflammatory and anti-catabolic properties in human chondrocytes
Inhibited NOS2 mRNA expression and activity, and the NF-κB pathway
Reduced MMP1 and MMP13 gene expression
Decreased the phosphorylation of JNK, p38, and ERK1/2
Increased TIMP1 and TIMP3 mRNA
Decreased COL1 mRNA and promoted the
maintenance of the differentiated chondrocyte phenotype		[220]
MyricetinLabisia pumila
Trigonella foenum graecum L.
Anacardium and Mangifera species (Anacardiaceae)
Grapes, berries, chard spinach, broadbeans, garlic, peppers
Flavonol		Effects in IL-1β stimulated chondrocytes:
Inhibited inflammatory mediators and cytokines and exerted no significant dose-dependent cytotoxicity
Inhibited NOS2 and COX2 mRNA and protein
Decreased NO and PGE2 production
Suppressed TNF-α and IL-6 levels
Inhibited ECM degradation and inhibited
ADAMTS5 and MMP13 gene expression
Promoted ACAN and COL2A1 gene
Inhibited NF-κB p65 nuclear translocation and activation and inhibited IκBα degradation
Increased NRF2 translocation into the nucleus and activation, and HO-1 expression in cytoplasm against inflammation response via PI3K/Akt		[221]
Oleocanthal
(decarboxymethyl ligstroside
aglycone)		(Olea europea L.)
Fruits, leaves, extra virgin oil
Secoiridoid derivative
(Phenolic compounds)		Effects in LPS-activated OA chondrocytes:
Suppressed inflammation and OA progression
Blocked MAPKs/NF-κB pathways
Inhibition of NOS2 and NO protein synthesis
Inhibited IL6, IL8, COX2, NOS2, MIP1α, TNFA, LCN2, MMP13 and ADAMTS5 mRNA expression		[222]
Oleuropein(Olea europea L.)
Olive leaves and seeds,
pulp and peel of unripe
olives, extra virgin oil
High amounts in unprocessed olive fruit
Secoiridoid (phenolic
compounds)		Effects in IL-1β-stimulated OA chondrocytes:
Suppressed phosphorylation of NF-κB p65 and nuclear translocation, IκB-α degradation, and MAPK activation
Inhibited COX2, NOS2, MMP1, MMP13, and
ADAMTS5 mRNA expression
Inhibited degradation of ACAN and COL2A1
Inhibited NO and PGE2 production		[223]
Effects in primary OA chondrocytes (OACs)/human mesenchymal stem cells/synoviocytes/bone cells:
Reduced connexin 43 protein expression, gap junction intercellular communication and TWIST1 mRNA and increased COL2A1 and ACAN mRNA in OACs
Reduced inflammatory and catabolic factors
IL1B, IL6, COX2 and MMP3 mRNA expression and protein levels in OACs
Restored chondrocyte phenotype
Enhanced osteogenesis and chondrogenesis in hMSCs
Improved cartilage and joint regeneration
Caused a significant reduction in senescent cells in OACs, synoviocytes and bone cells		[224]
Oleuropein
Hydroxytyrosol,
Verbascoside,
Luteolin,
(ZeyEX)		(Olea europaea L., olive
leaves)
Olive leaf extract
Polyphenolic compounds		Effects in OA chondrocytes:
Inhibited IL-6, IL-1β, and TNF-α and improved COL2A1 levels
Inhibited p-JNK/JNK ratio but no effect of ibuprofen
Inhibited Casp-1/ICE, ROS, lipid hydroperoxide, 4-Hydroxynonenal-protein adduct, advanced glycation (glycoxidation) end product protein adduct AGE, 3-Nitrotyrosine 3-NT, GM-CSF, COMP, receptor for advanced glycation end product RAGE and TLR4 levels		[225]
Puerarin
(Radix puerariae)
Root of Pueraria
Phytoestrogen
(Isoflavone)		Effects in IL-1β-induced OA chondrocytes:
Showed antioxidative and anti-inflammatory
effects and increased cell proliferation
Decreased PGE-2, IL-6 and TNF-α levels
Effects in IL-1β-treated monocytes/macrophage:
Reduced IL-6, IL-12 and TNF-α expression
Increased TGF-β1 and IL-10 levels		[226]
Quercetin (Achyranthes bidentata)
Flavonol (flavonoid) 		The docking of PIM1-quercetin, CYP1B1-quercetin, and HSPA2-quercetin by Achyranthes bidentate were the key targeted proteins of quercetin in the treatment of OA [227]
ResveratrolRoot extracts of the weed Polylygonum cuspidatum
Vitis vinifera
red grapes, blueberries
cranberries, peanuts,
Stilbenes (polyphenols)		Effects in IL-1β-induced SW1353 cell line:
TLR4 inhibition related to PI3K/Akt activation
PI3K/Akt activation was attenuated after the TLR-4 pathway was blocked by the TLR-4 inhibitor CLI-095
Unable to reduce TLR4 protein expression after the PI3K inhibitor LY294002 blocked PI3K/Akt signalling		[228]
Effects in knee OA patients:
Demonstrated efficacy and safety as an adjuvant with meloxican during a 90-day period
Decreased knee joint pain (dose 500 mg/day) without adverse effects
Effects in serum:
Decreased biomarkers of inflammation IL-1β, IL-6, TNF-α, CRP		[229]
Effects in IL-1β-stimulated chondrocytes:
Showed chondroprotective effects
Suppressed the activation of IL-1β-induced catabolism and apoptosis in human chondrocytes in vitro
Blocked the downregulation of cartilage matrix marker COL2A1 and the cell matrix receptor β1-integrin protein expression
Inhibited caspase-3 activation and PARP cleavage in a time-dependent manner		[230]
Effects in IL-1β-stimulated chondrocytes:
Protected against catabolic effects
Inhibited membrane-bound IL-1β and mature IL-1β protein production
Inhibited p53 accumulation in a dose-dependent manner and produced degradation of p53 by the ubiquitin-independent pathway
Inhibited p53-dependent apoptosis
Suppressed ROS, caspase 3 activation, and PARP cleavage		[231]
Effects in IL-1β-stimulated OA chondrocytes:
Blocked mitochondrial membrane depolarization, maintained mitochondrial function and restored ATP levels
Inhibited apoptosis via the inhibition of PGE2 through the suppression of COX2 mRNA and protein expression
Reduced (apoptotic markers) cytochrome c release from mitochondria and annexin V
Inhibited DNA fragmentation
Effects of IL-1β-stimulated OA cartilage explants:
Increased PG synthesis
Decreased MMP-1, MMP-3, MMP-13
Inhibited PGE2 and leukotriene B4 levels 		[232]
Effects in IL-1β-induced SW1353 cells:
Demonstrated anti-inflammatory and anti-osteoarthritic properties
Inhibited TLR4/NF-кB and inflammatory responses via the inhibition of MyD88-dependent and -independent signalling pathways
Decreased IL-6 levels
Activated PI3K/Akt pathway and deactivated FoxO1 in a time-dependent manner
Inactivated FoxO1 reduced TLR4 expression and inflammation
PI3K/Akt and FoxO1 are TLR4-regulated
Established a self-limiting system of inflammation		[233]
Mixture
Resveratrol and
Curcumin		(Phenolic compounds)Effects in IL-1β-induced chondrocytes:
Anti-inflammatory, antiapoptotic and anti-cytotoxic synergistic effects
Increased antiapoptotic proteins Bcl-2, Bcl-xL and Traf1 in a time-dependent manner
Supressed NF-κB activation and nuclear translocation in a time- and concentration-dependent manner
Inhibited COX-2, MMP-3, MMP-9, VEGF, caspase-3, and PARP cleavage levels
Increased COL2A1 and SOX-9 production
Resveratrol blocked IκBα degradation and curcumin inhibited IKK		[234]
Effects in IL-1β- or U0126-stimulated chondrocytes:
Showed synergistic chondroprotective efficacy and ameliorated inflammatory effects
Decreased apoptotic cells and resveratrol potentiated antiapoptotic effects of curcumin
Inhibited caspase-3 activation and degradation of β-integrins
Blocked the downregulation of Erk1/2 in a dose- and time-dependent manner		[174]
SanguinarineThe roots of:
Sanguinaria canadensis
Benzophenanthridine
alkaloid		Effects in IL-1β-induced chondrocytes:
Inhibited OA progression
Inhibited MMP1a, MMP3, MMP13, and ADAMTS5 mRNA and protein expression
Inhibited NF-κB and JNK signalling pathways 		[235]
Schisantherin A The fruits of:
Schisandra sphenathera
Dibenzocyclooctadiene
Lignan		Effects in IL-1β-induced chondrocytes:
Anti-inflammatory and chondroprotective
Inhibited NOS2, COX-2, NO, PGE2, and TNF-α, MMP-1, MMP-3, and MMP-13 production
Inhibited NF-κB p65 translocation to the nucleus, and inhibited MAPKs activation and IκBα degradation in a dose-dependent manner		[236]
SesaminSesamun indicum
sesame seed oil
lignan		Effects in IL-1β induced chondrocytes:
Inhibited p38 and JNK phosphorylation
Decreased MMP1, MMP3 and MMP13 mRNA and protein expression 		[237]
SulforaphaneBrassica oleracea italica
cruciferous vegetables
(abundant in broccoli)
Isothiocyanate		Effects in IL-1β- or TNF-α-treated OA chondrocytes/cartilage explant:
Showed anti-inflammatory and immune-modulatory effects
Induced the phase 2 enzymes activity NQO1 (one of the most potent inducers)
Inhibited NF-κB p65 pathway by down-regulating IκB-α degradation and IKK-αβ and IκB-α phosphorylation
Inhibited COX2, PTGES and NOS2 mRNA and protein expression even at low concentrations
Inhibited PGE2 and NO production in chondrocytes and explant culture
Suppressed PG and COL2A1 degradation in cartilage explant culture		[238]
Effects in IL-1 or TNF-α-treated OA chondrocytes:
Sulforaphane was not cytotoxic at up to 20 μM
Demonstrated anti-inflammatory mechanism
mediated by NQO1 activity
Inhibited NF-κB and JNK activation
Inhibited MMP1, MMP3 and MMP13 mRNA and protein expression		[239]
Effects in C-28/I2 cell line/OA chondrocytes induced by TNF/CHX, DENSPM/CHX, H2O2 GROα:
Showed cytoprotective effects
Inhibited apoptosis, hypertrophic differentiation and ECM degradation
Reduced the active/phosphorylated JNK
Inhibition of p38 MAPK phosphorylation and suppressed caspase 3, caspase 8 and caspase 9 activation
Increased active/phosphorylated Akt protein		[240]
Effects in IL-1/OSM-induced OA chondrocytes/SW-1353 cell line/synovial cells:
Inhibited ADAMTS4, ADAMTS5, MMP1, MMP13, and mRNA expression (sulforaphane acted independently of NRF2) in chondrocytes and synoviocytes
Induced HMOX1 (an NRF2-regulated gene) mRNA expression
Inhibited NOS2, IL6, IL8 genes
Blocked inflammation and inhibited cartilage destruction by attenuating NF-κB signalling
Inhibition of p38 MAPK isoform
Accumulated sulforaphane-GSH metabolites		[241]
Effects in knee OA patients:
Isothiocyanates were detected in the synovial fluid and in blood plasma of the high glucosinolate group, but not the low one
Demonstrated biological impact on the joint tissues
Synovial fluid protein profile and common plasma proteins showed significantly different levels of expression between both groups
Decreased CXCL10 and increased IRX3 in fat tissue in the high-glucosinolate group 		[242]
Sulforaphane–
microsphere system		Sulforaphane-Poly (D, L-lactic-co-glycolic) acid (PLGA) microspheresEffects in LPS-induced OA chondrocytes:
Showed chondroprotective properties
Inhibited anti-inflammatory markers
Inhibited COX2, ADAMTS5 and MMP2 mRNA and protein expression 		[243]
TaraxasterolTaraxacum officinale
Pentacyclic-triterpene		Effects in IL-1β-stimulated chondrocytes:
Suppressed inflammatory mediators via
inhibition of NF-κB p65 translocation from
cytoplasm to nucleus and IκBα degradation
Inhibited NO, NOS2, PGE2, COX-2, MMP-1, MMP-3, and MMP-13 production in a dose-dependent manner		[244]
Terpenoid compounds
(tuberatoide B, loliolide,
sargachromenol, sargachromanol D,
sargachromanol G,
sargaquinoic acid,
sargahydroquinoic acid, isoketocharolic acid/IKCA,
isonahocol E3, and fucosterol)
Phlorotannins
Eicosapentaenoic acid EPA		Sargassum seaweed
(Terpenoids)
Polyphenols
Fatty acid		Effects in IL-1β-induced SW1353 cell line:
Inhibited oxidative stress and inflammatory responses
Suppressed NF-κB, p38 MAPK, and PI3K/Akt signalling pathways
Inhibited IL-1β-induced NOS2 and COX2 mRNA and protein expression
Decreased NO and PGE2 production
Inhibited IL-1β-induced MMP1, MMP3, and MMP13 mRNA and protein expression 		[245]
Thymoquinone
(active metabolite)		Nigella sativa
Black cumin oil
Monoterpene		Effects in IL-1β-stimulated OA chondrocytes:
Showed chondroprotective and anti-inflammatory effects via inhibition of NF-κB p65 and MAPKs activation
Inhibited IκBα degradation
Suppressed COX-2, NOS2, NO, PGE2, MMP-1, MMP-3, and MMP-13 production 		[246]
WogoninThe root extract of:
Scutellaria baicalensis
Flavone 		Effects in IL-1β-induced OA chondrocytes:
Showed chondroprotective effects
Decreased IL6 and MMP13 mRNA and protein expression in a dose-dependent manner
Suppressed MMP3, MMP9 and ADAMTS4 mRNA expression
Suppressed oxidative and nitrosative stress by suppressing NOS2 gene and protein expression, ROS and reactive nitrogen species
Supressed COX2 mRNA and protein expression and PGE2 production
Inhibited c-Fos/AP-1 activity
Enhanced COL2A1 and ACAN gene expression		[247]
Effects in IL-1β-induced OA cartilage explant:
Suppressed glycosaminoglycan release
Effects in IL-1β-induced OA chondrocytes:
Suppressed oxidative stress, inflammation and matrix degradation
Increased NRF2 activation and activated transcription of NRF2-dependent genes HO1, GCLC, SOD2 and NQO1 and the upstream kinase ERK1/2
Inhibited MMP13, MMP3, MMP9, ADAMTS4 mRNA expression and protein expression
Inhibited IL6, COX2 and NOS2 mRNA and protein expression
Inhibited NO and PGE2 production
Upregulated COL2A1, and ACAN mRNA and protein expression
Effects in IL-1β-induced cartilage explants:
Restored COL2A1 and GAG contents in a dose-dependent manner		[248]
Effects in IL-1β-induced OA chondrocytes:
Demonstrated cytoprotective properties
Showed genomic DNA binding ability through intercalation mechanism, and the intercalation was found between DNA base pairs guanine and cytosine
Inhibited genomic DNA fragmentation and ROS generation
Provided stability of DNA against chemical denaturation
Inhibited DNA denaturation mediated by dimethylsulphoxide (DMSO)
Inhibited apoptosis and apoptotic pathways and upregulated antiapoptotic proteins 		[249]
Table 2. Bioactive compounds and nutraceuticals for the management, treatment, or prevention of OA in animals.
Table 2. Bioactive compounds and nutraceuticals for the management, treatment, or prevention of OA in animals.
Bioactive CompoundsSources/ClassesEffects of Bioactive Compounds Ref.
ALM16
Herbal mixture
Major active compounds:
(calycosin,
calycosin-7-O-β-D-glucopyranoside)
lithospermic acid		Dried roots of
(Astragalus
membranaceus)
Isoflavonoids

(Lithospermum
erythrorhizon)
Phenolic acid		Effects in OA cartilage/OA-induced rats:
Showed synergistic or additive chondroprotective properties of each extract
Demonstrated a potent protective effect on articular cartilage, anti-inflammatory and analgesic actions (dose 200 mg/Kg)
Attenuated histopathological lesions in cartilage, pain symptoms, mechanical allodynia, and thickness of the paw edema 		[146]
Amurensin H
(Vam3) 		Vitis amurensis
Dihydroxy-stilbene
Oligostilbenoid
(resveratrol dimer)		Effects in IL-1β-stimulated rat chondrocytes:
Showed anti-inflammatory and chondroprotective effects
Inhibited oxidative stress, mitochondrial damage and ECM degradation (increased glycosaminoglycan and Col2a1 levels)
Inhibited Nos2, nitric oxide, Pge2, Cox-2, Il-6, Il-17, Tnf-α, Mmp-9, Mmp-13 levels, Tlr4, Traf-6, Syk and Nf-κb protein expression in a dose-dependent manner
Effects in OA cartilage/subchondral bone:
decreased OA progression, cartilage fibrillation, cartilage loss, subchondral bone erosion and inflammation 		[250]
Arctigenin
(Phenylpropanoid dibenzylbutyrolactone)		Arctium lappa
Greater burdock
Lignan		Effects in OA cartilage
Inhibited OA development, attenuated histological damage and showed lower OARSI score
Mitigated cartilage erosion, hypocellularity and PG loss		[152]
Artesunate
(Artemisinin)		Artemissia annua
Sesquiterpene lactone		Effects in osteoclast/synovium/OA-induced rat:
Showed anti-inflammatory activity
Inhibited osteoclastogenesis and angiogenesis
Downregulated Vegf, Hgf and Angp1
Inhibited Il-6, Il-1β, Tnf-α, Pge2 activity and JAK/STAT pathway
Increased Col2a1, Il-4, Igf-1 and Tgf-β 		[251]
Effects in rat OA cartilage:
Inhibited OA development
Upregulated Igf-1 and reduced Opn and c-telopeptides of type II collagen levels 		[252]
Avocado/soybean
Unsaponificables ASU
(β-sitosterol, campesterol, and
stigmasterol)
Triterpenes		Persea gratissima and
Glycine max
mixture of avocado and
soybean unsaponifiables
(Phytosterols)
Triterpene alcohols		Effects in bovine articular chondrocytes:
Showed chondroprotective properties
Enhanced Tgfb1, Tgfb2 mRNA expression
Increased Pai-1 production
Induced ECM repair mechanisms 		[253]
Effects in bovine chondrocytes:
Showed anti-inflammatory effects
Reduced the progression of cartilage damage
Inhibited Tnfa, Il1b, Cox2, and Nos2 gene expression and downregulated Pge2 and nitrite production in LPS-activated chondrocytes		[159]
Effects in OA cartilage/synovial membrane/subchondral bone/OA-induced rat:
Showed anti-oxidative and anti-inflammatory properties in MIA-induced OA rat
Reduced histopathological damage of all joint tissues with a significant decrease in the Mankin score
Decreased Tnf-α and Mmp-13 and increased Col2a1 and Acan synthesis
Reduced Nos2 in both OA cartilage and subchondral bone		[254]
Mixture:
ASU and
Epigallocatechin-3-O-gallate		 Effects in IL-1β and TNF-α-activated equine chondrocytes:
This combination potentiated the anti-inflammatory activity
Suppressed Cox2 gene expression and Pge2
production, related to Nf-κb translocation inhibition from cytoplasm to the nucleus 		[255]
Effects in equine chondrocytes:
Demonstrated anti-inflammatory activity in cytokine-activated articular chondrocytes
Decreased Tnfa, Il6, Cox2 and Il8 gene expression and Pge-2 synthesis through Nf-κb nuclear translocation inhibition		[256]
ASU + α-lipoic
acid combination		 Effects in LPS, IL-1β or H2O2-activated equine chondrocytes:
Showed a potential combination of anti-inflammatory and antioxidant capacities in OA management
Inhibited Pge-2 production significantly more than ASU alone or α-lipoic acid alone
Reduced nuclear translocation/activation of Nf-κb		[257]
Combination (ASU +glucosamine
+chondroitin)		 Effects in canine chondrocytes:
The combination stimulated the anti-inflammatory effect of a low concentration of NSAID for OA management
Stronger inhibitory effect on Il-6, Il-8, and Mcp-1 production than carprofen in IL-1β-stimulated chondrocyte microcarrier spinner cultures
The combination together with a lower dose of carprofen reduced Pge2 production significantly more than either treatment alone		[258]
Baicalin(Scutellaria baicalensis
Georgi)
Mainly extracted from
dry root
Flavone glycoside (flavonoid)		Effects in mice OA cartilage/synovium/OA-induced mice:
Attenuated OA progression
Decreased PG loss, cartilage degradation and the OARSI scores
Ameliorated synovitis 		[157]
Effects in mouse chondrocytes:
Enhanced ECM synthesis by activating the Hif-1α/Sox-9 pathway and chondrogenic marker expression
Increased Col2a and Acan gene expression
Inhibited catabolic genes: Adamts5, Mmp9, Mmp13 and prolyl hydroxylases		[259]
Effects in rat chondrocytes:
Inhibited oxidative activity, ROS production and apoptotic cell death of endplate chondrocytes induced by H2O2
Upregulated Enos mRNA
Reduced malondialdehyde levels and increased sod
Downregulated apoptotic signalling indicators: Parp cleavage, Bax and pro-Casp-3 protein expression		[260]
BerberineMedicinal herbs:
Hydrastis canadensis
Berberis aristate
Cortex phellodendri
Coptis chinensis
isoquinoline-derivative alkaloid		Effects in IL-1β-induced rabbit chondrocytes:
Inhibited Mmp3 and Adamts5 gene expression in chondrocytes
Increased Timp1, Acan and Col2a1 gene expression
Effects in rabbit cartilage explants:
Inhibited cartilage degradation
Inhibited release of collagen and GAG fragment 		[261]
Effects in IL-1β-induced rat chondrocytes/cartilage explants:
Showed chondroprotective properties and reduced articular cartilage destruction
Inhibited glycosaminoglycan release and no production of high-dose berberine
Suppressed Mmp1, Mmp3 and Mmp13 mRNA and protein expression in a dose-dependent manner and upregulated Timp1 mRNA and protein expression in chondrocytes/cartilage explant (100 µm optimum concentration) 		[262]
Effects in IL-1β-stimulated rat chondrocytes:
Showed the maintenance of chondrocyte survival and promoted matrix production in IL-1β-stimulated articular chondrocytes
Activated Akt/p70S6K/S6 signalling pathway
Effects in rat OA cartilage:
Protected articular cartilage and reduced matrix degradation
Enhanced Col2a1, p-Akt and p-S6 levels 		[263]
Effects in rat chondrocytes:
Attenuated SNP-stimulated chondrocyte apoptosis via activating AMPK signalling and inhibition of p38 MAPK activity
Suppressed SNP-induced Nos2 protein expression
Effects in OA cartilage:
Showed chondroprotective effect
Decreased cartilage degradation, Casp-3, and Bax protein expression
Increased Bcl-2 expression, and enhanced Col2a1 synthesis 		[264]
Effects in rat chondrocytes:
Promoted SNP-stimulated chondrocyte proliferation via activation of Wnt/β-catenin pathway
Upregulated Ccnd1, Ctnnb1 and Myc gene expression
Reduced Gsk3b and Mmp7 mRNA expression
Effects in OA cartilage:
Decreased OA progression and cartilage degradation
Reduced Mankin scores
Enhanced Ctnnb1 and Pcna expression		[265]
Effects in IL-1β -induced rat OA cartilage:
Prevented cartilage degradation
Inhibited PG loss
Decreased immunostaining of IL-1β in the superficial and middle zones of cartilage		[158]
Effects in rat chondrocytes:
Demonstrated anti-catabolic and anti-inflammatory properties
Inhibited Nos2, Cox2, Mmp3, Mmp13, Tnfa, and Il6 mRNA and protein expression
Decreased the phosphorylation of MAPK (ERK, JNK, and p38) signalling pathway
Increased Col2a1 protein expression 		[266]
ButeinRhus verniciflua
stem bark of cashews
and the genera Dahlia,
Butea, Searsia (Rhus)
and Coreopsis are
common sources
Chalcones (flavonoids)		Effects in rat OA cartilage/synovium/subchondral bone:
Inhibited PG loss and cartilage fibrillation and degradation
Decreased OARSI score
Alleviated synovitis
Reduced subchondral bone plate thickness 		[159]
Celastrol(Tripterygium wilfordii
Hook F.)
root bark “Thunder of
God Vine”
Pentaciclic Triterpenes		Effects in rat chondrocytes/OA articular cartilage (dose-dependent manner):
Inhibited inflammatory response and Nf-κb signalling pathway
Ameliorated apoptosis by enhancing autophagy
Decreased cleaved Casp-3, p-IκBα, p-p65 protein expression and Bax, Sqstm1, Il6, Tnfa mRNA and protein expression
Increased Bcl2, Ccnd1 mRNA and protein expression and Lc3-II levels
Attenuated articular cartilage degradation
Ameliorated cartilage loss and osteophyte formation 		[267]
Effects in OA cartilage:
Attenuated cartilage damage and joint pain
Suppressed Sdf1/Cxcr4 mRNA pathway
Decreased Mmp13 and Adamts5 mRNA and protein expression
Increased Col2a1 and Acan mRNA expression		[268]
Effects in rabbit chondrocytes:
Decreased apoptosis via Atf6/Chop pathway
Inhibited Bip, Aft6, Chop and Xbp1 (endoplasmic reticulum stress, ERs markers) mRNA and protein expression
Decreased Casp3 and Casp9 mRNA and protein expression
Effects in rat OA articular cartilage/synovium:
Reduced cartilage injury, synovial hyperplasia and wear in the knee joints 		[269]
Celastrol
Nanocomplex		Celastrol+ Hollow mesoporous silica nanoparticles+ChitosanEffects in rat chondrocytes
Inhibited Mmp-3, Mmp-13, Il-1β, Tnf-α levels
and Nf-kb signalling pathway
Reduced inflammation
Effects in OA cartilage/synovium/subchondral bone/OA-induced rat:
Demonstrated high biosolubility and decreased cartilage damage
Showed protective effect on cartilage and subchondral bone
Reduced knee swelling and synovial inflammation		[270]
Compound KPanax ginseng
roots, fruits, leaves,
flower buds
Gingenoside (tetracyclic
triterpenoid)		Effects in mouse pre-osteoblastic MC3T3-E1 cells:
Protected against H2O2-induced cytotoxicity
Alleviated inflammatory response
Stimulated osteoblastic cell differentiation and mineralization
Inhibited ROS and NO levels
Increased Alp, Col2a, and Ocn mRNA
Decreased Ikk and Il1b mRNA expression 		[271]
Criptotanshinon(Salvia miltiorrhiza
Bunge)
Extracted from the root of the plant
Diterpene quinones		Effects in OA cartilage/suchondral bone/OA-induced mice:
Decreased cartilage destruction and protected against OA progression
OARSI scores and subchondral bone plate thickness reduction		[163]
Crocin Effects in mouse skeletal muscle cell line C2C12:
Suppressed Il-6 by downregulation of Jnk level
Effects in muscle tissue/OA-induced rats:
Reduced joint pain, inflammation, muscular lipid peroxidation and Nrf2 mRNA expression
Attenuated muscular oxidative stress through inhibiting muscular ROS generation
Attenuated muscle dysfunction and decreased muscular Il-6 production
Increased citrate synthase activity and Myh9 mRNA expression
Increased glutathione production and Gpx1 mRNA and activity 		[272]
Effects in IL-1β-induced rabbit chondrocytes:
Inhibited Mmp1, Mmp3 and Mmp13 gene and protein expression
Inhibited Nf-κb pathway and suppressed degradation of IκBα
Effects in rabbit OA cartilage:
Suppressed cartilage degradation
Reduced Mmp1, Mmp3 and Mmp13 genes		[273]
Curcuminoids:

Curcumin
Demethoxycurcumin,
Bisdemethoxycurcumin		(Curcuma longa)
(Curcuma domestica)
Turmeric rhizome
Diarylheptanoids
(Phenolic compounds)		Effects in IL-1β-stimulated equine articular cartilage explants:
Inhibited cartilage degradation
Decreased GAG release at high concentrations 		[274]
Effects in IL-1β-stimulated equine cartilage explants:
Showed anti-catabolic and anti-inflammatory properties at low concentrations (non-cytotoxic concentrations)
Reduced PG loss
Decreased Pge2 and Mmp-3 release 		[275]
Effects in rat temporomandibular joint OA cartilage:
Showed anti-inflammatory and chondroprotective properties
Reduced cartilage erosion and PG loss
Decreased Nos2, Cox2, Il1b, Mmp9, Mmp13 protein levels and increased Nrf2 protein level		[172]
Effects in IL-1β-induced rat chondrocytes:
Blocked Nf-κb signalling pathway by suppressing Ikba mRNA phosphorylation and subunit Rela mRNA nuclear translocation
Decreased Mmp13 mRNA and protein expression, and upregulated Col2a1 mRNA and protein expression in a time-dependent manner		[276]
Effects in IL-1β-induced rat chondrocytes:
Suppressed apoptosis marker (Casp-3) through autophagy via Mapk/Erk1/2 activation pathway and increased autophagy markers (Lc3-II, and Beclin-1) 		[277]
Effects in rats OA cartilage/synovial tissues/rat OA-induced knee:
Improved inflammatory lesions by intra-articular injection
Inhibited LPS-induced overexpression of Tlr4 and its downstream Nfkb pathway mRNA and protein expression
Decreased inflammatory cytokines LPS-induced Il-1β and Tnf-α production in synovial membrane		[278]
Curcumin
nanoparticles		Topical treatmentEffects in cartilage/OA mice:
Slowed OA progression and decreased ECM degradation, cartilage erosion, and aggrecan loss
Reduced Mmp-13 and Adamts-5 levels
Reduced pain and improved locomotor behaviour
Effects in infrapatellar fat pad:
Suppressed Cfd, Lep, Adipoq, adipo-regulatory transcription factors/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma, and Mmp13 and Adamts5 mRNA
Effects in synovium/subchondral bone:
Reduced synovitis and subchondral plate thickness 		[173]
Mixture:
Curcuminoids
Hydrolysed
collagen and
Epigallocatechin-3-gallate 		(Curcuma longa L.)
Turmeric
Polyphenols

Hydrolysed collagen
(High levels of glycine
and proline, amino acids essential for stability and cartilage regeneration)

(Camellia sinensis)
Green tea
Epigallocatechin-3-gallate (Flavanol) 		Effects in IL-1β-stimulated bovine chondrocytes:
Demonstrated anticatabolic, anti-inflammatory, additive and synergistic properties
Decreased Il6, Nos2, Cox2, Mmp3, Adamts5 and Adamts4 gene expression
Inhibited NO, Pge2 production 		[180]
Herbal composition LI73014F2 (2:1:2 ratio):
Gallic acid, chebulagic acid, chebulic acid, chebulinic acid, gallotannins, ellagitannins (punicalagin), ellagic acid

Diferuloylmethane
Demethoxycurcumin
Bisdemethoxycurcumin, and
turmeric acid

Boswellic acids:
3-O-acetyl-11-keto-β-boswellic acid, 11-keto-β-boswellic acid, and β-boswellic acid		(Terminalia chebula)
Fruit myrobalan
Tannins (polyphenols)




(Curcuma longa)
Polyphenols



(Boswellia serrata)
Olibanum
Pentacyclic triterpenes 		Effects in cartilage/synovium/OA-induced rats:
Decreased pro-inflammatory mediators such as Cox-2, Pge2, Lox5, and Ltb-4
Decreased pro-inflammatory cytokines: Il-1β, Il-6, and Tnf-α, 89%, 84%, and 38%, respectively
Reduced Mmp-2, Mmp-3, Mmp-13 levels
Alleviated joint pain by suppressing synovial
membrane and cartilage degradation (dose 50 mg/Kg/day for 3 weeks)		[279]
Ellagic acidFruit peel of raspberries,
strawberries, cranberries,
pomegranate, walnuts,
pecans, grapes
Dimeric derivative of
gallic acid
Phenolic compound		Effects in cartilage/synovium/OA-induced mouse
Protected against cartilage degradation
Inhibited PG loss
Decreased OARSI score
Alleviated synovitis
Delayed OA progression		[186]
EmodinRoot and rhizome of Rheum palmatum
Anthraquinone derivative (Phenols)		Effects in IL-1β-induced rat chondrocytes:
Decreased Mmp3, Mmp13, Adamts4 and Adamts5 mRNA and protein expression by suppression of NF-κB and Wnt/β-catenin pathways
Increased Acan and Col2a1 mRNA and protein expression
Effects in cartilage/OA-induced rats:
Protected against the development and progression of OA
Reduced cartilage degradation
Decreased Mmp3, Mmp13 and Ctnnb1 mRNA		[280]
Effects in IL-1β-induced rat chondrocytes:
Reduced cytotoxicity in a dose-dependent manner
Inhibited no and pge-2 levels, and Mmp1 and Mmp13 mRNA expression
Inhibited ERK activation and Wnt/β-catenin pathway		[281]
Effects in IL-1β-induced rat chondrocytes/cartilage:
Alleviated inflammation and reduced Mmp3, Mmp13 and Adamts4 mRNA and protein expression
Reduced cartilage matrix degradation
Protected knee joint cartilage
Effects in serum/OA-induced rat:
Inhibited Nos2, No, Cox-2 and Pge2 levels
Emodin at 80 mg/Kg is comparable to celecoxib at 2.86 mg/Kg		[282]
Fatty acids
n-3 PUFAs
omega 3
polyunsaturated fatty acids		Soybean, canola, olive
oils, flaxseed, walnuts,
marine phytoplankton
and fish oil
ALA: α-linolenic acid
EPA: eicosapentaenoic
DHA: docosahexaenoic		Effects in equine synoviocyte culture:
n-3 PUFAs EPA and DHA modulated inflammatory response and reduced Adamts4, Mmp1, Mmp13, Il1b, Il6, and Cox2 genes, stimulated by recombinant equine (re) IL-1β
DHA-derived docosanoids such as resolvin D1 and D2, maresin 1 and protectin DX reduced Adamts4, Mmp1, Mmp13, Il6, and Cox2 genes 		[283]
Effects in IL-1β-mediated bovine cartilage explants:
EPA and DHA reduced ECM degradation
Demonstrated that EPA maintained a reduced expression of Adamt4, Adamts5, Mmp3 and Mmp13, and Cox2 gene until the end of the 5-day treatment		[284]
Effects in IL-1α-induced bovine chondrocytes:
n-3 PUFAs showed favourable effects against
inflammation and cartilage degradation
EPA was the most effective, then DHA and ALA
n-6 PUFA, arachidonic acid had no effect
n-3 PUFAs reduced Cox2, Adamts4, Adamts5, Mmp3, Mmp13, Il1a, Il1b and Tnfa mRNA		[285]
Effects in OA cartilage/OA-induced mouse
EPA intra-articular injection treatment decreased matrix degradation and Mankin scores
Reduced Mmp-13 protein expression
Inhibited OA progression 		[194]
GeniposideExtract of the fruit
Gardenia jasminoides
Ellis, zhizi
Iridoid glycoside (monoterpenoids)		Effects in rabbit OA chondrocytes/synovial fluid/OA-induced rabbit:
Showed anti-inflammatory effects by inhibiting p38 MAPK signalling pathway
Inhibited Il1b, Tnfa, and Mmp13 gene expression and protein expression
Inhibited oxidative stress 		[286]
Effects in IL-1β-induced rat chondrocytes:
Inhibited inflammation and apoptosis
Inhibited Bax, Cyto-c, cleaved-Casp3, no, Pge2, Nos2, Cox-2, and Mmp-13 protein expression
Increased Bcl-2 and Col2a1 protein expression
Inhibited Pi3k/Akt/Nf-κb phosphorylation signalling pathway
Effects in OA cartilage/OA-induced rat:
Reduced cartilage damage and OARSI scores
Inhibited OA progression		[287]
Effects in rat chondrocytes:
Promoted chondrocytes proliferation
Inhibited sodium nitroprusside-induced apoptosis via the reduction of NO levels		[288]
Genistein(Gycine max)
soybean
Isoflavone (flavonoids)		Effects in OA condyle cartilage/temporomandibular joint in OA-induced rat:
Observed more therapeutic effects on cartilage repair at high doses
Decreased NF-κB phospho-p65 signalling
Inhibited Il1b and Tnfa mRNA expression		[289]
Effects in IL-1β-induced OA cartilage/OA-induced rat
Reduced inflammation and prevented ECM degradation
Decreased OARSI score and attenuated OA progression 		[196]
Effects in IL-1β-induced OA cartilage/OA-induced rat
Reduced cartilage degradation
Increased collagen II, Acan, and ERα levels Downregulated caspase 3 levels
Effects in synovial fluid:
Reduced Tnf-α and Il-1β levels 		[197]
Halofuginone Dichroa febrifuga
Alkaloid 		Effects in cartilage/OA-induced rodents:
Decreased PG loss and articular cartilage calcification
Reduced Col10, Mmp-13 and Adamts-5
Increased lubricin, Col2a1, and Acan levels
Effects in subchondral bone:
Inhibited osteoclastogenesis by decreasing Th17 cells and Rankl expression
Inhibited osteoid islets’ formation by suppressing Tgf-β activity
Attenuated aberrant angiogenesis		[290]
Effects in cartilage/OA-induced mice
Attenuated cartilage degradation and OA progression
Reduced Col10 and Mmp-13 levels
Effects in subchondral bone:
Improved subchondral bone microarchitecture
Reduced abnormal bone resorption
Decreased abnormally elevated Tgf-β activity and release from bone mineral matrix and inhibited osteoid islets’ formation
Inhibited aberrant angiogenesisin in early-stage OA administered by oral gavage		[291]
Effects in ATDC5 murine chondrogenic cell line:
6.25-25 ng/mL did not affect chondrocytic viability
Inhibited Tgf-β1 signalling and downregulated p-Smad2 protein in a dose- and time-dependent manner
Effects in cartilage/OA-induced murine:
Prevented cartilage damage by Tgf-β1 signalling inhibition
Reduced p-Smad2/3 levels
Downregulated PG loss
Decreased Col10 expression and Mmp-13 levels		[292]
Harpargoside, harpagide and
procumbide
β-cariofileno, α-humuleno and α-copaeno
Oleanolic acid, ursolic acid and 3β-acetyloleanolic acid
Eugenol
Acteoside and isoacteoside		Harpagophytum procumbens (HP)
Devil’s claw root extract
Iridoid glucosides
Sesquiterpenes
Triterpenes
Monoterpene
Phenolic glycosides		Effects in cartilage/OA-induced rabbit:
Showed chondroid regeneration
Increased elastic and collagen fibres
Increased Timp2 mRNA expression		[293]
Hydroxytyrosol (HT)Olea europea L.
Olive leaf extract
Fruits
Extra virgin olive oil
HT is more abundant in
processed fruit and
olive oil
Secoiridoid derivative		Effects in cartilage/synovial membrane/OA-induced rat
Showed anti-inflammatory activity and prevented articular cartilage and bone destruction induced by kaolin and carrageenan
Attenuated synovial membrane and periarticular soft tissue edema and reduced inflammatory infiltration
Ameliorated paw swelling 		[294]
Effects in cartilage/synovial cells/STR/ort mice:
Inhibited cartilage destruction and suppressed OA progression on knee joint
Enhanced Has2 mRNA expression and improved high molecular hyaluronan production by synovial cells		[295]
Hydroxytyrosol/Procyanidins

(Oleogrape®SEED)		(Extract from olive and
grape seed):
(Olea europea L.)
mainly found in olive leaf and oil
Phenolic compound

(Vitis vinifera, grape)
Flavonoids
Other sources: pine bark, cocoa, raspberry, vegetables, legumes, nuts		Effects in IL-1β-induced OA chondrocytes/OA-induced rabbit:
Showed anti-inflammatory and chondroprotective properties
Inhibited Nos2, Cox2, Mmp13 genes and NO, Pge2 and Mmp-13 production
Effects in cartilage:
Reduced OARSI score and cartilage degradation
Effects in serum:
Downregulated NO, Pge2 and Mmp-13 levels
Conserved their bioactivity and bioavailability in serum after undergoing digestive process		[296]
Hyperoside(Hypericum perforatum)
fruits and herbs of different plant families (Hypericaceae, Rosaceae, Ericaceae, Campanulaceae,
and Labiatae)

Flavonoid glycoside		Effects in IL-1β-induced chondrocytes/OA-induced mice:
Inhibited inflammation and ECM degradation
Reduced Nos2, Cox-2, Adamts-5, Mmp-3, and Mmp-13
Upregulated collagen II, Acan, and Sox-9
Suppressed Pi3k/Akt/Nf-κb and Mapk pathways
Attenuated oxidative stress and apoptosis via Nrf2/Bax/Bcl-xl axis
Decreased ROS levels
Enhancing Nrf2/Ho-1 pathway to counteract
Nf-κb activation
Effects in cartilage:
Inhibited GAG loss and cartilage degradation, and decreased the OARSI scores
Increased Nrf2 levels		[297]
IcariinEpimedium sagittatum
flavonol glycoside		Effects in bone mesenchymal stem cells:
Icarin promoted chondrogenic differentiation and Acan, Bmp2 and Col2a1 protein expression
Effects in rabbit cartilage tissue:
Repaired knee cartilage damage and enhanced Col2a1 expression (treatment with icarin plus bone mesenchymal stem cells was even more effective than the effect produced by either treatment alone in a time-dependent manner)		[298]
Effects in ATDC5 cell line/rat chondrocytes:
Promoted ECM secretion and enhanced Col2a1 and Sox9 gene expression in a concentration-dependent manner
Enhanced Ift88 gene and protein expression and ciliary assembly and promoted Erk phosphorylation
Effects in cartilage/OA-induced rat:
Improved histological cartilage phenotype and attenuated cartilage degradation		[299]
Effects in TDP-43 chondrocyte lines/synovial tissue/serum/OA-induced rat
Inhibited Tdp43 overexpression-induced apoptosis
Attenuated the formation of neovascularization in the synovial tissue of a rat OA model
Decreased Vegf and Hif-1α in synovial tissue and serum		[300]
Effects in IL-1β-induced rat chondrocytes:
Inhibited chondrocyte apoptosis and inflammatory cytokines’ production through the suppression of Nf-κb p65 phosphorylation and Mapk signalling
Upregulated Akt activation
Increased Ikbα protein
Induced chondrocyte autophagy
Decreased Il6 and Tnfa gene and protein expression 		[301]
Effects in oxygen, glucose and serum deprivation-induced rabbit bone marrow-derived mesenchymal stem cells:
Inhibited ERs markers levels and autophagy
Protected against cytotoxicity and apoptosis by inactivation of Mapk signalling via three specific siRNAs (Erk, p38 and Jnk) pathway 		[302]
Indole tetracyclic alkaloids
Oxindole alkaloids
Indole pentacyclic alkaloid
Glycoindole alkaloids
Quinovic acids
Tannins		Uncaria guianensis
Uncaria tomentosa
Cat’s claw
Alkaloids
Triterpenes heterosides
Polyphenols		Effects in LPS-induced murine macrophages (RAW 264.7 cells):
Showed antioxidants and anti-inflammatory
Properties, potentially an effective treatment for OA-Inhibited Tnf-α and Pge2 production		[214]
Isofraxidin Siberian ginseng and
Apium graveolens
Coumarin (phenolic
compound)		Effects in OA cartilage/serum/OA-induced mouse:
Reduced subchondral bone plate thickness and prevented calcification and erosion of cartilage
Inhibited inflammatory cytokines in serum		[215]
Licochalcone A Glycyrrhiza glabra,
licorice root
Glycyrrhiza inflate
Flavonoids		Effects in IL-1β-induced rat chondrocytes:
Reduced Adamts5, Adamts4, Mmp13 and Mmp1 mRNA expression
Inhibited Ikkα/β and p65 phosphorylation, and increased Iκbα expression
Inhibited Wnt/β-catenin signalling pathway
Upregulated Col2a1 expression		[303]
Effects in LPS-induced mouse chondrocyte:
Mitigated ECM degradation by enhancing Acan and Col2a1production
Decreased chondrocytes pyroptosis through
Nrf2/Ho-1/Nf-κb pathway
Inhibited Nlrp3, Asc, Gsdmd, Casp1, Il18, Il1b mRNA and protein expression
Reduced Iκb-α degradation and the translocation of p65
Effects in cartilage/OA-induced mouse:
Inhibited cartilage erosion and PG loss and reduced OARSI score
Enhanced Nrf2 and mitigated OA progression
Decreased Il-1β and Il-18 protein expression in air pouch mouse model		[304]
Ligustrazine
(Tetramethylpyrazine)		Ligusticum chuanxiong
Hort
Rhizoma
Alkaloids		Effects in IL-1β-exposed rat chondrocytes:
Suppressed apoptosis and ER stress-related factors (Grp78 and Chop)
Suppressed Il6, Il1b, Nos2, Cox2, Tnfa, Mmp3, Mmp13, Adamts4 and Adamts5 mRNA expression
Prevented ECM destruction
Increased Acan and Col2a1 mRNA		[305]
Tetramethylpyrazine-Poly lactic-co-glycolic
acid microspheres		 Effects in cartilage/synovium/OA-induced rats:
Improved efficacy and therapeutic effect by intra-articular injection of microspheres
Demonstrated to be histologically safe
Protected against cartilage damage
Inhibited PG loss
Decreased articular inflammation and
reduced joint swelling		[306]
MagnoflorineSinomenium acutum
alkaloid		Effects in subchondral trabecular bone/osteoblastic cell line/cartilage/OA-induced guinea pig:
Promoted subchondral bone regeneration and prevented OA progression
Stimulated osteoblasts’ proliferation and mineralization
Upregulated Lrp5, Ctnnb1, Runx2, Ocn and Erk2 mRNA expression and downregulated Nfκb (p105) gene in osteoblasts
Attenuated cartilage degradation and increased Acan, Bmp7, Sox5, Tgf-β1 and chondrogenic cells 		[307]
Effects in cartilage/primary chondroprogenitor cells/synovial fluid/subchondral bone/OA-induced rats:
Promoted cartilage regeneration and enhanced
Acan, Bmp7, Sox5, Tgf-β1 and chondrogenic cells
Increased chondrogenesis and chondrogenic signals such as Col2a, Comp, Tnc and Sox9 mRNA expression and downregulated Nf-κb (p105) and Erk2 gene in chondrogenic cells
Decreased pro-inflammatory cytokines Il-17a, Il-12, Tnf-α, Inf-γ and Il-6 and increased anti-inflammatory cytokine Il-10 in synovial fluid
Maintained the stabilization of trabecular bone microstructure		[308]
Myricetin Labisia pumila
Trigonella foenum-graecum L.
Species of Anacardium and Mangifera (Anacardiaceae)
Grapes, berries, chard spinach, broadbeans, garlic, peppers
Flavonol 		Effects in cartilage/OA-induced mice:
Inhibited articular cartilage matrix degradation and reduced OARSI score by intragastric administration
Inhibited inflammation response and ameliorated OA progression through Pi3k/Akt, which mediated the increased Nrf2/Ho-1 signalling pathway
Inhibition of Pi3k/Akt signalling abolished Nrf2/Ho-1 pathway activation and the suppression of Nf-κb 		[221]
Oleocanthal
(decarboxymethyl ligstroside
aglycone)		(Olea europea L.)
Fruits, leaves, extra virgin oil
Secoiridoid derivative
(Phenolic compounds)		Effects of LPS-induced ATDC-5 murine chondrogenic cell line:
Oleocanthal and its derivative 231 reduced Nos2 protein expression and NO production in a dose-dependent manner
Decreased p38 protein expression at the highest dose (25 µM was linked to a cytotoxic effect)
Synthetic derivative 231 showed no cytotoxicity even at higher concentrations		[309]
Effects in LPS-induced murine chondrogenic cell line/murine macrophages:
Demonstrated anti-inflammatory effects
Inhibited Mip1a and Il6 mRNA and protein expression in chondrocytes and macrophages
Inhibited nitric oxide production via Nos2 downregulation and decreased Il-1β, Tnf-α and Gm-csf levels in macrophages 		[310]
Procyanidin (Vitis vinifera)
grape seed extracts
(Malus pumila, Malus
domestica Borkh. cv.
Fuji)
Apple
Procyanidins (flavonoid)		Effects in H2O2 or IL-1β-treated chondrocytes/cartilage/synovial tissue/OA-induced mice:
Demonstrated anti-oxidant, antiapoptotic, and anti-inflammatory effects
Enhanced Acan and Col2a1 mRNA
Suppression of Nos2 mRNA expression
Prevented heterotopic cartilage formation
Reduced Inos protein levels in synovial tissues		[311]
Effects in chondrocytes/OA-induced mice:
Inhibited cartilage damage induced by mitochondrial dysfunction of chondrocytes
Enhanced mitochondrial biogenesis with upregulation of Pgc1a gene expression
Promoted mitochondrial dehydrogenase activity
Upregulated Acan gene synthesis and regulated PG homeostasis
Downregulated Mmp3 and Mmp13 catabolic genes		[312]
Puerarin(Radix puerariae)
Root of Pueraria
Phytoestrogen
(Isoflavone)		Effects in cartilage/OA-induced mice:
Attenuated inflammatory responses
Ameliorated cartilage damage and synovitis
Effects in blood monocytes/macrophages:
Decreased myeloid-derived C-C chemokine receptor 2+/lymphocyte Ag 6C+ monocytes
Reduced Ccl2 mRNA
Suppressed proinflammatory monocyte recruitment 		[226]
Effects cartilage/OA-induced rats
Anti-inflammatory and chondroprotective
Ameliorated cartilage loss and upregulated Col2a1 levels
Inhibited Mmp-3, Mmp-13, Adamts-5, and Cox-2
Effects in serum:
Inhibited Il-1β, Il-6, and Tnf-α levels
Inhibited OA biomarkers: Ctx-II, Ctx-I and Comp, stimulated the N-terminal propeptide of type II collagen expression, inhibited bone resorption and promoted bone formation
[313]
Effects on IL-1β-induced chondrocytes:
Suppressed inflammatory mediators, apoptosis, and ECM degradation by inhibiting Nf-κb
through Nrf2 nucleus expression and activation
and Ho-1 cytoplasm expression in a dose-dependent manner
Decreased Bax and Casp-3
Reduced Nos2, Cox2, Tnfa and Il6 mRNA and protein expression
Decreased NO and Pge2 production
Decreased Mmp-13 and Adamts-5 levels
Upregulated Acan and Col2a1
Effects on cartilage/OA-induced mice:
Decreased cartilage damage and OARSI score
Alleviated OA progression and pain symptoms		[314]
Effects on OA and OA-associated mitochondrial dysfunctions in rats:
Alleviated mechanical hyperalgesia and cartilage damage
Increased mitochondrial biogenesis
Attenuated mitochondrial dysfunctions in OA rats
AMPK inhibitor compound C abolished puerarin’s effects		[315]
QuercetinAchyranthes bidentata
Ageratum conyzoides
Chrysanthemum psyllium,
Eleutherococcus senticosus
Juglans regia L.
flowers, leaves, and fruits
broccoli, onions, apples, berry crops, grapes, dark cherries, and green vegetables
Flavonol (flavonoid)		Effects in cartilage/serum/synovial tissue/
synovial fluid/OA-induced rabbit:
Showed comparable effects as celecoxib
Reduced cartilage damage and OARSI score
Inhibited Mmp-13, oxidative stress and increased Sod (major active molecule to scavenge free radical) and Timp-1 levels
[316]
Effects in IL-1β-induced chondrocytes:
Showed anti-inflammatory, antiapoptotic and immunomodulatory effects
Inhibited the degradation of cartilage matrix, Col2a1 and Acan mRNA and protein expression
Inhibited Akt activation and Iκbα degradation
Inhibited Nf-κb p65 phosphorylation and translocation into the nucleus
Decreased Pge2, NO, and Mmp13, Nos2 and
Cox2 mRNA expression and protein levels
Decreased Adamts4 mRNA expression
Decreased apoptosis by inhibiting Casp-3
Restored mitochondrial membrane potential
Effects on synovial macrophage/OA-induced rat:
Induced M2 polarization of macrophages and promoted pro-chondrogenic cytokines for cartilage repair, and attenuated OA progression
[317]
Effects in OA-induced rats:
Showed anti-inflammatory effects and reduced toe volume and joint diameter
Alleviated OA symptoms in a dose-dependent manner
Effects in serum:
Inhibited Il-1β and Tnf-α production
Effects in joint tissues:
Improved cartilage structure
Suppressed Tlr4 and Nf-κb pathway 		[318]
Quercetin
Nanoparticle gel		FlavonolEffects in blood serum/OA-induced rat
Quercetin-loaded nanoparticle gel and A. conyzoides L. extract gel reduced Il-1β, Mmp-9, Mmp-13 and Adamts-5 levels
Effects in knee joint:
Prevented OA progression and PG degradation		[319]
Compound:
Quercetin with
palmitoylethanolamide
(PEA-Q)		Flavonol with fatty acid
amide		Effects in cartilage/OA-induced rat
Reduced histological cartilage damage induced by sodium monoiodoacetate injection
Decreased hyperalgesia and infiltration of inflammatory cells and reduced myeloperoxidase induced by carrageenan
Improved locomotor function
Effects in serum:
Reduced Il-1β, Tnf-α, Mmp-1, Mmp-3 and Mmp-9, as well as nerve growth factor levels associated with nociceptive and neuropathic pain
Showed similar or even greater effects when compared to oral meloxicam		[320]
ResveratrolRoot extracts of the weed Polylygonum cuspidatum
Vitis vinifera
red grapes, blueberries
cranberries, peanuts,
Stilbenes (polyphenols)		Effects in cartilage/OA-induced mice
Reduced articular cartilage damage and Mankin and OARSI scores
Decreased pro-inflammatory cytokine levels by Tlr4/Nf-κb signalling inhibition via downregulation of Myd88-dependent and -independent signalling pathways
Activation of Pi3k/Akt pathway		[228]
Effects in cartilage/OA-induced rabbit
Exhibited cartilage-protective effect in a dose-dependent manner of 10–50 μMol/Kg
Reduced matrix PG content loss
Inhibited chondrocyte apoptosis in vivo
Effects in synovial fluid:
Reduced No production
[321]
Effects in cartilage/OA-induced rabbits:
Protected against cartilage destruction by intra-articular injection (10 µMol/Kg resveratrol once a day for two weeks)
Decreased cartilage lesions such as fibrillation and fissures and reduced matrix PG content loss
Effects in synovium:
Statistically, scores of synovial inflammation did not show difference between control rabbits receiving DMSO only and resveratrol in DMSO groups
[322]
Effects in joint tissues/OA-induced rats
Tnf-α, Il-1β, Il-6, Il-18, Casp-3 and Casp-9 activity inhibition
Suppressed Nf-κb and Nos2 protein expression
Activated Ho-1/Nrf-2 signalling
[323]
Effects in cartilage/OA-induced C57BL/6J mice fed a high-fat diet:
Inhibited cartilage lesion and suppressed chondrocyte apoptosis on obesity-related OA
Decreased body weight in obese mice and inhibited OA development by reducing biomechanical overloading and inflammatory factors (doses of 22.5 mg/Kg and 45 mg/Kg) by oral gavage
Reduced the degradation of Col2a1
Effects in serum:
Reduced triglyceride and cholesterol levels in serum but none these reductions were statistically significant
Decreased levels of Ctx-II (45 mg/Kg doses)		[324]
Rutin
(quercetin-3-O-rutinoside)
Oleuropein
Rutin/Curcumin		Abundantly found in:
Ruta graveolens, rue
Passionflower
Buckwheat
Apple
Flavonol		Effects in cartilage/blood samples/synovium/OA-induced guinea pig:
Decreased OA progression, reduced cartilage degradation and protected against inflammatory and catabolic processes
Rutin decreased OA biomarkers: Coll2-1, Coll2-1NO2, and args neoepitope aggrecan fragments levels in serum
Oleuropein decreased osteophyte formation in cartilage, decreased synovial histological score and decreased Pge2 and Coll2-1NO2 levels in serum
Rutin/curcumin mixture decreased Coll2-1, Fib3-1 and Fib3-2 in serum		[325]
SanguinarineThe roots of:
Sanguinaria canadensis
Benzophenanthridine
alkaloid		Effects in IL-1β-induced cartilage explants:
Inhibited OA progression and protected against cartilage degradation
Inhibited Mmp-1a-, Mmp-3-, Mmp-13-, and Adamts-5-positive cells
Effects in cartilage/OA-induced mice:
Improved cartilage surface in a dose-dependent manner and decreased OARSI score
Inhibited Mmp1a, Mmp3, Mmp13, and Adamts5 mRNA expression and positive cells 		[235]
SclareolSalvia sclarea
Diterpene		Effects in IL-1β-induced chondrocytes:
Chondroprotective properties and no adverse effects on cell viability with concentrations of 1–10 μg/mL
Inhibited Mmp1, Mmp3, Mmp13, Cox2 and Nos2 gene and protein expression
Suppressed Mmp1, Cox2 and Nos2 protein level
Inhibited NO and Pge2 production
Upregulated Timp1 gene and protein expression
Effects in cartilage/OA-induced rabbit:
Decreased Mmp1, Mmp3, Mmp13, Cox2 and Nos2 and increased Timp1 gene expression
Ameliorated cartilage degradation by intra-articular injection and reduced Mankin score		[326]
SesaminSesamun indicum
sesame seed oil
lignan		Effects in porcine cartilage explants:
Inhibited degradation of PG cultures treated with IL-1β
Inhibition of IL-1β/OSM-induced collagen degradation and hydroxyproline release
Effects in cartilage/papain-induced OA rat
Inhibited cartilage degradation and OA progression
Increased PG and Col2a1 deposition
in a dose-dependent manner		[237]
ShikoninDried roots of
Lithospermum
erythronrhizon
Naphthoquinone
(phenols)		Effects in blood samples/OA tissue/OA-induced rat
Inhibited inflammation and inhibited Il-1β, Tnf-α and Nos2 in blood
Suppressed Nf-κb pathway protein expression Decreased Cox-2 protein expression and Casp-3 activity
Upregulated phosphorylated Akt protein level		[327]
Effects in IL-1β-induced rabbit chondrocytes:
Anti-inflammatory and chondro-protective properties
Inhibited Mmp1, Mmp3 and Mmp13 gene and protein expression
Increased timp1 gene and protein expression
Suppressed Nf-κb p65 activation
Suppressed Iκbα degradation
Effects in cartilage/OA-induced rabbit:
Decreased cartilage damage by intra-articular injection treatment
Suppressed Mmp1, Mmp3 and Mmp13 gene
Enhanced Timp1 gene expression		[328]
Effects in IL-1β-induced rat chondrocytes:
Reduced the cytotoxicity induced by IL-1β
Inhibited chondrocyte apoptosis by enhancing Pi3k/Akt signalling pathway
Suppressed Casp-3 activation and reduced cytochrome c release
Increased Bcl-2 and decreased Bax expression
Inhibited Mmp13 mRNA and protein expression
Increased Timp1 mRNA and protein expression 		[329]
Sinomenine Sinomenium acutum
Alkaloids		Effects in IL-1β-treated rabbit cartilage explants:
Showed chondroprotective effects
Inhibited PG degradation
Suppressed Mmp3 gene and protein expression
Upregulated Timp1 mRNA and protein expression in a dose-dependent manner
Effects in IL-1β-induced chondrocytes:
Reduced DNA fragmentation
Inhibited Casp-3 activity and apoptotic chondrocytes in a dose-dependent manner		[330]
Effects in IL-1β-induced mice chondrocytes:
Inhibited inflammatory response and ECM degradation in a dose-dependent manner
Decreased Mmp-3, Mmp-13 and Adamts-5 levels
Upregulated Col2a1 and Acan synthesis
Inhibited NO, Pge2, Nos2, Cox-2, Il-6 and Tnf-α protein levels
Protected against OA progression via the activation of Nrf2/Ho-1 the signalling pathway and the inhibition of p-Nf-κb p65 nuclear translocation and activation, and inhibited Iκbα degradation
Effects in cartilage/OA-induced mouse:
Reduced OARSI scores and inhibited cartilage degradation		[331]
Sulforaphane Brassica oleracea italica
cruciferous vegetables
(abundant in broccoli)
Isothiocyanate		Effects in IL-1/OSM-induced bovine nasal cartilage explant/OA induced murine
Showed chondroprotective effects
Inhibited GAG and hydroxyproline release
Inhibited cartilage destruction		[241]
SFX-01®, a stable
synthetic form of
sulforaphane		Synthetic sulforaphane-
alpha-cyclodextrin inclusion complex		Effects in STR/Ort OA mice:
Led to greater symmetry in gait
Improved bone microarchitecture
Reduced osteoclast number and bone resorption
Enhanced trabecular bone mass in the metaphyseal compartment
Enhanced cortical bone mass
Decreased Ctx-I protein levels in serum
Increased procollagen type I NH2-terminal propeptide protein level in serum		[332]
Sulforaphane–
microsphere system		Sulforaphane-Poly (D, L-lactic-co-glycolic) acid (PLGA) microspheresEffects in cartilage/OA-induced rat:
Decreased cartilage degradation and OA
progression by intra-articular injection system
Decreased fibrillation, PG loss and OARSI score
Reduced synovial inflammation		[243]
Terpenoid compounds
(tuberatolide B, loliolide,
sargachromenol, sargachromanol D,
sargachromanol G, sargaquinoic acid, sargahydroquinoic acid, isoketochabrolic acid/IKCA,
isonahocol E3 and fucosterol)
Phlorotannins
Eicosapentaenoic acid EPA		Sargassum seaweed
(Terpenoids)
Polyphenols
Fatty acid		Effects in IL-1β-induced rat chondrocytes:
Demonstrated antioxidant activity
Inhibited Nos2 and Cox2 mRNA and protein expression
Decreased NO, Pge2 production
[245]
Triterperne concentrates (lupeol, α-amyrin, β-amyrin, butyrospermol)Vitellaria paradoxa nut
triterpenoids		Effects in plasma/knee cartilage/OA-induced
obese rat:
Reduced oxidative stress and suppressed proinflammatory cytokines
Enhanced enzymatic antioxidant activities
Reduced total cholesterol and increased high-density lipoprotein-cholesterol in blood plasma sample
Decreased Tnf-α, Il-1β, and Il-6 levels
Reduced malondialdehyde (lipid peroxidation) level and NO release in plasma
Attenuated cartilage damage and suppressed OA development
Reduced knee swelling, weight-bearing and pain		[333]
WogoninThe root extract of:
Scutellaria baicalensis
Flavone 		Effects in IL-1β-induced rabbit chondrocytes:
Showed chondroprotective effects
Inhibited Mmp3, Mmp1, Mmp13, and Adamts4 and restored Col2a1 gene expression
Inhibited Mmp3 protein synthesis and its caseinolytic activity
Effects in IL-1β-induced cartilage/OA-induced rats:
Inhibited Mmp3 production via intraarticular injection into the knee joint (dose 50 or 100 μM)		[334]
Effects in cartilage/OA-induced mice:
Demonstrated efficacy and safety as a transdermal cream treatment
Inhibited OA progression, and reduced OARSI and Mankin scores
Increased running wheel activity and decreased pain perception
Decreased biomarkers associated with cartilage degradation
Inhibited Tgf-β1, Htra1, Mmp-13 and Nf-κb protein expression		[335]
Table 3. Bioactive compounds as epigenetic modulators for the management, treatment, or prevention of OA in humans.
Table 3. Bioactive compounds as epigenetic modulators for the management, treatment, or prevention of OA in humans.
Bioactive CompoundsSources/ClassesEffects of Bioactive Compounds Ref.
Baicalin (Scutellaria baicalensis
Georgi)
Mainly extracted from
dry root
Flavone glycoside
(Flavonoid)		High lncRNA HOTAIR expression levels inhibited in OA chondrocytes
Reduction in p-PI3K and p-AKT protein levels
Increase in PTEN, APN and ADIPOR1 protein levels		[357]
Effects in IL-1β-induced OA chondrocytes:
Protected against ECM degradation and apoptosis
Restored autophagy activity via the upregulation of miR-766-3p
BAX and cleaved-caspase-3 expression suppression
Promoted BCL-2 protein expression and increased GAG content		[358]
Effects in IL-1β-induced OA chondrocytes:
Protected against inflammatory injury
Deactivated NF-κB signalling pathway by downregulation of miR-126 on IL-1β-stimulated cells
IL-6, IL-8 and TNF-α downregulation and decreased cell apoptosis		[359]
Cryptotanshinone(Salvia miltiorrhiza
Bunge)
Extracted from the root
of the plant
Diterpene quinones		Effects in chondrocytes:
Increased miR-106a-5p and PAX5 expression
miR-106a-5p was positively associated with PAX5 and negatively correlated with GLIS3 expression
Effects on tissues:
PAX5/miR-106a-5p/GLIS3 regulation protects against cartilage degradation		[360]
Epigallocatechin-3-gallate Camellia sinensis
Green tea
Flavan-3-ols (flavanols)		Effects in OA patients’ cartilage tissues and IL-1β-stimulated chondrocytes:
Increases viability and decreases miR-29b-3p, MMP-12 and IL-6 levels in cells
MiR-29b-3p mimics reversed the effects above 50 μM EGCG, and these effects were revoked by PTEN overexpression 		[361]
Effects in IL-1β-induced OA chondrocytes:
Inhibited inflammatory response via modulation of miRNAs expressions
Inhibited ADAMTS5 gene expression via upregulation of miR-140-3p
Decreased let-7e-5p, miR-103a-3p, miR-151a-5p, miR-195-5p, miR-222-3p, miR-23a-3p, miR-23b-3p, miR-26a-5p, miR-27a-3p, miR-29b-3p, miR-3195, miR-3651, miR-4281, miR-4459, miR-4516, miR-762, and miR-125b-5p
Upregulated let-7 family, miR-140-3p, miR-193a-3p, miR-199a-3p, miR-27b-3p, miR-29a-3p, miR-320b, miR-34a-5p, miR-3960, miR-4284, miR-4454, miR-497-5p, miR-5100, and miR-100-5p		[362]
Effects in OA chondrocytes:
Inhibited inflammatory response via miRNAs expression modulation
miR-199a-3p upregulation inhibited COX2 expression and PGE2 production 		[363]
FisetinPersimmons, mangos,
grapes, apples, peaches,
strawberries, peaches,
onions, tomatoes, and
cucumbers
Acacia greggii, Acacia berlandieri, Butea frondosa, Gleditsia triacanthos, Quebracho colorado
Flavonol		Effects in IL-1β-induced OA chondrocytes:
Showed anti-inflammatory effects through activating SIRT-1
Inhibited the degradation of SOX9, ACAN and COL2A1 mRNA and protein expression
Decreased NO, PGE2, IL-6, TNF-α production
Inhibited NOS2, COX2, MMP3, MMP13 and ADAMTS5 expression at the mRNA and protein levels 		[364]
Hydroxytyrosol (HT)Olea europea L.
fruits and leaves
Extra virgin olive oil
Secoiridoid derivative		Effects in C-28/I2 and primary OA chondrocytes:
Showed chondroprotective and antioxidant effects
Protected from DNA damage and cell death induced by oxidative stress
Increased P62 mRNA transcription and autophagy activation by SIRT1 pathways		[365]
Effects in OA chondrocytes:
Oxidative stress and DNA damage reduction
Prevented the increase in cell death and caspases activation
Decreased expression of pro-inflammatory genes (COX2, NOS2) and of genes involved in chondrocyte terminal differentiation (RUNX2, MMP13 and VEGF)
Increased SIRT1 mRNA expression in GROa-stimulated micromasses		[366]
Effects in C-28/I2 and OA chondrocytes:
Protected against oxidative stress and modulated through epigenetic mechanism
Reduced miR-9 levels (involved in oxidative stress and influenced OA-related gene expression) by enhancing SIRT-1
Reduced MMP13, VEGF and RUNX2 genes		[367]
Effects in C-28/I2 chondrocytes:
miR-9 promoters’ demethylation by SIRT1 silencing
miR-9 promoters’ hypomethylation in H2O2-treated cells and hypermethylation in cells treated with HT alone or together with H2O2 under oxidative stress conditions		[368]
Oleanolic acid Ligustri lucidi
extracted from fructus
pentacyclic triterpenoid 		Showed SIRT3 anti-inflammatory effect, preventing IL-1β-induced FLS dysfunction in vitro
SIRT3 activation inhibited synovial inflammation by NF-κB signal pathway suppression in FLS		[369]
Effects in IL-1β-induced chondrocytes:
Alleviated chondrocytes’ growth inhibition and the cell membrane and DNA damage
Protective effects induced by activating miR-148-3p-mediated FGF2
Showed antiapoptotic effect by the inhibition of FGF2		[370]
Quercetin(Achyranthes bidentata)
(Ageratum conyzoides)
flowers, leaves, and fruits of plants such as
Chrysanthemum
psyllium, Eleutherococcus senticosus, Juglans regia L.
onions, apples, broccoli, berry crops, grapes, dark cherries, and green vegetables
Flavonol
(Flavonoid)		Role of BMSC-derived exosomes both in vitro and in vivo (OA patients)
Conditioned medium of quercetin-treated BMSCs was able to revert IL-1β effects in chondrocytes (decreased MMP13 and ADAMT5, and increased COL2A1 expression)
OA progression inhibition through miR-124-3p upregulation 		[371]
ResveratrolRoot extracts of the
weed: Polylygonum cuspidatum
Vitis vinifera
Red grapes, blueberries
cranberries, peanuts
Stilbenes (polyphenols)		In vitro studies in IL-1β-treated chondrocytes:
Resveratrol increased SIRT1 expression and FoxO1 phosphorylation, promoting the expression of cholesterol efflux factor liver X receptor alpha, and inhibiting the expression of cholesterol synthesis-associated factor sterol-regulatory element binding proteins 2, reducing cholesterol accumulation
In vivo experiments showed that RES can alleviate cholesterol build-up and pathological changes in OA cartilage via the SIRT1/FoxO1 pathway		[372]
Bioinformatics methods allowed us to identify 1016 differentially expressed lncRNAs (493 downregulated) between control and resveratrol-treated chondrocytes[373]
Effects in OA chondrocytes:
Increased SIRT1 mRNA and protein expression
SIRT-1 regulated apoptosis and ECM degradation via the WNT/β-catenin signalling pathway
Decreased BAX, proCASP-3 and proCASP-9, MMP-1, MMP-3, MMP-13, WNT3A, WNT5A, WNT7A, and CTNNB1 protein expression		[374]
Effects in IL-1β-induced chondrocytes:
Prevented OA progression by increase in SIRT1 and silencing NF-κB p65 and HIF-2α
Decreased NOS2 and MMP13 and reestablished COL2A1 and ACAN gene expression 		[49]
Effects in OA osteoblasts/subchondral bone tissue:
Reduced ALP activity at a high dose
Upregulated SIRT-1 activity and reduced the expression of leptin
Increased the mineralization
Increased the phosphorylation of ERK1/2 and WNT/β-catenin signalling		[375]
Table 4. Bioactive compounds as epigenetic modulators for the management, treatment, or prevention of OA in animals.
Table 4. Bioactive compounds as epigenetic modulators for the management, treatment, or prevention of OA in animals.
Bioactive CompoundsSources/ClassesEffects of Bioactive CompoundsRef.
Cryptotanshinone(Salvia miltiorrhiza
Bunge)
Extracted from the root
of the plant
Diterpene quinones		Effects in OA mouse model:
Affects chondrocyte apoptosis by regulating miR-574-5p expression and then interfering with YAF2
Regulates miR-574-5p promoter methylation		[376]
Curcuminoids:

Curcumin
Demethoxycurcumin,
Bisdemethoxycurcumin		(Curcuma longa)
(Curcuma domestica)
Turmeric rhizome
Diarylheptanoids
(Phenolic compounds)		Effects in knee OA rat model:
Protective effect against quadriceps femoris atrophy and improves knee OA
ROS-induced autophagy decreases via the SIRT3-SOD2 pathway		[377]
Effects in TBHP-treated rat chondrocytes:
Protected from oxidative stress-induced apoptosis
Suppressed ER stress biomarkers Perk-Eif2a-Atf4-Chop pathway via activation of the mRNA and Sirt1 protein expression
Increased Col2a1 and Bcl2 gene expression and downregulated cleaved-Casp-3 and cleaved-Parp (proapoptotic proteins) levels
Effects in cartilage/OA-induced rat:
Demonstrated therapeutic efficacy (treatment: 50 mg/Kg and 150 mg/Kg once daily for 8 weeks by intraperitoneal injection)
Attenuated knee joint degradation and inhibited OA progression
Reduced cleaved-Casp-3 and Chop levels
Activated Sirt1 expression and decreased chondrocyte apoptosis and ER stress
Ameliorated chondrocytes and PG loss
Decreased OARSI score in a dose-dependent manner		[378]
Effects in IL-1β-induced primary chondrocytes/OA-induced mice:
Attenuated OA progression and decreased apoptosis by exosomes derived from curcumin-treated mesenchymal stem cells
Upregulated miR-143 and miR-124 expression by hypomethylation of their promoters
Inhibited Nfkb, Rock1 and Tlr9 mRNA and protein expression 		[379]
FisetinPersimmons, mangos,
grapes, apples, peaches,
strawberries, peaches,
onions, tomatoes, and
cucumbers
Acacia greggii, Acacia berlandieri, Butea frondosa, Gleditsia triacanthos, Quebracho colorado
Flavonol		Effects on DMM rats and IL-1β-treated chondrocytes:
FST can activate SIRT6
Positive effects against inflammation, ECM degradation, apoptosis, and senescence in IL-1β-stimulated chondrocytes
In chondrocytes, FST reduces injury-induced aging-related phenotype changes via SIRT6 targeting		[380]
Effects in cartilage/subchondral bone/synovium/
OA-induced mice models
Exhibited less cartilage destruction and attenuated OA progression
Decreased OARSI score
Reduced subchondral bone plate thickness
Alleviated synovitis 		[364]
Hydroxytyrosol (HT)Olea europea L.
fruits and leaves
Extra virgin oil
Secoiridoid derivative		Effects in TNF-α-induced rat chondrocytes:
Showed anti-inflammatory activity
Inhibited Il-1β, Il-6 and Mcp-1 proteins by upregulating Sirt6 mRNA and protein levels
Promoted autophagy process through Sirt6		[381]
Quercetin (Achyranthes bidentata)
(Ageratum conyzoides)
flowers, leaves, and
fruits of plants such as
Chrysanthemum psyllium,
Eleutherococcus senticosus, Juglans regia L.
Onions, apples, broccoli, berry crops, grapes, dark cherries, and green vegetables
Flavonol
(Flavonoid)		Inhibited the expression of IL-1β-induced MMP-3, MMP13, iNOS and COX-2, and promoted COL type II expression in vitro. This effect is mediated by SIRT1/Nrf-2/HO-1 activation and ferroptosis inhibition
[382]
In an ACLT-OA rat model, QUE treatment improved articular function (cartilage damage, joint pain, and subchondral bone remodelling).
QUE also reduced serum IL-1β, TNF-α, MMP3, CTX-II, and COMP, thereby slowing the progression of OA		[383]
Effects in chondrocytes/OA-induced rat:
Chondroprotective and antioxidant properties
Inhibited oxidative and endoplasmic reticulum stress, and chondrocyte apoptosis by activating Sirt-1 and Ampk signalling pathway
Downregulated Chop, Grp78, P-perk, P-ire1α, Atf6 (ERstress biomarkers), cleaved-Casp-3 and cleaved-Parp (apoptosis biomarkers) levels
Upregulated Bcl-2 protein expression levels
Attenuated cartilage degradation of knee joint (dose: intraperitoneal injection of 50–100 mg/Kg once daily, 12 weeks)		[384]
Effects in rat OA chondrocytes:
Upregulated Ampk/Sirt-1 signalling pathway
Effects on cartilage/blood/OA-induced rat:
Inhibited inflammation, mitochondrial dysfunction and ROS (100 mg/Kg oral treatment/daily, 7 days)
Increased ATP, GSH and GPx levels
Inhibited nitrite, Mmp-3 and Mmp-13 levels in blood samples
ResveratrolRoot extracts of the
weed: Polylygonum cuspidatum
Vitis vinifera
Red grapes, blueberries
cranberries, peanuts
Stilbenes (polyphenols)		ECM metabolism, autophagy, and apoptosis regulation of OA chondrocytes via SIRT1/FOXO1 pathway to improve IL-1β-induced chondrocyte damage[385]
Effects in OA cartilage/OA-induced mice:
Prevented OA cartilage destruction and improved cartilage structure (dose: 100 µg) by intraarticular injection
Increased Sirt-1 expression and reduced Nf-κb p65 and Hif-2α
Reduced subchondral bone plate thickness and prevented calcified cartilage damage
Decreased Nos2 and Mmp-13 and inhibited Col2a1 degradation and PG loss 		[49]
Effects in chondrocytes/cartilage/OA-induced mice:
Promoted chondroprotective effects by intra-articular injection chondrocyte and increased the growth rate of chondrocyte
Reduction in Il-6, Mmp-13 and Casp-3 protein expression levels
Increased miR-9 expression levels
Decreased Malat1 and Nfkb1 gene and protein expression
Malat1 and Nfκb1 were identified as potential target genes of miR-9		[386]
Effects in IL-1β-induced rat chondrocytes:
Exerted anti-inflammatory properties and inhibited Nf-κb signalling pathway by activating Sirt-1
Suppressed Nos2 expression and NO production
Decreased DNA-binding activity of p65 by upregulation of Sirt-1
Inhibited Lys310-acetylated p65 accumulation in the nucleus 		[387]
Saikosaponin DRadix bupleri
Triterpene saponin		In vivo, SSD decreased cartilage damage and inflammatory factors and induced autophagy in OA mice
MiR-199-3p expression was downregulated and transcription factor-4 expression was upregulated in cartilage
In vitro experiments showed that SSD decreased the inflammation and induced autophagy in OA chondrocytes
MiR-199-3p downregulation attenuated the SSD effect on OA chondrocytes		[388]
Sinomenine Sinomenium acutum
Alkaloids 		Effects on cartilage/OA mice:
Inhibited cartilage damage by miR-223-3p upregulation via inactivation of the inflammasome signalling
Nlrp3 was a direct target of miR-223-3p
Blocked inflammatory markers (Tnf-α, Il-1β, Il-6, and Il-18)
Effects in chondrocytes:
MiR-223-3p overexpression inhibited both IL-1β-induced apoptosis and Il-1β and Il-18 levels		[389]
TXC compound:
Paeoniflorin
Ferulic acid
Isofraxidin
Rosmarinic acid		Dried roots of:
(Paeonia lactiflora Pall, Morindae officinalis
Ligusticum wallichii
Sarcandra glabra)
Monoterpene glycosides
Hydroxycinnamic acid
Coumarin
Hydroxycinnamic acid		Effects in knee OA cartilage/subchondral bone/OA-induced rats:
Showed therapeutic effects in cartilage protection and subchondral bone remodelling
Downregulated Mmp9, Adamts5, Col5a1, Col1a1, Mmp3, Mmp13, and Postn gene and protein expression
Effects in LPS-exposed rat chondrocytes:
Decreased Il-1β, Il-6, Tnf-α, Mmp-9 and p38 MAPK pathway in LPS-exposed chondrocytes
Increased miR-27b, miR-140, and miR-92a-3p and decreased miR-34a expression
Suppressed Adamts4, Adamts5, Mmp3, and Mmp13 mRNA and protein expression 		[390]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Villagrán-Andrade, K.M.; Núñez-Carro, C.; Blanco, F.J.; de Andrés, M.C. Nutritional Epigenomics: Bioactive Dietary Compounds in the Epigenetic Regulation of Osteoarthritis. Pharmaceuticals 2024, 17, 1148. https://doi.org/10.3390/ph17091148

AMA Style

Villagrán-Andrade KM, Núñez-Carro C, Blanco FJ, de Andrés MC. Nutritional Epigenomics: Bioactive Dietary Compounds in the Epigenetic Regulation of Osteoarthritis. Pharmaceuticals. 2024; 17(9):1148. https://doi.org/10.3390/ph17091148

Chicago/Turabian Style

Villagrán-Andrade, Karla Mariuxi, Carmen Núñez-Carro, Francisco J. Blanco, and María C. de Andrés. 2024. "Nutritional Epigenomics: Bioactive Dietary Compounds in the Epigenetic Regulation of Osteoarthritis" Pharmaceuticals 17, no. 9: 1148. https://doi.org/10.3390/ph17091148

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop